Substituted thiophenecarboxamides and their derivatives as microbicides

By developing compositions containing compounds of formula (I), multiple challenges of existing microbialicides in crop protection have been solved, effective prevention and treatment of plant pathogenic microorganisms have been achieved, safety and selectivity have been improved, and drug resistance has been delayed The appearance of

CN115087650BActive Publication Date: 2024-12-06BAYER AG
View PDF 46 Cites 0 Cited by

Patent Information

Application Number
CN202080096172.7
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2019-12-20
Filing Date
2020-12-17
Publication Date
2024-12-06
Estimated Expiration
2040-12-17

AI Technical Summary

Technical Problem

When facing the environmental and economic requirements of modern crop protectors and compositions, existing microbialicides have problems such as scope of action, safety, selectivity, application rate, residue formation and drug resistance, and lack new compounds. to meet these challenges.

Method used

Develop a composition comprising a compound of formula (I) for the control of plant pathogenic microorganisms by applying a compound of formula (I) or a composition thereof to plants, plant sites, seeds or soil to achieve bactericidal and fungicidal effect. The structure of the compound of formula (I) includes specific alkyl groups, alkoxy groups, alkylthio groups and other groups, which can be combined with suitable carriers in agriculture to form an effective method of preventing and controlling plant diseases.

Benefits of technology

While improving the bactericidal and fungicidal effects, the composition reduces the harm to the environment, delays the emergence of drug resistance, meets the multiple requirements of modern crop protectors, and provides better application rate and safety.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure FDA0004905078670000011
    Figure FDA0004905078670000011
  • Figure GDA0004905078680000061
    Figure GDA0004905078680000061
  • Figure GDA0004905078680000151
    Figure GDA0004905078680000151
Patent Text Reader

Abstract

The present invention relates to substituted thiophenecarboxamide derivatives, their use for controlling plant pathogenic microorganisms and compositions containing the same.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to substituted thiophenecarboxamide derivatives, their use for controlling plant pathogenic microorganisms and compositions containing the same. Background Art

[0002] Although many microbicides have been developed so far, there is still a need to develop new microbicidal compounds to address the ever-increasing environmental and economic requirements for modern crop protection agents and compositions. This includes, for example, improving the scope of action, safety, selectivity, application rate, formation of residues and good preparation capabilities. It may also be necessary to have new compounds to prevent the emergence of drug resistance.

[0003] The present invention provides novel compounds that are superior to known compounds and compositions in at least some of these respects.

[0004] EP 0 450 355 discloses thiophenecarboxamide derivatives which can be used for protecting plants from attack by plant-destroying microorganisms.

[0005] WO 2004 / 024692 discloses heterocyclic carboxylic acid derivatives and their use as fungicides and bactericides for protecting plants or materials, such as wood. Summary of the invention

[0006] The present invention relates to compounds of formula (I) as described herein as well as isomers, polymorphs, salts, N-oxides and solvates thereof.

[0007] The present invention relates to a composition comprising at least one compound of formula (I) or as defined herein and at least one agriculturally suitable carrier.

[0008] The present invention relates to processes for the preparation of compounds of formula (I) and intermediates thereof as described herein.

[0009] The present invention relates to a method for controlling phytopathogenic microorganisms, which method comprises the step of applying at least one compound of formula (I) as defined herein or a composition as defined herein to plants, plant parts, seeds, fruits or soil in which the plants grow.

[0010] definition

[0011] The term "alkyl" as used herein in the context of alkyl or alkylsulfonyl, alkylsulfinyl, alkylthio, alkylamino, for example, is to be understood as preferably meaning branched and unbranched alkyl groups, meaning for example methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, tert-butyl, sec-butyl, pentyl, isopentyl, hexyl, heptyl, octyl, nonyl and decyl and isomers thereof.

[0012] As used herein, the term "alkenyl" is to be understood as preferably meaning branched and unbranched alkenyl groups, for example ethenyl, propen-1-yl, propen-2-yl, but-1-en-1-yl, but-1-en-2-yl, but-2-en-1-yl, but-2-en-2-yl, but-1-en-3-yl, 2-methyl-prop-2-en-1-yl or 2-methyl-prop-1-en-1-yl groups.

[0013] As used herein, the term "alkynyl" is to be understood as preferably meaning branched and unbranched alkynyl groups, such as ethynyl, prop-1-yn-1-yl, but-1-yn-1-yl, but-2-yn-1-yl or but-3-yn-1-yl groups.

[0014] As used herein, the term "halogen" or "Hal" shall be understood to mean fluorine, chlorine, bromine or iodine.

[0015] The term "halo" or "halogeno" (e.g., haloalkyl, "C 1 -C 6 -haloalkyl" or "C 1 -C 8 -haloalkyl”) means that one or more halogen substituents which may be the same or different are optionally present.

[0016] As used herein, the term "haloalkyl" is understood to preferably mean branched and unbranched alkyl as defined above, wherein one or more hydrogen substituents are replaced by halogen in the same or different manner. Particularly preferably, the haloalkyl is, for example, chloromethyl, fluoropropyl, fluoromethyl, difluoromethyl, trichloromethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, bromobutyl, trifluoromethyl, iodoethyl and isomers thereof.

[0017] As used herein, the term "haloalkenyl" is understood to denote preferably branched and unbranched alkenyl groups as defined above, wherein one or more hydrogen substituents are replaced in the same or different manner by halogen.

[0018] As used herein, the term "haloalkynyl" is to be understood as preferably denotes branched and unbranched alkynyl groups as defined above, wherein one or more hydrogen substituents are replaced in the same or different manner by halogen.

[0019] As used herein, the term "alkoxy" refers to a group of the formula (alkyl)-O-, wherein the term "alkyl" is as defined herein. 1 -C 8Examples of -alkoxy groups include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-methylethoxy, n-butoxy, 1-methylpropoxy, 2-methylpropoxy, 1,1-dimethylethoxy, n-pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, n-hexyloxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy, and 1-ethyl-2-methylpropoxy.

[0020] As used herein, the term "haloalkoxy" refers to an alkoxy group as defined above wherein one or more hydrogen atoms are replaced by one or more halogen atoms which may be the same or different. 1 -C 8 Examples of -haloalkoxy include, but are not limited to, chloromethoxy, bromomethoxy, dichloromethoxy, trichloromethoxy, fluoromethoxy, difluoromethoxy, trifluoromethoxy, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 1-chloroethoxy, 1-bromoethoxy, 1-fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy, pentafluoroethoxy, and 1,1,1-trifluoropropane-2-oxy.

[0021] As used herein, the term "alkylthio" refers to a saturated straight or branched chain group of the formula (alkyl)-S-, wherein the term "alkyl" is as defined herein. 1 -C 8 Examples of -alkylthio include, but are not limited to, methylthio, ethylthio, propylthio, isopropylthio, butylthio, sec-butylthio, isobutylthio, tert-butylthio, pentylthio, isopentylthio, hexylthio.

[0022] As used herein, the term "haloalkylthio" refers to an alkylthio group as defined above wherein one or more hydrogen atoms are replaced by one or more halogen atoms which may be the same or different.

[0023] As used herein, the term "alkylsulfinyl" refers to a saturated straight or branched chain group of the formula (alkyl)-S(=O)-, wherein the term "alkyl" is as defined herein. 1 -C 8Examples of the alkylsulfinyl group include, but are not limited to, saturated straight or branched chain alkylsulfinyl groups having 1 to 8, preferably 1 to 6, and more preferably 1 to 4 carbon atoms, such as, but not limited to, methylsulfinyl, ethylsulfinyl, propylsulfinyl, 1-methylethylsulfinyl, butylsulfinyl, 1-methylpropylsulfinyl, 2-methylpropylsulfinyl, 1,1-dimethylethylsulfinyl, pentylsulfinyl, 1-methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methylbutylsulfinyl, 2,2-dimethylpropylsulfinyl, 1-ethylpropylsulfinyl, 1,1-dimethylpropylsulfinyl, 1,2-dimethylpropylsulfinyl. sulfonyl, hexylsulfinyl, 1-methylpentylsulfinyl, 2-methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl, 1,1-dimethylbutylsulfinyl, 1,2-dimethylbutylsulfinyl, 1,3-dimethylbutylsulfinyl, 2,2-dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl, 1-ethylbutylsulfinyl, 2-ethylbutylsulfinyl, 1,1,2-trimethylpropylsulfinyl, 1,2,2-trimethylpropylsulfinyl, 1-ethyl-1-methylpropylsulfinyl and 1-ethyl-2-methylpropylsulfinyl.

[0024] As used herein, the term "haloalkylsulfinyl" refers to an alkylsulfinyl group as defined above wherein one or more hydrogen atoms are replaced by one or more halogen atoms which may be the same or different.

[0025] As used herein, the term "alkylsulfonyl" refers to a radical of the formula (alkyl)-S(=O) 2 - a saturated straight or branched chain group, wherein the term "alkyl" is as defined herein. 1 -C 8Examples of alkylsulfonyl groups include, but are not limited to, methylsulfonyl, ethylsulfonyl, propylsulfonyl, 1-methylethylsulfonyl, butylsulfonyl, 1-methylpropylsulfonyl, 2-methylpropylsulfonyl, 1,1-dimethylethylsulfonyl, pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 2,2-dimethylpropylsulfonyl, 1-ethylpropylsulfonyl, 1,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, hexylsulfonyl, 1-methylpentylsulfonyl, 2- methylpentylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1,1-dimethylbutylsulfonyl, 1,2-dimethylbutylsulfonyl, 1,3-dimethylbutylsulfonyl, 2,2-dimethylbutylsulfonyl, 2,3-dimethylbutylsulfonyl, 3,3-dimethylbutylsulfonyl, 1-ethylbutylsulfonyl, 2-ethylbutylsulfonyl, 1,1,2-trimethylpropylsulfonyl, 1,2,2-trimethylpropylsulfonyl, 1-ethyl-1-methylpropylsulfonyl and 1-ethyl-2-methylpropylsulfonyl.

[0026] As used herein, the term "haloalkylsulfonyl" refers to a C 1 -C 8 -alkylsulfonyl radicals in which one or more hydrogen atoms are replaced by one or more halogen atoms which may be the same or different.

[0027] As used herein, the term "alkylcarbonyl" refers to a saturated straight or branched chain group of the formula (alkyl)-C(=O)-, wherein the term "alkyl" is as defined herein.

[0028] As used herein, the term "haloalkylcarbonyl" refers to an alkylcarbonyl group as defined above wherein one or more hydrogen atoms are replaced by one or more halogen atoms which may be the same or different.

[0029] As used herein, the term "alkoxycarbonyl" refers to a saturated straight or branched chain group of the formula (alkoxy)-C(=O)-, wherein the term "alkoxy" is as defined herein.

[0030] As used herein, the term "haloalkoxycarbonyl" refers to an alkoxycarbonyl group as defined above wherein one or more hydrogen atoms are replaced by one or more halogen atoms which may be the same or different.

[0031] As used herein, the term "cycloalkyl" refers to a non-aromatic monocyclic carbon-containing ring having 3 to 8 carbon atoms. Examples of saturated cycloalkyl include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl and cyclodecyl.

[0032] As used herein, the term "heterocyclyl" refers to a four-, five- or six-membered saturated or partially unsaturated heterocyclic ring containing one to four heteroatoms independently selected from oxygen, nitrogen and sulfur. If the ring contains more than one oxygen atom, they are not directly adjacent.

[0033] As used herein, the term "aryl" refers to an aromatic hydrocarbon ring system containing 6 to 15 carbon atoms, or 6 to 12 carbon atoms, preferably 6 to 10 carbon atoms. The ring system can be a monocyclic or fused polycyclic (e.g., bicyclic or tricyclic) aromatic ring system. Examples of aryl include, but are not limited to, phenyl, azulenyl, naphthyl, and fluorenyl. It should also be understood that when the aryl is substituted with one or more substituents, the substituents may be located at any position on the aromatic ring. In particular, in the case where the aryl is a phenyl group, the substituents may occupy one or two ortho positions, one or two meta positions, or para positions, or any combination of these positions. This definition also applies to aryl groups that are part of a composite substituent (e.g., aryloxy).

[0034] As used herein, the term "aralkyl" refers to a C substituted with an aryl group as defined herein. 1 -C 6 -alkyl. Examples of aralkyl groups include benzyl (-CH 2 -C 6 H 5 ).

[0035] As used herein, the term "aromatic 5- to 14-membered heterocycle" or "heteroaryl" refers to an aromatic ring system containing 1 to 4 heteroatoms independently selected from oxygen, nitrogen and sulfur. Aromatic heterocycles include aromatic 5- or 6-membered monocyclic heterocycles and 6- to 14-membered polycyclic (e.g., bicyclic or tricyclic) aromatic heterocycles. The 5- to 14-membered aromatic heterocycle can be attached to the parent molecular moiety through any carbon atom or nitrogen atom contained within the heterocycle.

[0036] As used herein, the term “C 1 -C 6 ”, for example in “C 1 -C 6 -alkyl" or "C 1 -C 6 In the context of the definition of "-alkoxy", it is understood to mean a group having a finite number of carbon atoms of 1 to 6, i.e. 1, 2, 3, 4, 5 or 6 carbon atoms.

[0037] As used herein, the term “C 1 -C 8 ”, for example in “C 1 -C 8 -alkyl" or "C 1 -C 8In the context of the definition of "-alkoxy", it is understood to mean a radical having a limited number of carbon atoms of 1 to 8, i.e. 1, 2, 3, 4, 5, 6, 7 or 8 carbon atoms.

[0038] As used herein, the term "oxy" refers to an oxygen atom bound to a carbon atom or a sulfur atom through a double bond.

[0039] As used herein, the term "leaving group" is understood to mean a group that is displaced from a compound in a substitution or elimination reaction, such as a halogen atom, a triflate group, an alkoxy group, a mesylate, a p-toluenesulfonate, and the like. DETAILED DESCRIPTION

[0040] The present invention relates to compounds of formula (I):

[0041]

[0042] in

[0043] R 1 and R 2 Same, it is chlorine or bromine;

[0044] R 3 It is methyl;

[0045] R 4 and R 5 are independently selected from hydrogen, halogen, cyano, hydroxyl, C 1 -C 6 -alkyl, C 1 -C 6 -Hydroxyalkyl, C 1 -C 6 -alkoxy, C 1 -C 6 Haloalkyl, -OC(=O)-C 1 -C 6 -alkyl, C 3 -C 6 -Carbocyclic ring, 4-, 5- or 6-membered non-aromatic heterocyclic ring, -C(=O)-NH 2 、-C(=O)-NH(C 1 -C 6 -alkyl), -C(=O)-N(C 1 -C 6 -alkyl) 2 , -C(=O)-OH, -C(=O)-OC 1 -C 6 -alkyl, aryl, 5- to 9-membered heteroaryl, -C 1 -C 6 -alkyl-C 1 -C6 -alkoxy, -C 1 -C 6 Alkyl-C 1 -C 6 -haloalkyl, -C 1 -C 6 -alkyl-C 3 -C 6 -Carbon ring, -C 1 -C 6 -alkyl-4, 5 or 6-membered non-aromatic heterocyclic group, -C 1 -C 6 -alkyl-aryl, -C 1 -C 6 -alkyl-hydroxyaryl, -C 1 -C 6 -alkyl-5 to 9-membered heteroaryl, -C 1 -C 6 -Alkyl-SC 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-SC(=O)-C 1 -C 6 -alkyl, -C 1 -C 6 Alkyl-O-(C=O)-C 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-C(=O)-NH 2 , -C 1 -C 6 -alkyl-C(=O)-NH(C 1 -C 6 -alkyl), -C 1 -C 6 -alkyl-C(=O)-N(C 1 -C 6 -alkyl) 2 , -C 1 -C 6 -alkyl-C(=O)-OH, -C 1 -C 6 -alkyl-C(=O)-OC 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-NH-C(=NH)-NH 2 , -SC 1 -C 6 -alkyl, -SC(=O)-C 1 -C6 -alkyl, -SC(=O)-OC 1 -C 6 -alkyl, -SC(=S)-OC 1 -C 6 -alkyl, -SC(=O)-SC 1 -C 6 -alkyl, -SC(=O)-NH 2 ,-SC(=O)-NH(C 1 -C 6 -alkyl), -SC(=O)-NH(C 1 -C 6 -alkyl) 2 ,-SC(=S)-NH 2 ,-SC(=S)-NH(C 1 -C 6 -alkyl), -SC(=S)-NH(C 1 -C 6 -alkyl) 2 , -C 1 -C 6 -alkyl-SC(=O)-OC 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-SC(=O)-SC 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-SC(=O)-NH 2 , -C 1 -C 6 -alkyl-SC(=O)-NH(C 1 -C 6 -alkyl), -C 1 -C 6 -alkyl-SC(=O)-NH(C 1 -C 6 -alkyl) 2 , -C 1 -C 6 -alkyl-SC(=S)-NH 2 , -C 1 -C 6 -alkyl-SC(=S)-NH(C 1 -C 6 -alkyl), -C 1 -C 6 -alkyl-SC(=S)-NH(C 1 -C 6alkyl) 2 , where the non-cyclic R 4 , R 5 The group may be one or more R w Substituent substitution, cyclic R 4 , R 5 The group may be one or more R x Substituent substitution, where R 4 and R 5 At least one is hydrogen, C 1 -C 6 -alkyl or C 3 -C 6 -Carbocyclic, or R 4 and R 5 Together with the carbon atom to which they are attached, they form carbonyl, thiocarbonyl, C 3 -C 6 - carbocyclic or 3 to 6-membered heterocyclic ring, wherein the C 3 -C 6 -Carbocyclic and 3- to 6-membered heterocyclic rings may be replaced by one or more R x Substituent substitution, where R w Independently selected from the following groups: nitro, hydroxyl, cyano, carboxyl, amino, sulfanyl, pentafluoro-λ 6 -sulfanyl, formyl, carbamoyl, carbamate, C 3 -C 7 -cycloalkyl, C having 1 to 5 halogen atoms 3 -C 7 -halogenated cycloalkyl, C 1 -C 8 -Alkylamino, di-C 1 -C 8 -Alkylamino, C 1 -C 8 -alkoxy, C having 1 to 5 halogen atoms 1 -C 8 -haloalkoxy, C 1 -C 8 -alkylsulfanyl, C 1 -C 8 Halogenated alkylsulfanyl, C 1 -C 8 -alkylcarbonyl, C 1 -C 8 Haloalkylcarbonyl, C 1 -C 8 -alkylcarbamoyl, di-C 1 -C 8 Alkylcarbamoyl, C 1 -C 8-alkoxycarbonyl, C having 1 to 5 halogen atoms 1 -C 8 -haloalkoxycarbonyl, C 1 -C 8 -alkylcarbonyloxy, C 1 -C 8 -haloalkylcarbonyloxy, C 1 -C 8 -alkylcarbonylamino, C 1 -C 8 -haloalkylcarbonylamino, C 1 -C 8 -alkylsulfinyl, C 1 -C 8 -haloalkylsulfinyl, C 1 -C 8 -alkylsulfonyl, C having 1 to 5 halogen atoms 1 -C 8 -haloalkylsulfonyl; C 1 -C 8 -alkylsulfonylamino, C having 1 to 5 halogen atoms 1 -C 8 -haloalkylsulfonylamino; sulfamoyl; C 1 -C 8 -alkylsulfonamide and di-C 1 -C 8 -alkylsulfamoyl; wherein R x Independently selected from the following groups: halogen, nitro, hydroxyl, cyano, carboxyl, amino, sulfanyl, pentafluoro-λ 6 -sulfanyl, formyl, carbamoyl, carbamate, C 1 -C 8 -alkyl, C 3 -C 7 -cycloalkyl, C having 1 to 5 halogen atoms 1 -C 8 Haloalkyl, C 3 -C 7 -halogenated cycloalkyl, C 2 -C 8 -Alkenyl, C 2 -C 8 -Alkynyl, C 1 -C 8 -Alkylamino, di-C 1 -C 8 -Alkylamino, C 1 -C 8 -alkoxy, C having 1 to 5 halogen atoms1 -C 8 -haloalkoxy, C 1 -C 8 -alkylsulfanyl, C 1 -C 8 Halogenated alkylsulfanyl, C 1 -C 8 -alkylcarbonyl, C 1 -C 8 Haloalkylcarbonyl, C 1 -C 8 -alkylcarbamoyl, di-C 1 -C 8 Alkylcarbamoyl, C 1 -C 8 -alkoxycarbonyl, C having 1 to 5 halogen atoms 1 -C 8 -haloalkoxycarbonyl, C 1 -C 8 -alkylcarbonyloxy, C 1 -C 8 -haloalkylcarbonyloxy, C 1 -C 8 -alkylcarbonylamino, C 1 -C 8 -haloalkylcarbonylamino, C 1 -C 8 -alkylsulfanyl, C 1 -C 8 -halogenated alkylsulfanyl, C 1 -C 8 -alkylsulfinyl, C 1 -C 8 -haloalkylsulfinyl, C 1 -C 8 -alkylsulfonyl, C having 1 to 5 halogen atoms 1 -C 8 -haloalkylsulfonyl; C 1 -C 8 -alkylsulfonylamino, C having 1 to 5 halogen atoms 1 -C 8 -haloalkylsulfonylamino; sulfamoyl; C 1 -C 8 -alkylsulfonamide and di-C 1 -C 8 -Alkylsulfamoyl;

[0046] R 6and R 7 are independently selected from hydrogen, C 1 -C 6 -alkyl, C 3 -C 6 -Carbocyclic ring; or R 6 and R 7 Together with the carbon atom to which they are attached, they form C 3 -C 6 -Carbocyclic or 3- to 6-membered heterocyclic ring;

[0047] n is 0 or 1;

[0048] W is oxygen or sulfur;

[0049] Y is NR 8 , R 8 It is hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -Cyanoalkyl, hydroxyl, C 1 -C 6 -alkoxy or C 3 -C 6 -Carbon ring;

[0050] Z is selected from cyano, -C(=O)-OR a , -C(=O)-SR a 、-C(=O)-NR b R c 、-C(=S)-NR b R c or -C(=O)-NH-CR d R e -C(=O)-OR a , where R a Selected from hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -Cyanoalkyl, C 2 -C 6 -Alkenyl, C 2 -C 6 -Alkynyl, C 3 -C 8 Cycloalkyl, aryl, aralkyl, 4, 5 or 6 membered non-aromatic heterocyclic group, -C 1 -C 6 -Alkyl-Si(C 1 -C 6 -alkyl)3 , -C 1 -C 6 -alkyl-C 3 -C 8 -cycloalkyl, 5- to 9-membered heteroaryl, and -C 1 -C 6 -alkyl-5 to 9-membered heteroaryl, or R a Can be used with R 4 Together with the atoms to which they are attached, they form a 4- to 7-membered heterocyclic ring, R b and R c are independently selected from hydrogen, C 1 -C 6 -alkyl, hydroxyl, C 1 -C 6 -alkoxy, cyano, C 1 -C 6 - cyanoalkyl, or R b Can be used with R 4 Together with the atoms to which they are attached, they form a 4- to 7-membered heterocyclic ring, R d and R e are independently selected from hydrogen, cyano, hydroxyl, C 1 -C 6 -alkyl, C 1 -C 6 -Hydroxyalkyl, C 1 -C 6 -alkoxy, -OC(=O)-C 1 -C 6 -alkyl, C 3 -C 6 -Carbocycle, -C(=O)-NH 2 、-C(=O)-NH(C 1 -C 6 -alkyl), -C(=O)-N(C 1 -C 6 -alkyl) 2 , -C(=O)OH, -C(=O)-OC 1 -C 6 -alkyl, aryl, 5- to 9-membered heteroaryl, -C 1 -C 6 -alkyl-C 1 -C 6 -alkoxy, -C 1 -C 6 -alkyl-C 3 -C 6 -Carbon ring, -C 1 -C 6 -alkyl-aryl, -C 1 -C 6 -alkyl-hydroxyaryl, -C1 -C 6 -alkyl-5 to 9-membered heteroaryl, -C 1 -C 6 -Alkyl-SC 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-SC(=O)-C 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-O-(C=O)-C 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-C(=O)-NH 2 , -C 1 -C 6 -alkyl-C(=O)-NH(C 1 -C 6 -alkyl), -C 1 -C 6 -alkyl-C(=O)-N(C 1 -C 6 -alkyl) 2 , -C 1 -C 6 -alkyl-C(=O)-OH, -C 1 -C 6 -alkyl-C(=O)-OC 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-NH-C(=NH)-NH 2 , where R d and R e At least one is hydrogen, C 1 -C 6 -alkyl or C 3 -C 6 Carbon ring, or R d and R e Together with the carbon atom to which they are attached, they form a carbonyl group, C 3 -C 6 - a carbocyclic or 3- to 6-membered heterocyclic group;

[0051] Where W is oxygen, Y is NH, n=0, R 4 Selected from hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -alkyl-aryl, C 1 -C6 -alkylhydroxyaryl, -C 1 -C 6 -Alkyl-SC 1 -C 6 -alkyl, R 5 is hydrogen, or R 4 and R 5 Together with the carbon atom to which they are attached, they form a cyclopropyl group, then Z is selected from cyano, C(=O)-SR a 、-C(=O)-NR b R c 、-C(=S)-NR b R c 、-C(=O)-NH-CR d R e -C(=O)-OR a Group;

[0052] Provided that ethyl {[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]amino}(phenyl)acetate and ethyl {[(4,5-dichloro-3-methyl-2-thienyl)carbonyl]amino}(phenyl)acetate are excluded.

[0053] In a preferred embodiment, R 1 and R 2 is chlorine, and R 3 It's methyl.

[0054] In a similarly preferred embodiment, R 1 and R 2 is bromine, and R 3 It's methyl.

[0055] In another preferred embodiment, R 4 and R 5 independently selected from hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -Hydroxyalkyl, C 3 -C 6 -Carbocyclic, aryl, -C 1 -C 6 -alkyl-C 1 -C 6 -alkoxy, -C 1 -C 6 -alkyl-C 3 -C 6 -Carbon ring, C 1 -C 6 -alkyl-O-(C=O)-C 1 -C 6 -alkyl, -C 1-C 6 -alkyl-C(=O)-OH; -C 1 -C 6 -alkyl-aryl, -C 1 -C 6 -Alkyl-SC 1 -C 6 -alkyl-, wherein the non-cyclic R 4 , R 5 The group may be one or more R w Substituent substitution, wherein the cyclic R 4 , R 5 The group may be one or more R x Substituent substitution, where R 4 and R 5 At least one of them is hydrogen, C 1 -C 6 -alkyl or C 3 -C 6 Carbon ring, or R 4 and R 5 Together with the carbon atom to which they are attached, they form C 3 -C 6 - carbocyclic or 3 to 6-membered heterocyclic ring, wherein the C 3 -C 6 -Carbocyclic and 3- to 6-membered heterocyclic rings may be replaced by one or more R x Substituent substitution.

[0056] In a further preferred embodiment W is oxygen.

[0057] According to another preferred embodiment, wherein Y is NR 8 And R 8 It is C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -Cyanoalkyl, hydroxyl, C 1 -C 6 -alkoxy or C 3 -C 6 - carbocyclic ring, wherein Y is preferably NR 8 , R 8 It's hydrogen.

[0058] In another preferred embodiment, Z is selected from cyano, -C(=O)SR a 、-C(=O)-NR b R c 、-C(=S)-NR b R cor -C(=O)-NH-CR d R e -C(=O)-OR a group, and wherein Z is preferably -C(=O)-OR a .

[0059] In another preferred embodiment

[0060] R 1 and R 2 is chlorine, and R 3 It is methyl;

[0061] R 4 and R 5 independently selected from hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -Hydroxyalkyl, C 3 -C 6 -Carbocyclic, aryl, -C 1 -C 6 -alkyl-C 1 -C 6 -alkoxy, -C 1 -C 6 -alkyl-C 3 -C 6 -Carbon ring, C 1 -C 6 -alkyl-O-(C=O)-C 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-C(=O)-OH; -C 1 -C 6 -alkyl-aryl, -C 1 -C 6 -Alkyl-SC 1 -C 6 -alkyl-, wherein the non-cyclic R 4 , R 5 The group may be one or more R w Substituent substitution, wherein the cyclic R 4 , R 5 The group may be one or more R x Substituent substitution, where R 4 and R 5 At least one of them is hydrogen, C 1 -C 6 -alkyl or C 3 -C 6 Carbon ring, or R 4 and R 5Together with the carbon atom to which they are attached, they form C 3 -C 6 A carbocyclic ring or a 3- to 6-membered heterocyclic ring, wherein the C 3 -C 6 -Carbocyclic and 3- to 6-membered heterocyclic rings may be replaced by one or more R x Substituent substitution.

[0062] W is oxygen;

[0063] Y is NR 8 , R 8 It is C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -Cyanoalkyl, hydroxyl, C 1 -C 6 -alkoxy or C 3 -C 6 - carbocyclic ring, wherein Y is preferably NR 8 , R 8 For hydrogen.

[0064] Z is selected from cyano, -C(=O)-SR a 、-C(=O)-NR b R c , -C(=S)-NR b R c or -C(=O)-NH-CR d R e -C(=O)-OR a group, and wherein Z is preferably -C(=O)-OR a .

[0065] In another preferred embodiment

[0066] R 1 and R 2 is bromine, and R 3 It is methyl;

[0067] R 4 and R 5 independently selected from hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -Hydroxyalkyl, C 3 -C 6 -Carbocyclic, aryl, -C 1 -C 6 -alkyl-C 1 -C 6 -alkoxy, -C1 -C 6 -alkyl-C 3 -C 6 -Carbon ring, C 1 -C 6 -alkyl-O-(C=O)-C 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-C(=O)-OH group; 1 -C 6 -alkyl-aryl, -C 1 -C 6 -Alkyl-SC 1 -C 6 -alkyl-, wherein the non-cyclic R 4 , R 5 The group may be one or more R w Substituent substitution, wherein the cyclic R 4 , R 5 The group may be one or more R x Substituent substitution, where R 4 and R 5 At least one of them is hydrogen, C 1 -C 6 -alkyl or C 3 -C 6 Carbon ring, or R 4 and R 5 Together with the carbon atom to which they are attached, they form C 3 -C 6 A carbocyclic ring or a 3- to 6-membered heterocyclic ring, wherein the C 3 -C 6 -Carbocyclic and 3- to 6-membered heterocyclic rings may be replaced by one or more R x Substituent substitution.

[0068] W is oxygen;

[0069] Y is NR 8 , R 8 It is C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -Cyanoalkyl, hydroxyl, C 1 -C 6 -alkoxy or C 3 -C 6 - carbocyclic ring, wherein Y is preferably NR 8 , R 8 For hydrogen.

[0070] Z is selected from cyano, -C(=O)-SR a 、-C(=O)-NR b R c 、-C(=S)-NR b R c or -C(=O)-NH-CR d R e -C(=O)-OR a group, and wherein Z is preferably -C(=O)-OR a .

[0071] In some embodiments, wherein R 1 and R 2 is chlorine, R 3 is a methyl group. In some embodiments, wherein R 1 and R 2 is bromine, R 3 It is a methyl group.

[0072] In another embodiment, R 4 and R 5 are independently selected from halogen, cyano, hydroxyl, C 1 -C 6 -alkoxy, C 1 -C 6 Haloalkyl, -OC(=O)-C 1 -C 6 -alkyl, 4-, 5- or 6-membered non-aromatic heterocyclic group, -C(=O)-NH 2 、-C(=O)-NH(C 1 -C 6 -alkyl), -C(=O)-N(C 1 -C 6 -alkyl) 2 , -C(=O)-OH, -C(=O)-OC 1 -C 6 -alkyl, 5- to 9-membered heteroaryl, -C 1 -C 6 -alkyl-C 1 -C 6 -haloalkyl, -C 1 -C 6 -alkyl-4, 5 or 6-membered non-aromatic heterocyclic group, -C 1 -C 6 -alkyl-hydroxyaryl, -C 1 -C 6 -alkyl-5 to 9-membered heteroaryl, -C 1 -C 6 -alkyl-SC(=O)-C 1 -C6 -alkyl, -C 1 -C 6 -alkyl-C(=O)-NH 2 , -C 1 -C 6 -alkyl-C(=O)NH(C 1 -C 6 -alkyl), -C 1 -C 6 -alkyl-C(=O)-N(C 1 -C 6 -alkyl) 2 , -C 1 -C 6 -alkyl-C(=O)-OC 1 -C 6 -alkyl, -C 1 -C 6 -alkylNH-C(=NH)-NH 2 , -SC 1 -C 6 -alkyl, -SC(=O)-C 1 -C 6 -alkyl, -SC(=O)-OC 1 -C 6 -alkyl, -SC(=S)-OC 1 -C 6 -alkyl, -SC(=O)-SC 1 -C 6 -alkyl, -SC(=O)-NH 2 ,-SC(=O)-NH(C 1 -C 6 -alkyl), -SC(=O)-NH(C 1 -C 6 -alkyl) 2 SC(=S)-NH 2 ,-SC(=S)-NH(C 1 -C 6 -alkyl), -SC(=S)-NH(C 1 -C 6 -alkyl) 2 , -C 1 -C 6 -alkyl-SC(=O)-OC 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-SC(=O)-SC 1 -C 6 -alkyl, -C1 -C 6 -alkyl-SC(=O)-NH 2 , -C 1 -C 6 -alkyl-SC(=O)-NH(C 1 -C 6 -alkyl), -C 1 -C 6 -alkyl-SC(=O)-NH(C 1 -C 6 -alkyl) 2 , -C 1 -C 6 -alkyl-SC(=S)-NH 2 , -C 1 -C 6 -alkyl-SC(=S)-NH(C 1 -C 6 -alkyl), -C 1 -C 6 -alkyl-SC(=S)-NH(C 1 -C 6 -alkyl) 2 , where the non-cyclic R 4 , R 5 The group may be one or more R w Substituent substitution, cyclic R 4 , R 5 The group may be one or more R x Substituent substitution, where R 4 and R 5 At least one is hydrogen, C 1 -C 6 -alkyl or C 3 -C 6 -carbocyclic ring. In another embodiment, R 4 and R 5 independently selected from hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -Hydroxyalkyl, C 3 -C 6 -Carbocyclic, aryl, -C 1 -C 6 -alkyl-C 1 -C 6 -alkoxy, -C 1 -C 6 -alkyl-C 3 -C 6 -Carbon ring, C 1 -C 6-alkyl-O-(C=O)-C 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-C(=O)-OH; -C 1 -C 6 -alkyl-aryl, -C 1 -C 6 -Alkyl-SC 1 -C 6 -alkyl, where the non-cyclic R 4 , R 5 The group may be one or more R w Substituent substitution, wherein the cyclic R 4 , R 5 The group may be one or more R x Substituent substitution, where R 4 and R 5 At least one is hydrogen, C 1 -C 6 -alkyl or C 3 -C 6 -Carbocyclic ring; or R 4 and R 5 Together with the carbon atom to which they are attached, they form C 3 -C 6 - carbocyclic or 3 to 6-membered heterocyclic ring, wherein the C 3 -C 6 -Carbocyclic and 3- to 6-membered heterocyclic rings may be replaced by one or more R x In another embodiment, R 4 It is hydrogen, C 1 -C 6 -alkyl, C 1 -C 6 -Hydroxyalkyl, C 3 -C 6 -Carbocycle, C(=O)-OH, -C(=O)-OC 1 -C 6 -alkyl, -C 1 -C 6 -alkyl-C 1 -C 6 -alkoxy, -C 1 -C 6 -alkyl-C 1 -C 6 -haloalkyl, -C 1 -C 6 -alkyl-C 3 -C 6 -Carbon ring, -C 1 -C 6 -alkyl-aryl, -C1 -C 6 -alkyl-hydroxyaryl, -C 1 -C 6 -Alkyl-SC 1 -C 6 -alkyl-, -C 1 -C 6 -alkyl-C(=O)-NH 2 ,-C 1 -C 6 -alkyl-C(=O)-OH,-C 1 -C 6 -alkyl-C(=O)-OC 1 -C 6 -alkyl, R 5 It is hydrogen, C 1 -C 6 -alkyl or C 3 -C 6 -Carbocyclic ring; or R 4 and R 5 Together with the carbon atom to which they are attached, they form C 3 -C 6 -carbocyclic ring. In another embodiment, R 4 It is hydrogen, C 1 -C 6 -alkyl, C 3 -C 6 -Carbon ring, -C 1 -C 6 -alkyl-C 1 -C 6 -haloalkyl, -C 1 -C 6 -alkyl-C 3 -C 6 -Carbon ring, -C 1 -C 6 -alkyl-aryl, C 1 -C 6 -alkyl-hydroxyaryl, -C 1 -C 6 -Alkyl-SC 1 -C 6 -alkyl-, R 5 is hydrogen or C 1 -C 6 -alkyl; or R 4 and R 5 Together with the carbon atom to which they are attached, they form C 3 -C 6 -carbocyclic ring. In another embodiment, R 4 It is hydrogen, C 1 -C 6 -alkyl, C3 -C 6 -Carbon ring, -C 1 -C 6 -alkyl-C 1 -C 6 -haloalkyl, -C 1 -C 6 -alkyl-C 3 -C 6 -Carbon ring, -C 1 -C 6 -alkyl-aryl, -C 1 -C 6 -alkyl-hydroxyaryl, -C 1 -C 6 -Alkyl-SC 1 -C 6 -alkyl-, R 5 is hydrogen or C 1 -C 6 In another embodiment, R 4 and R 5 Together with the carbon atom to which they are attached, they form C 3 -C 6 -carbocyclic or 3 to 6 membered heterocyclic ring. In another embodiment, R 4 and R 5 Together with the carbon atom to which they are attached, they form C 3 -C 6 -carbocyclic ring. In another embodiment, R 4 and R 5 Together with the carbon atom to which they are attached they form a cyclopropyl or cyclobutyl group.

[0073] In another embodiment, n is 0. In another embodiment, n is 1.

[0074] In another embodiment, W is oxygen. In another embodiment, W is sulfur.

[0075] In another embodiment, Y is NR 8 , R 8 In another embodiment, Y is NR 8 , R 8 It is C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -Cyanide, hydroxyl, C 1 -C 6 -alkoxy or C 3 -C 6 -Carbon ring.

[0076] In another embodiment, Z is selected from cyano, -C(=O)-SR a 、-C(=O)-NR b R c , -C(=S)-NR b R c or -C(=O)-NH-CR d R e -C(=O)-OR a In another embodiment, Z is -C(=O)-OR a .

[0077] Particular preference is given to the example compounds I.1 to I.177.

[0078] Compounds resulting from combinations that violate the laws of nature are not included herein, and therefore a person skilled in the art will exclude them based on his / her expertise. For example, ring structures with three or more adjacent oxygen atoms are excluded.

[0079] Depending on the nature of the substituents, compounds of formula (I) may exist in the form of different stereoisomers. These stereoisomers are, for example, enantiomers, diastereomers, atropisomers or geometric isomers. Therefore, the present invention includes pure stereoisomers and any mixture of these isomers. When a compound can exist in two or more tautomeric forms of equilibrium, the compound mentioned by describing a tautomer is considered to include all tautomeric forms.

[0080] Depending on the number of double bonds in the compound, any compound of the invention may also exist in one or more geometrical isomers. Geometrical isomers determined by the nature of the substituents around the double bonds or rings may exist in cis (=Z-) or trans (=E-) form. Therefore, the present invention also relates to all possible mixtures of all geometrical isomers and in all proportions.

[0081] The compound of formula (I) may suitably be in free form, salt form, N-oxide form or solvate form (eg hydrate).

[0082] Depending on the nature of the substituents, the compounds of the formula (I) can be present in the form of free compounds and / or of their salts (for example agrochemically active salts).

[0083] Agrochemically active salts include acid addition salts of inorganic and organic acids and salts of common bases. Examples of inorganic acids are hydrohalic acids such as hydrogen fluoride, hydrogen chloride, hydrogen bromide and hydrogen iodide, sulfuric acid, phosphoric acid and nitric acid, and acid salts such as sodium hydrogen sulfate and potassium hydrogen sulfate. Useful organic acids include, for example, formic acid, carbonic acid and alkanoic acids, such as acetic acid, trifluoroacetic acid, trichloroacetic acid and propionic acid, as well as glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic acid, cinnamic acid, oxalic acid, saturated or mono- or di-unsaturated fatty acids having 6 to 20 carbon atoms, alkyl sulfate monoesters, alkyl sulfonic acids (sulfonic acids having linear or branched alkyl groups having 1 to 20 carbon atoms), aryl sulfonic acids or aryl disulfonic acids (aryl groups with one or two sulfonic acid groups, such as phenyl and naphthyl), alkyl phosphonic acids (phosphonic acids having linear or branched alkyl groups having 1 to 20 carbon atoms), aryl phosphonic acids or aryl diphosphonic acids (aryl groups, such as phenyl and naphthyl groups, which have one or two phosphonic acid groups), wherein the alkyl and aryl groups may have other substituents, for example p-toluenesulfonic acid, salicylic acid, p-aminosalicylic acid, 2-phenoxybenzoic acid, 2-acetoxybenzoic acid, etc.

[0084] A solvate of a compound of formula (I) or a salt thereof is a stoichiometric composition of the compound and a solvent.

[0085] The compound of formula (I) may exist in a variety of crystalline and / or non-crystalline forms. Crystalline forms include non-solvated crystalline forms, solvates and hydrates.

[0086] The present invention relates to any compound of formula (I) disclosed in the table and their use in crop protection (ie for controlling phytopathogenic fungi and / or bacteria on plants or plant parts).

[0087] Another aspect of the present invention relates to a composition comprising at least one compound of formula (I) according to the invention and at least one agriculturally suitable adjuvant.

[0088] Another aspect of the present invention relates to a method for controlling bacterial and / or fungal diseases, comprising the step of applying at least one compound of formula (I) according to the invention or a composition according to the invention to plants, plant parts, seeds, fruits or the soil in which the plants grow.

[0089] Another aspect of the present invention relates to the use of a compound according to the invention or a composition according to the invention for controlling bacterial and / or fungal diseases on plants or plant parts. Preferably, it is used for controlling fungal diseases on plants or plant parts.

[0090] A further aspect of the present invention relates to the use of a compound according to the invention or a composition according to the invention for controlling nematodes on plants or plant parts.

[0091] A further aspect of the present invention relates to the use of a compound according to the invention or a composition according to the invention for controlling viruses on plants or plant parts.

[0092] Preferably, the compounds or compositions according to the invention are used to combat diseases caused by powdery mildew pathogens, such as Podosphaera species (e.g. Podosphaera leucotricha), Sphaerotheca species (e.g. Sphaerotheca fuliginea); diseases caused by rust pathogens, such as Uromyces species (e.g. Uromyces appendiculatus); diseases caused by Oomycetes pathogens, such as Peronospora species (e.g. Peronospora parasitica), Phytophthora species (e.g. Phytophthora infestans), Plasmopara species (e.g. Plasmopara spp. viticola), Pseudoperonospora species (e.g. Pseudoperonospora humuli or Pseudoperonospora cubensis), Pythium species (e.g. Pythium ultimum); by, for example, Alternaria species (e.g. Alternaria solani), Cercospora, Cercospora species (e.g. Cercospora beticola), Colletotrichum species (e.g. Colletotrichum lindemuthanium), leaf spot and leaf blight caused by Venturia species (e.g. Venturia inaequalis); diseases caused by bacterial pathogens, such as Xanthomonas species (e.g. Xanthomonas campestris pv. Campestris), Pseudomonas species (e.g. Pseudomonas syringae pv.Tomato), Erwinia species (e.g., Erwinia amylovora), Liberibacter species (e.g., Liberibacter Candidatus), Ralstonia species (e.g., Ralstonia solanacearum).

[0093] According to another aspect of the invention, the compounds or compositions of the invention are used as plant defense activators.Plant defense inducers according to the invention are compounds or compositions which stimulate the plant's own defense system.

[0094] Preparation method of compound of formula (I)

[0095] The present invention relates to processes for preparing compounds of formula (I). Compounds of formula (I) can be prepared by various routes analogous to known methods (see references therein) and by one or more of the following synthetic routes described below and in the experimental part.

[0096] General synthetic route for compounds of formula (I)

[0097] Unless otherwise stated, in the following text, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , W, Y, Z and n have the same meanings as given above for the compounds of formula (I).

[0098] Method A1

[0099] The compounds of formula (Ia) as defined herein can be prepared by process A1 comprising the step of reacting a compound of formula (II) or one of its salts with a compound of formula (III) or one of its salts, as shown in the following reaction scheme:

[0100]

[0101] Among them U 1 is halogen, hydroxyl or C 1 -C 6 -alkoxy groups.

[0102] When U 1When represents a hydroxyl group, method A1 is advantageously carried out in the presence of a condensing agent. Suitable condensing agents may be selected from the following non-limiting list, acyl halide forming agents, such as phosgene, phosphorus tribromide, phosphorus trichloride, phosphorus pentachloride, phosphorus trichloride, phosphorus oxychloride, oxalyl chloride or thionyl chloride; acid anhydride forming agents, such as ethyl chloroformate, methyl chloroformate, isopropyl chloroformate, isobutyl chloroformate or methanesulfonyl chloride; carbodiimide, such as N,N'-dicyclohexylcarbodiimide (DCC), N-(3-dimethylaminopropyl)-N'-ethylcarbodiimide hydrochloride (EDC) or other commonly used condensing agents, such as phosphorus pentoxide, polyphosphoric acid, bis(2-oxy-3-oxazolidinyl)phosphinyl chloride (phosphinic chloride), 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate (HATU), 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethylammonium tetrafluoroborate (TBTU), (1-cyano-2-ethoxy-2-oxyethylenaminooxy)dimethylamino-morpholinyl-carbenium hexafluorophosphate, N,N'-carbonyl-diimidazole, 2-ethoxy-N-ethoxycarbonyl-1,2 -dihydroquinoline (EEDQ), triphenylphosphine / tetrachloromethane, 4-(4,6-dimethoxy[1.3.5]-triazin-2-yl)-4-methylmorpholinium chloride hydrate, bis(2-oxo-3-oxazolidinyl)phosphinyl chloride (BOP-CI), bromotripyrrolidiniumphosphonium hexafluorophosphate (PyBroP), 2-chloro-1,3-dimethylimidazolinium chloride (DMC), propanephosphonic anhydride (T3P), and 3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one (DEPBT).

[0103] When U 1 When represents a halogen, method A1 is advantageously carried out in the presence of an acid binder. Suitable acid binders for implementing method A1 are in each case all inorganic and organic bases commonly used for such reactions. Preferred are alkali metal carbonates, such as cesium carbonate, sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate, alkaline earth metal acetates, such as sodium acetate, potassium acetate, calcium acetate and tertiary amines, such as trimethylamine, triethylamine, diisopropylethylamine, tributylamine, N,N-dimethylaniline, N-methylpiperidine, N,N-dimethylpyridine-4-amine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) or diazabicycloundecene (DBU), or aromatic bases, such as pyridine.

[0104] When U 1 Represents C 1 -C 6 In the case of -alkoxy groups, process A1 can be carried out with an excess of the amine component, optionally in the presence of a Lewis acid (eg trimethylaluminum).

[0105] Process A1 can be carried out, if appropriate, in the presence of a base and, if appropriate, in the presence of a solvent, preferably under anhydrous conditions.

[0106] Suitable solvents for carrying out process A1 are not particularly limited. They may be customary inert organic solvents, provided that they do not dissolve the compounds to be reacted therewith or show any particular interaction. Preference is given to using optionally halogenated, aliphatic, alicyclic or aromatic hydrocarbons, for example petroleum ether, pentane, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene, decalin, ISOPAR TM E or ISOPAR TM G, chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane or trichloroethane; ethers, for example diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 2-methyltetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane or anisole; nitriles, for example acetonitrile, propionitrile, n-butyronitrile or isobutyronitrile or benzonitrile; amides, for example N,N-dimethylformamide, N,N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric acid triamide; ureas, for example 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone; esters, for example methyl acetate or ethyl acetate, sulfoxides, for example dimethyl sulfoxide, or sulfones, for example sulfolane; and mixtures thereof.

[0107] Method A1 can be carried out in an inert atmosphere (such as argon or nitrogen atmosphere). When implementing method A1, 1 mole or an excess of compound of formula (III) and 1 to 5 moles of base can be used per mole of compound of formula (II). Other ratios of reaction components can also be used. Subsequent treatment is carried out by known methods.

[0108] The compound of formula (III) is commercially available or can be prepared by well-known methods (J. Med. Chem. 2018, 61, 8670-8692; Tetrahedron, 44 (1), 195-202; 1988, W02009070485; W02019086142; Chem. Res. Toxicol. 1990, 3, 118-124; JP49035334; JP49000223; Journal of Organic Chemistry (1989), 54 (12), 2940-2949).

[0109] Among them U 1 The compound of formula (IIa) representing a hydroxyl group is commercially available and can be prepared from 1 Represents C 1 -C 6The -alkoxy compound of formula (IIb) is prepared by a well-known method such as basic hydrolysis, or can be prepared by a known method (Beilstein J. Org. Chem. 2007, 3, No. 23).

[0110] Among them U 1 Compounds of formula (IIc) representing halogen are commercially available or can be prepared by well-known methods from which U 1 Preparation of compounds of formula (IIa) representing a hydroxyl group.

[0111] Among them U 1 Represents C 1 -C 6 -alkoxy compounds of formula (IIb) can be prepared by well-known methods wherein U 1 Preparation of compounds of formula (IIa) representing a hydroxyl group.

[0112] Method B1

[0113] The compound of formula (Ib) can be prepared by sulfurization reaction of the compound of formula (Ia) by method B1, as shown in the following reaction scheme:

[0114]

[0115] Process B1 according to the invention is carried out in the presence of a sulphurizing agent.

[0116] Suitable sulfiding agents for carrying out process B1 according to the invention may be sulfur (S), hydrosulfuric acid (H 2 S), sodium sulfide (Na 2 S), sodium hydrosulfide (NaHS), boron trisulfide (B 2 S 3 ), bis(diethylaluminum) sulfide ((AIEt 2 ) 2 S), ammonium sulfide (NH 4 ) 2 S), phosphorus pentasulfide (P 2 S 5), Lawesson's reagent (2,4-bis(4-methoxyphenyl)-1,2,3,4-dithiadiphosphatane 2,4-disulfide) or polymer-supported sulfiding agents, such as described in Journal of the Chemical Society, Perkin 1 (2001), 358, optionally in the presence of a catalytic amount or a stoichiometric amount or an excess of a base (such as an inorganic and organic base). Preferably, alkali metal carbonates such as sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate; heterocyclic aromatic bases such as pyridine, picoline, lutidine, collidine; and tertiary amines such as trimethylamine, triethylamine, tributylamine, N,N-dimethylaniline, N,N-dimethylpyridine-4-amine or N-methyl-piperidine are used.

[0117] Suitable solvents for carrying out the process B1 according to the invention may be customary inert organic solvents. Preference is given to using optionally halogenated aliphatic, alicyclic or aromatic hydrocarbons, for example petroleum ether, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin, chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane, ethers, for example diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 1,2-dimethoxyethane or 1,2-diethoxyethane, nitriles, for example acetonitrile, propionitrile, n-butyronitrile or isobutyronitrile or benzonitrile, sulfur-containing solvents, for example sulfolane or carbon disulfide.

[0118] When carrying out process B1 according to the invention, it is possible to use 1 mol or an excess of sulfur equivalents of the sulfurizing agent and 1 to 3 mol of the base per mole of the amide reactant (Ia).

[0119] Other ratios of the reaction components can also be used. Subsequent processing is carried out by known methods.

[0120] Method C1

[0121] The compound of formula (I) can be prepared by method C1, which comprises the step of reacting a compound of formula (IV) or one of its salts with a compound of formula (V) or one of its salts, as shown in the following reaction scheme:

[0122]

[0123] Among them U 3 is a boron derivative, such as boric acid, a borate ester derivative, a potassium trifluoroborate derivative, or a halogenated metal complexed with 1 to 2 ligands, such as a halogenated magnesium or a halogenated zinc,

[0124] And among them U 2 is bromine, iodine, mesylate, toluenesulfonate or triflate, provided that when R 1 and R 2When it is bromine, U 2 Not bromine.

[0125] Method C1 can be carried out in the presence of a transition metal catalyst (e.g. palladium), if appropriate in the presence of a phosphine ligand or an N-heterocyclic carbene ligand, if appropriate in the presence of a base, and if appropriate in the presence of a solvent according to known methods (WO2012054721, Angew.Chem.Int.Ed.2017,56,1581, Angew.Chem.Int.Ed.2017,56,7078, and references cited therein).

[0126] Method C1 can be carried out in the presence of a catalyst, such as a metal salt or a complex. Suitable metal derivatives for this purpose are transition metal catalysts, such as palladium. Suitable metal salts or complexes for this purpose are, for example, palladium chloride, palladium acetate, tetrakis(triphenylphosphine)palladium(0), bis(dibenzylideneacetone)palladium(0), tris(dibenzylideneacetone)dipalladium(0), dichlorobis(triphenylphosphine)palladium(II), [1,1'-bis(diphenylphosphino)ferrocene]dichloropalladium(II), bis(cinnamyl)dichlorodipalladium(II), bis(allyl)dichlorodipalladium(II), [1,1'-bis(di-tert-butylphosphino)ferrocene]dichloropalladium(II), di-p-iodobis(tri-tert-butylphosphino)dipalladium(I) or di-p-bromobis(tri-tert-butylphosphino)dipalladium(I).

[0127] The palladium complex can also be generated in the reaction mixture by separately adding to the reaction of a palladium salt and a ligand or salt such as triethylphosphine, tri-tert-butylphosphine, tri-tert-butylphosphine tetrafluoroborate, tricyclohexylphosphine, 2-(dicyclohexylphosphino)biphenyl, 2-(di-tert-butylphosphino)biphenyl, 2-(dicyclohexylphosphino)-2'-(N,N-dimethylamino)biphenyl, 2-(tert-butylphosphino)-2'-(N,N-dimethylamino)biphenyl, 2-di-tert-butylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2,6'-dimethoxybiphenyl, 2-dicyclohexylphosphino-2',6'-diisopropoxybiphenyl, triphenylphosphine, 3-(o-tolylphosphino)biphenyl, 2-(tert-butylphosphino)-2'-(N,N-dimethylamino)biphenyl, 2-(tert-butylphosphino)-2'-(N,N-dimethylamino)biphenyl, 2-di-tert-butylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2',4',6'-triisopropylbiphenyl, 2-dicyclohexylphosphino-2,6'-dimethoxybiphenyl, 2-dicyclohexylphosphino-2',6'-diisopropoxybiphenyl, triphenylphosphine, 3-(o-tolylphosphino)biphenyl, 2-(tert-butylphosphino)-2' )phosphine, sodium 3-(diphenylphosphino)benzenesulfonate, tri-2-(methoxy-phenyl)phosphine, 2,2'-bis(diphenylphosphino)-1,1'-binaphthyl, 1,4-bis(diphenylphosphino)butane, 1,2-bis(diphenylphosphino)ethane, 1,4-bis(dicyclohexylphosphino)butane, 1,2-bis(dicyclohexylphosphino)-ethane, 2-(dicyclohexylphosphino)-2'-(N,N-dimethylamino)-biphenyl, 1,1'-bis(diphenylphosphino)-ferrocene, (R)(-)-1-[(S)-2-diphenyl-phosphino)ferrocene]ethyldicyclohexylphosphine, tri-(2,4-tert-butylphenyl)phosphite, di(1-adamantyl)-2-morpholinophenylphosphine or 1,3-bis(2,4,6-trimethylphenyl)imidazolium chloride.

[0128] It may also be advantageous to select suitable catalysts and / or ligands from commercial catalogues, for example "Metal Catalysts for Organic Synthesis" from Strem Chemicals or "Phosphorous Ligands and Compounds" from Strem Chemicals.

[0129] Suitable bases for carrying out process C1 may be inorganic bases and organic bases commonly used for such reactions. Preference is given to using alkaline earth metal or alkali metal hydroxides, such as sodium hydroxide, calcium hydroxide, potassium hydroxide or other ammonium hydroxide derivatives; alkaline earth metal, alkali metal or ammonium fluorides, such as potassium fluoride, cesium fluoride or tetrabutylammonium fluoride; alkaline earth metal or alkali metal carbonates, such as sodium carbonate, potassium carbonate, potassium bicarbonate, sodium bicarbonate or cesium carbonate; alkali metal or alkaline earth metal acetates, such as sodium acetate, lithium acetate, potassium acetate or calcium acetate; alkali metal or alkaline earth metal phosphates, such as triphosphate; Potassium base; alkali metal alkoxides such as potassium tert-butoxide or sodium tert-butoxide; tertiary amines such as trimethylamine, triethylamine, tributylamine, N,N-dimethylaniline, N,N-dicyclohexylmethylamine, N,N-diisopropylethylamine, N-methylpiperidine, N,N-dimethylaminopyridine, diazabicyclooctane (DABCO), diazabicyclononene (DBN) or diazabicycloundecene (DBU); and aromatic bases such as pyridine, picoline, lutidine or collidine.

[0130] Suitable solvents for carrying out process C1 may be customary inert organic solvents. Preference is given to using optionally halogenated aliphatic, alicyclic or aromatic hydrocarbons, for example petroleum ether, pentane, hexane, heptane, cyclohexane, methylcyclohexane, benzene, toluene, xylene or decalin; chlorobenzene, dichlorobenzene, dichloromethane, chloroform, carbon tetrachloride, dichloroethane or trichloroethane; ethers, for example diethyl ether, diisopropyl ether, methyl tert-butyl ether, methyl tert-amyl ether, dioxane, tetrahydrofuran, 2-methyltetrahydrofuran, 1,2-dimethoxyethane, 1,2-diethoxyethane; nitriles, for example acetonitrile, propionitrile, n-butyronitrile or isobutyronitrile or benzonitrile; amides, for example N,N-dimethylformamide, N,N-dimethylacetamide, N-methylformanilide, N-methylpyrrolidone or hexamethylphosphoric acid triamide; ureas, for example 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone; esters, for example methyl acetate or ethyl acetate, sulfoxides, for example dimethyl sulfoxide, or sulfones, for example sulfolane; and mixtures thereof.

[0131] It may also be advantageous to carry out process C1 using a cosolvent, for example water or an alcohol, such as methanol, ethanol, propanol, isopropanol or tert-butanol.

[0132] Method C1 can be carried out in an inert atmosphere such as argon or nitrogen. When carrying out method C1, 1 mole or excess of compound of formula (V) and 1 to 5 moles of base and 0.01 to 20 mole % of palladium complex can be used per mole of compound of formula (IV). Other proportions of reaction components can also be used. Subsequent treatment is carried out by known methods.

[0133] Compounds of formula (V) are commercially available or can be prepared by well-known methods.

[0134] Compounds of formula (IVa) wherein W is oxygen can be prepared by reacting a compound of formula (VI) with a compound of formula (III) under the conditions described for method A1:

[0135]

[0136] Among them U 2 and U 1 As defined herein.

[0137] Among them U 2 Compounds of formula (VIa) which are chloro, bromo or iodo are commercially available or can be prepared by well known methods using reaction conditions similar to those disclosed for the preparation of compounds of formula (II).

[0138] Among them U 2 The compound of formula (VIb) which is a mesylate group, a tosylate group or a triflate group can be prepared by a well-known method by 2 The corresponding compounds with hydroxyl groups are prepared.

[0139] Method D1

[0140] The compound of formula (I) as defined herein can be prepared by method D1 from a compound of formula (VII) or one of its salts by halogenation reaction as shown in the following reaction scheme:

[0141]

[0142] Among them U 4 and U 5 are independently hydrogen, chlorine or bromine, provided that U 4 or U 5 At least one of them is hydrogen.

[0143] Method D1 can be carried out according to known methods (Angewandte Chemie, International Edition, 52 (16), 4440-4444; 2013; ACS Catalysis, 6 (11), 7839-7843; 2016; Journal of the American Chemical Society, 2017, 139, 888; Angewandte Chemie, International Edition, 2014, 53, 7928; Journal of the American Chemical Society, 2018, 140, 2789; W02008156879; W02012114285; W02008109786; W02007098356).

[0144] Process D1 is carried out in the presence of a halogenating agent and, if appropriate, a solvent.

[0145] Suitable halogenating agents for carrying out method D1 are not particularly limited as long as they can be used for bromination or chlorination. Examples of brominating agents include bromine, N-bromosuccinimide, 1,2-dibromotetrachloroethane and 1,3-dibromo-5,5-dimethyl-2,4-imidazole alkane dione. Examples of chlorinating agents include N-chlorosuccinimide, sulfuryl chloride, hexachloroethane and 1,3-dichloro-5,5-dimethyl-2,4-imidazole alkane dione.

[0146] Suitable solvents for carrying out method D1 are not particularly limited. They can be commonly used inert organic solvents, as long as it does not dissolve the compound reacted therewith or show any specific interaction. Suitable solvents can be, for example, solvents disclosed for method A1. In order to carry out method D1, it is also advantageous to use an organic acid (such as acetic acid or trifluoroacetic acid) as a solvent or co-solvent. In order to carry out method D1, it is also advantageous to use a Lewis acid (such as zinc (II) chloride) as a catalyst. In order to carry out method D1, it is also advantageous to use a transition metal catalyst (such as a palladium catalyst). In order to carry out method D1, it is also advantageous to use a suitable organometallic reagent (such as n-butyl lithium). In order to carry out method D1, according to known methods (WO2020079205), it is also advantageous to use a suitable base before halogenation, such as n-butyl lithium, lithium diisopropylamine, tetramethyl piperidine lithium, bis (trimethylsilyl) amine lithium, methyl lithium or chloro (2,2,6,6-tetramethyl-1-piperidyl) magnesium, etc., preferably under anhydrous conditions. Optionally, lithium chloride may be used in a preformed combination with these reagents.

[0147] Method E1

[0148] The compounds of formula (I) as defined herein may be prepared by process E1 which comprises the steps of diazotizing a compound of formula (VIII) or one of its salts followed by aromatic substitution to provide a compound of formula (I) as shown in the following reaction scheme:

[0149]

[0150] Among them U 6 and U 7 are independently amino, chlorine or bromine, provided that U 6 or U 7 At least one of them is an amino group.

[0151] Method E1 can be carried out according to known methods (The Chemistry of diazonium and diazogroups; Saul Patai; Wiley-Interscience; 1978; 288-280 and 645-657; Account of Chemical Research (2018), 51, 496 and references cited therein).

[0152] The compound of formula (VIII) as defined herein or one of its salts can be prepared by a method comprising the step of reducing the nitro group according to well-known methods (Science of Synthesis: Catalytic Reduction in Organic Synthesis 2; JG de Vries, 2018, chapter 2.7: Reduction of Nitro Compounds to Amines, Azo Compounds, Hydroxylamines, and Oximes, and Reduction of N-Oxides to Amines, and references therein) or by deprotecting the protected amino group according to well-known methods.

[0153] Examples of the protecting group for the amino group include a benzyl group, a 4-methoxybenzyl group, an allyl group, an unsubstituted or substituted C 1 -C 6 -alkylsulfonyl, trifluoromethylsulfonyl, unsubstituted or substituted phenylsulfonyl, unsubstituted or substituted C 1 -C 6 - alkoxycarbonyl, unsubstituted or substituted benzyloxycarbonyl, allyloxycarbonyl, acetyl or trifluoroacetyl groups.

[0154] The deprotection method can be carried out according to known methods for removing protecting groups (Greene's Protective Groups in Organic Synthesis; Peter GMWuts; Wiley; Fifth Edition; 2014; 895-1194). For example, tert-butoxycarbonyl and benzyloxycarbonyl protecting groups can be removed in an acidic medium (e.g., with hydrochloric acid or trifluoroacetic acid). The benzyl protecting group can be removed by hydrogenolysis with hydrogen in the presence of a catalyst (e.g., palladium on activated carbon). The trifluoroacetyl group can be removed in an alkaline medium (e.g., with potassium carbonate or lithium hydroxide).

[0155] Where Z is -C(=O)-OR a , where R a Selected from C 1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -Cyanoalkyl, C 2 -C 6 -Alkenyl, C 2 -C 6 -Alkynyl, C 3 -C 8 -cycloalkyl, aryl, aralkyl, 4-, 5- or 6-membered non-aromatic heterocyclic group, -C 1 -C 6 -Alkyl-Si(C 1 -C 6 -alkyl) 3 , -C 1 -C 6 -alkyl-C 3 -C 8 -cycloalkyl, 5- to 9-membered heteroaryl, and -C 1 -C 6 -alkyl-5 to 9 membered heteroaryl compounds of formula (Ic) can be prepared from compounds of formula (ld) wherein Z is -C(=O)-OR and the corresponding alcohol or one of its salts by well known coupling methods under the conditions described for method A1. a , where R a It's hydrogen.

[0156] Where Z is -C(=O)-OR a , where R a The compound of formula (Id) wherein Z is -C(=O)-OR a , where R a Selected from C1 -C 6 -alkyl, C 1 -C 6 -haloalkyl, C 1 -C 6 -Cyanoalkyl, C 2 -C 6 -Alkenyl, C 2 -C 6 -Alkynyl, C 3 -C 8 -cycloalkyl, aryl, aralkyl, 4-, 5- or 6-membered non-aromatic heterocyclic group, -C 1 -C 6 -Alkyl-Si(C 1 -C 6 -alkyl) 3 , -C 1 -C 6 -alkyl-C 3 -C 8 -cycloalkyl, 5- to 9-membered heteroaryl, and -C 1 -C 6 -alkyl-5 to 9 membered heteroaryl. Examples of hydrolysis agents include lithium hydroxide, potassium hydroxide, sodium hydroxide, trimethyltin hydroxide. The hydrolysis can be carried out as described in WO2008157844; WO2006002099; WO20050256107; Angewandte Chemie, International Edition (2005), 44 (9), 1378-1382.

[0157] Where Z is -C(=O)-SR a 、-C(=O)-NR b R c 、-C(=O)-NH-CR d R e -C(=O)-OR a The compound of formula (Ie) can be composed of wherein Z is -C(=O)-OR a , where R a The compound of formula (Id) which is hydrogen and the corresponding thiol, amine or one of its salts are prepared by well known coupling methods under the conditions described for process A1.

[0158] Compositions and preparations

[0159] The present invention also relates to a composition, in particular a composition for controlling harmful microorganisms, comprising one or more compounds of formula (I). The composition is preferably a fungicidal composition.

[0160] The compositions generally comprise one or more compounds of formula (I) and one or more acceptable carriers, especially one or more agriculturally acceptable carriers.

[0161] Carrier is generally inert solid or liquid, natural or synthetic, organic or inorganic material.Carrier usually improves compound application such as on plant, plant part or seed.The example of suitable solid carrier includes but is not limited to ammonium salt, natural rock powder, such as kaolin, clay, talc, chalk, quartz, attapulgite, montmorillonite and diatomaceous earth, and synthetic rock powder, such as finely divided silicon dioxide, aluminum oxide and silicate.The example of useful solid carrier commonly used for preparing granule includes but is not limited to crushed and decomposed natural rock, such as calcite, marble, pumice, sepiolite and dolomite, the synthetic particle of inorganic and organic powder and organic material such as paper, sawdust, coconut shell, corn cob and tobacco rod particle.The example of suitable liquid carrier includes but is not limited to water, organic solvent and combination thereof. Examples of suitable solvents include polar and nonpolar organic chemical liquids, such as aromatic and nonaromatic hydrocarbons (e.g. cyclohexane, alkanes, alkylbenzenes, xylenes, toluene, alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons such as chlorobenzene, vinyl chloride or methylene chloride), alcohols and polyols (which may also be optionally substituted, etherified and / or esterified, such as butanol or ethylene glycol), ketones (e.g. acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone), esters (including fats and oils) and (poly)ethers, unsubstituted and substituted amines, amides (e.g. dimethylformamide), lactams (e.g. N-alkylpyrrolidones) and lactones, sulfones and sulfoxides (e.g. dimethyl sulfoxide). The carrier may also be a liquefied gaseous extender, i.e. a liquid which is gaseous at standard temperature and standard pressure, such as an aerosol propellant, such as halogenated hydrocarbons, butane, propane, nitrogen and carbon dioxide. The amount of carrier is generally 1-99.99%, preferably 5-99.9%, more preferably 10-99.5%, most preferably 20-99% by weight of the composition.

[0162] The composition may further comprise one or more acceptable adjuvants commonly used in formulating compositions (eg agrochemical compositions), such as one or more surfactants.

[0163] Surfactant can be ionic (cationic or anionic) or nonionic surfactant, such as ionic or nonionic emulsifier, foaming agent, dispersant, wetting agent and any mixture thereof. The example of suitable surfactant includes but is not limited to polyacrylate, lignin sulfonate, phenol sulfonate or naphthalene sulfonate, ethylene oxide and / or propylene oxide and fatty alcohol, fatty acid or fatty amine condensation product (polyoxyethylene fatty acid ester, polyoxyethylene fatty alcohol ether, such as alkyl aryl polyglycol ether), substituted phenol (preferably alkylphenol or arylphenol), sulfosuccinate salt, taurine derivative (preferably taurine alkyl ester), polyethoxylated alcohol or phenol phosphate, fatty ester of polyol and derivative (such as alkyl sulfonate, alkyl sulfate, aryl sulfonate) and protein hydrolyzate, lignin sulfite waste liquor and methylcellulose containing sulfate, sulfonate, phosphate compound. When formula (I) compound and / or carrier are insoluble in water and applied with water, surfactant is usually used. Then, the amount of surfactant is usually 5-40% of the composition weight.

[0164] Other examples of adjuvants conventionally used in formulating agrochemical compositions include water-repellents, desiccants, binders (adhesives, tackifiers, fixatives, such as carboxymethylcellulose, natural and synthetic polymers in powder, granule or latex form, such as gum arabic, polyvinyl alcohol and polyvinyl acetate, natural phospholipids such as cephalin and lecithin and synthetic phospholipids, polyvinyl pyrrolidone, polyvinyl acetate, polyvinyl alcohol and sodium tylose), thickeners, stabilizers (such as cold stabilizers, preservatives, antioxidants, light stabilizers or other stabilizers that improve chemical and / or physical stability), dyes or pigments ( Such as inorganic pigments, for example iron oxide, titanium oxide and Prussian blue; organic dyes, for example alizarin, azo and metal phthalocyanine dyes), defoamers (for example silicone defoamers and magnesium stearate), preservatives (for example dichlorophenol and benzyl alcohol hemiformal), secondary thickeners (cellulose derivatives, acrylic acid derivatives, xanthan gum, modified clays and finely divided silica), adhesives, gibberellins and processing aids, mineral oils and vegetable oils, fragrances, waxes, nutrients (including trace nutrients, such as iron salts, manganese salts, boron salts, copper salts, cobalt salts, molybdenum salts and zinc salts), protective colloids, thixotropic substances, penetrants, chelating agents and complexing agents.

[0165] The selection of adjuvants is related to the expected mode of administration and / or physical properties of the compound of formula (I). In addition, the composition or the use form prepared therefrom can be given specific properties (technical, physical and / or biological properties) by selecting adjuvants. The selection of adjuvants can allow the composition to be customized according to specific needs.

[0166] The composition may be in any conventional form, such as solutions (e.g. aqueous solutions), emulsions, wettable powders, water-based and oil-based suspensions, dusts, powders, pastes, soluble powders, soluble granules, granules for broadcasting, suspoemulsion concentrates, natural or synthetic products impregnated with the compounds of the invention, fertilizers and microcapsules in polymeric materials. The compounds of formula (I) may be present in suspended, emulsified or dissolved form.

[0167] The composition can be provided to the end user as a ready-to-use formulation, i.e. the composition can be applied directly to plants or seeds by suitable devices such as spraying or dusting devices. Alternatively, the composition can be provided to the end user in the form of a concentrate, which must be diluted before use, preferably with water.

[0168] Such compositions may be prepared in conventional manner, for example by mixing a compound of formula (I) with one or more suitable auxiliaries, for example disclosed above.

[0169] The composition typically contains 0.01 to 99%, 0.05 to 98%, preferably 0.1 to 95%, more preferably 0.5 to 90%, most preferably 1 to 80% by weight of the compound of formula (I).

[0170] The compounds and compositions containing them can be mixed with other active ingredients, such as fungicides, bactericides, miticides, nematicides, insecticides, herbicides, fertilizers, growth regulators, safeners or chemical semiochemicals. This can broaden the spectrum of activity or prevent the development of resistance. Examples of known fungicides, insecticides, miticides, nematicides and bactericides are disclosed in Pesticide Manual, 17 th Edition.

[0171] The active ingredients designated herein by their common names are known and described in the Pesticide Manual (16 th Ed. British Crop Protection Council) or can be found on the website (e.g. www.alanwood.net / pesticides).

[0172] Where compound (A) or compound (B) can exist in tautomeric forms, such compounds are to be understood above and below as also comprising, where applicable, the corresponding tautomeric forms, even if these are not specifically mentioned in each case.

[0173] Examples of fungicides that can be mixed with the compounds of formula (I) and the compositions of the present invention are:

[0174] 1) Inhibitors of ergosterol biosynthesis, for example (1.001) cyproconazole, (1.002) difenoconazole, (1.003) epoxiconazole, (1.004) fenhexamid, (1.005) fenpropidin, (1.006) fenpropimorph, (1.007) fenpyrazamine, (1.008) fluquinconazole, (1.009) flutriafol, (1.010) imazalil, (1.011) imazalil sulfate sulphate), (1.012) ipconazole, (1.013) metconazole, (1.014) myclobutanil, (1.015) paclobutrazole, (1.016) prochloraz, (1.017) propiconazole, (1.018) prothioconazole, (1.019) pyrisoxazole, (1.020) spiroxamine, (1.021) tebuconazole, (1.022) tetraconazole, (1.023) triadimenol, (1.024) tridemorph, (1.025) trichlorfonazole (triticonazole), (1.026) (1R, 2S, 5S) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentanol, (1.027) (1S, 2R, 5R) -5- (4-chlorobenzyl) -2- (chloromethyl) -2-methyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentanol, (1.028) (2R) -2- (1-chlorocyclopropyl) -4-[ (1R)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.029) (2R)-2-(1-chlorocyclopropyl)-4-[(1S)-2,2-dichlorocyclopropyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.030) (2R)-2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.031) (2S) -2- (1-chlorocyclopropyl) -4- [(1R) -2,2-dichlorocyclopropyl] -1- (1H-1,2,4-triazol-1-yl) butan-2-ol, (1.032) (2S) -2- (1-chlorocyclopropyl) -4- [(1S) -2,2-dichlorocyclopropyl] -1- (1H-1,2,4-triazol-1-yl) butan-2-ol, (1.033) (2S) -2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1H-1,2,4-triazol-1-yl) propan-2-ol, (1.034) (R) - [3- (4-chloro-2-fluorophenyl) -5- (2,4-difluorophenyl) -1,2-oxazol-4-yl] (pyrrolidone) 1-({(2R,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.038) 1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.039) 1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.040) 1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.041) 1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.042) 1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.043) 1-({(2S,4S)-2-[2-chloro-4-(4-chlorophenoxy)phenyl]-4-methyl-1,3-dioxolan-2-yl}methyl)-1H-1,2,4-triazole, (1.044) 1-({(2S,4S)-2 1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate, (1.041) 1-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}-1H-1,2,4-triazol-5-yl thiocyanate thiocyanate, (1.042) 2-[(2R,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.043) 2-[(2R,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.044) 2-[(2R,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.046)045) 2-[(2R,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.046) 2-[(2S,4R,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.047) 2-[(2S,4R,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.04 8) 2-[(2S,4S,5R)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.049) 2-[(2S,4S,5S)-1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.050) 2-[1-(2,4-dichlorophenyl)-5-hydroxy-2,6,6-trimethylhept-4-yl]-2,4-dihydro-3H-1,2,4-triazole-3-thione, (1.051) 2-[2-chloro-4-(2 ,4-dichlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.052) 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.053) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)butan-2-ol, (1.054) 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)pentan-2-ol, (1.055) mefentrifluconazole )、(1.056) 2-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione、(1.057) 2-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione、(1.058) 2-{[rel(2R,3S)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}-2,4-dihydro-3H-1,2,4-triazole-3-thione、(1.059) 5-(4-chlorobenzyl)-2-(chloromethyl)-2-methyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol, (1.060) 5-(allylsulfanyl)-1-{[3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}-1H-1,2,4-triazole, (1.061) 5-(allylsulfanyl)-1-{[rel(2R,3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)oxirane-2-yl]methyl}-1H-1,2,4-triazole, (1.062) 5-(allylsulfanyl)-1-{[rel(2R,3S)-3-(2- N'-(2,5-dimethyl-4-{[3-(1,1,2,2-tetrafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methyliminocarboxamide, (1.064) N'-(2,5-dimethyl-4-{[3-(2,2,2-trifluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methyliminocarboxamide, (1.065) N'-(2,5-dimethyl-4-{[3-(2,2,3,3-tetrafluoropropoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methyliminocarboxamide 、(1.066) N'-(2,5-dimethyl-4-{[3-(pentafluoroethoxy)phenyl]sulfanyl}phenyl)-N-ethyl-N-methyliminocarboxamide、(1.067) N'-(2,5-dimethyl-4-{3-[(1,1,2,2-tetrafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methyliminocarboxamide、(1.068) N'-(2,5-dimethyl-4-{3-[(2,2,2-trifluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methyliminocarboxamide、(1.069) N'-(2,5-dimethyl-4-{3-[(2,2,3,3-tetrafluoropropyl)sulfanyl]phenoxy}phenyl )-N-ethyl-N-methyliminocarboxamide, (1.070) N'-(2,5-dimethyl-4-{3-[(pentafluoroethyl)sulfanyl]phenoxy}phenyl)-N-ethyl-N-methyliminocarboxamide, (1.071) N'-(2,5-dimethyl-4-phenoxyphenyl)-N-ethyl-N-methyliminocarboxamide, (1.072) N'-(4-{[3-(difluoromethoxy)phenyl]sulfanyl}-2,5-dimethylphenyl)-N-ethyl-N-methyliminocarboxamide, (1.073) N'-(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methyliminocarboxamide, (1.074) N'-(4-{3-[(difluoromethyl)sulfanyl]phenoxy}-2,5-dimethylphenyl)-N-ethyl-N-methyliminocarboxamide, (1.076)074) N'-[5-bromo-6-(2,3-dihydro-1H-inden-2-yloxy)-2-methylpyridin-3-yl]-N-ethyl-N-methyliminocarboxamide, (1.075) N'-{4-[(4,5-dichloro-1,3-thiazol-2-yl)oxy]-2,5-dimethylphenyl}-N-ethyl-N-methyliminocarboxamide, (1.076) N'-{5-bromo-6-[(1R)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminocarboxamide, (1.077) N'-{5-bromo-6-[(1S)-1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl} -N-ethyl-N-methyliminocarboxamide, (1.078) N'-{5-bromo-6-[(cis-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminocarboxamide, (1.079) N'-{5-bromo-6-[(trans-4-isopropylcyclohexyl)oxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminocarboxamide, (1.080) N'-{5-bromo-6-[1-(3,5-difluorophenyl)ethoxy]-2-methylpyridin-3-yl}-N-ethyl-N-methyliminocarboxamide, (1.081) ipfentrifluconazole, (1.082) 2-[4- (4-Chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1H-1,2,4-triazol-1-yl)propan-2-ol, (1.083) 2-[6-(4-bromophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, (1.084) 2-[6-(4-chlorophenoxy)-2-(trifluoromethyl)-3-pyridyl]-1-(1,2,4-triazol-1-yl)propan-2-ol, (1.085) 3-[2-(1-chlorocyclopropyl)-3-(3-chloro-2-fluoro-phenyl)-2-hydroxy-propyl]imidazole-4-carbonitrile, (1.086) 4-[[6-[rac-(2R)-2-(2,4 -difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-thioxo-4H-1,2,4-triazol-1-yl)propyl]-3-pyridinyl]oxy]benzonitrile, (1.087) N-isopropyl-N'-[5-methoxy-2-methyl-4-(2,2,2-trifluoro-1-hydroxy-1-phenylethyl)phenyl]-N-methyliminocarboxamide, (1.088) N'-{5-bromo-2-methyl-6-[(1-propoxyprop-2-yl)oxy]pyridin-3-yl}-N-ethyl-N-methyliminocarboxamide, (1.089) 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propionic acid methyl ester. .

[0175] 2) Inhibitors of respiratory chain complex I or II, such as (2.001) benzovindiflupyr, (2.002) bixafen, (2.003) boscalid, (2.004) carboxin, (2.005) fluopyram, (2.006) flutolanil, (2.007) fluxapyroxad, (2.008) furametpyr, (2.009) isofetamid, (2.010) Isopyrazam (trans epimers 1R, 4S, 9S), (2.011) Isopyrazam (trans epimers 1S, 4R, 9R), (2.012) Isopyrazam (trans epimers 1RS, 4SR, 9SR), (2.013) Isopyrazam (mixture of cis epimers 1RS, 4SR, 9RS and trans epimers 1RS, 4SR, 9SR), (2.014) Isopyrazam (cis epimers 1R, 4S, 9R), (2.015) Isopyrazam (cis epimers 1S, 4R, 9S), (2.016) Isopyrazam (cis epimers Isomers (racemic 1RS, 4SR, 9RS), (2.017) penflufen, (2.018) penthiopyrad, (2.019) pydiflumetofen, (2.020) pyraziflumid, (2.021) sedaxane, (2.022) 1,3-dimethyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.023) 1,3-dimethyl-N-[(3R)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl] -1H-pyrazole-4-carboxamide, (2.024) 1,3-dimethyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.025) 1-methyl-3-(trifluoromethyl)-N-[2'-(trifluoromethyl)biphenyl-2-yl]-1H-pyrazole-4-carboxamide, (2.026) 2-fluoro-6-(trifluoromethyl)-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)benzamide, (2.027) 3-(difluoromethyl)-1-methyl-N-(1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl)-1H-pyrazole-4-carboxamide, (2.028) inpyrfluxam, (2.029) 3-(difluoromethyl)-1-methyl-N-[(3S)-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1H-pyrazole-4-carboxamide, (2.030) fluindapyr, (2.031) 3-(difluoromethyl)-N-[(3R)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide, (2.032) 3-(difluoromethyl)-N-[(3S)-7-fluoro-1,1,3-trimethyl-2,3-dihydro-1H-inden-4-yl]-1-methyl-1H-pyrazole-4-carboxamide formamide, (2.033) 5,8-difluoro-N-[2-(2-fluoro-4-{[4-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)ethyl]quinazolin-4-amine, (2.034) N-(2-cyclopentyl-5-fluorobenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.035) N-(2-tert-butyl-5-methylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.036) N-(2-tert-butylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.037) N-(5- chloro-2-ethylbenzyl)-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.038) isoflucypram, (2.039) N-[(1R,4S)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.040) N-[(1S,4R)-9-(dichloromethylene)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-5-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.0 41) N-[1-(2,4-dichlorophenyl)-1-methoxyprop-2-yl]-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.042) N-[2-chloro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.043) N-[3-chloro-2-fluoro-6-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.044) N-[5-chloro-2-(trifluoromethyl)benzyl]-N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.045) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-1-methyl-N-[5-methyl-2-(trifluoromethyl)benzyl]-1H-pyrazole-4-carboxamide, (2.046) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-fluoro-6-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.047) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl-5-methylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.048) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-isopropyl 1-methyl-1H-pyrazole-4-carboxamide, (2.050) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(5-fluoro-2-isopropylbenzyl)-1-methyl-1H-pyrazole-4-carboxamide, (2.051) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.052) N-cyclopropyl-3-(difluoromethyl)-5-fluoro-N-(2-ethyl-4,5-dimethylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, -3-(difluoromethyl)-N-(2-ethyl-5-fluorobenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.053) N-cyclopropyl-3-(difluoromethyl)-N-(2-ethyl-5-methylbenzyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.054) N-cyclopropyl-N-(2-cyclopropyl-5-fluorobenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.055) N-cyclopropyl-N-(2-cyclopropyl-5-methylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl- 1H-pyrazole-4-carboxamide, (2.056) N-cyclopropyl-N-(2-cyclopropylbenzyl)-3-(difluoromethyl)-5-fluoro-1-methyl-1H-pyrazole-4-carboxamide, (2.057) pyrapropoyne, (2.058) N-[rac-(1S,2S)-2-(2,4-dichlorophenyl)cyclobutyl]-2-(trifluoromethyl)-nicotinamide, (2.059) N-[(1S,2S)-2-(2,4-dichlorophenyl)cyclobutyl]-2-(trifluoromethyl)nicotinamide, (2.060) fluorophenyl ether amide (flubeneteram). .

[0176] 3) Inhibitors at complex III of the respiratory chain, such as (3.001) ametoctradin, (3.002) amisulbrom, (3.003) azoxystrobin, (3.004) coumethoxystrobin, (3.005) coumoxystrobin, (3.006) cyazofamid, (3.007) dimoxystrobin, (3.008) enoxastrobin, (3.009) famoxadon e), (3.010) fenamidone, (3.011) flufenoxystrobin, (3.012) fluoxastrobin, (3.013) kresoxim-methyl, (3.014) metominostrobin, (3.015) orysastrobin, (3.016) picoxystrobin, (3.017) pyraclostrobin, (3.018) pyrametostrobin bin), (3.019) pyraoxystrobin, (3.020) trifloxystrobin, (3.021) (2E)-2-{2-[({[(1E)-1-(3-{[(E)-1-fluoro-2-phenylvinyl]oxy}phenyl)ethylidene]amino}oxy)methyl]phenyl}-2-(methoxyimino)-N-methylacetamide, (3.022) (2E,3Z)-5-{[1-(4-chlorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.023) (2R)-2-{2-[(2,5-di methylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.024) (2S)-2-{2-[(2,5-dimethylphenoxy)methyl]phenyl}-2-methoxy-N-methylacetamide, (3.025) fenpicoxamid, (3.026) mandestrobin, (3.027) N-(3-ethyl-3,5,5-trimethylcycloethyl)-3-formamido-2-hydroxybenzamide, (3.028) (2E,3Z)-5-{[1-(4-chloro-2-fluorophenyl)-1H-pyrazol-3-yl]oxy}-2-(methoxyimino)-N,3-dimethylpent-3-enamide, (3.029)029) methyl {5-[3-(2,4-dimethylphenyl)-1H-pyrazol-1-yl]-2-methylbenzyl}carbamate, (3.030) metyltetraprole, (3.031) florylpicoxamid. .

[0177] 4) Inhibitors of mitosis and cell division, for example (4.001) carbendazim, (4.002) diethofencarb, (4.003) ethaboxam, (4.004) fluopicolide, (4.005) pencycuron, (4.006) thiabendazole, (4.007) thiophanate-methyl, (4.008) zoxamide, (4.009) pyridachlometyl, (4.010) pyridachlometyl, (4.011) pyridachlometyl, (4.012) pyridachlometyl, (4.013) pyridachlometyl, (4.014) pyridachlometyl, (4.015) pyridachlometyl, (4.016) pyridachlometyl, (4.017) pyridachlometyl, (4.018) pyridachlometyl, (4.019) pyridachlometyl, (4.020) pyridachlometyl, (4.021) pyridachlometyl, (4.022) pyridachlometyl, (4.023) pyridachlometyl, (4.024) pyridachlometyl, (4.025) pyridachlometyl, (4.026) pyridachlometyl, (4.027) pyridachlometyl, (4.028) pyridachlometyl, (4.029) pyridachlometyl, (4.030) pyridachlometyl, (4.031) pyridachlometyl, (4.032) pyridachlometyl, (4.033) pyridachlometyl, (4.034) pyridachlometyl, ( 010) 3-chloro-5-(4-chlorophenyl)-4-(2,6-difluorophenyl)-6-methylpyridazine, (4.011) 3-chloro-5-(6-chloropyridin-3-yl)-6-methyl-4-(2,4,6-trifluorophenyl)pyridazine, (4.012) 4-(2-bromo-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.013) 4-(2-bromo-4-fluorophenyl)-N-(2-bromo-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.014) 4-(2-bromo-4-fluorophenyl)-N-(2-bromophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.015) 4-(2-Bromo-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.016) 4-(2-Bromo-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.017) 4-(2-Bromo-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.018) 4-(2-chloro-4-fluorophenyl)-N-(2,6-difluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.019) 4-(2-chloro-4-fluorophenyl)-N-(2-chloro-6-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5 -amine, (4.020) 4-(2-chloro-4-fluorophenyl)-N-(2-chlorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.021) 4-(2-chloro-4-fluorophenyl)-N-(2-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.022) 4-(4-chlorophenyl)-5-(2,6-difluorophenyl)-3,6-dimethylpyridazine, (4.023) N-(2-bromo-6-fluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.024) N-(2-bromophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.025) N-(4-chloro-2,6-difluorophenyl)-4-(2-chloro-4-fluorophenyl)-1,3-dimethyl-1H-pyrazol-5-amine, (4.026) fluopimomide.

[0178] 5) Compounds capable of multi-site action, such as (5.001) Bordeaux mixture, (5.002) captafol, (5.003) captan, (5.004) chlorothalonil, (5.005) copper hydroxide, (5.006) copper naphthenate, (5.007) copper oxide, (5.008) copper oxychloride, oxychloride), (5.009) copper (2+) sulphate, (5.010) dithianon, (5.011) dodine, (5.012) folpet, (5.013) mancozeb, (5.014) maneb, (5.015) metiram, (5.016) metiram zinc, (5.017) oxine-copper, (5.018) propineb, (5.019) sulfur and sulfur preparations including calcium polysulfide, (5.020) thiram, (5.021) zineb, (5.022) ziram, (5.023) 6-ethyl-5,7-dioxo-6,7-dihydro-5H-pyrrolo[3',4':5,6][1,4]dithiino[2,3-c][1,2]thiazole-3-carbonitrile.

[0179] 6) Compounds capable of inducing host defense, such as (6.001) acibenzolar-S-methyl, (6.002) isotianil, (6.003) probenazole, and (6.004) tiadinil.

[0180] 7) Inhibitors of amino acid and / or protein biosynthesis, for example (7.001) cyprodinil, (7.002) kasugamycin, (7.003) kasugamycin hydrochloride hydrate, (7.004) oxytetracycline, (7.005) pyrimethanil, (7.006) 3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinoline.

[0181] 8) Inhibitors of ATP production, for example (8.001) silthiofam.

[0182] 9) Inhibitors of cell wall synthesis, for example: (9.001) benthiavalicarb, (9.002) dimethomorph, (9.003) flumorph, (9.004) iprovalicarb, (9.005) mandipropamide, (9.006) pyrimorph, (9.007) valifenalate, (9.008) (2E)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one, (9.009) (2Z)-3-(4-tert-butylphenyl)-3-(2-chloropyridin-4-yl)-1-(morpholin-4-yl)prop-2-en-1-one.

[0183] 10) Inhibitors of lipid and membrane synthesis, for example: (10.001) prothiocarb, (10.002) propamocarb hydrochloride, (10.003) tolclofos-methyl.

[0184] 11) Melanin biosynthesis inhibitors, for example (11.001) tricyclazole, (11.002) tolprocarb.

[0185] 12) Nucleic acid synthesis inhibitors, for example (12.001) benalaxyl, (12.002) benalaxyl-M (kiralaxyl), (12.003) metalaxyl, (12.004) metalaxyl-M (mefenoxam).

[0186] 13) Signal transduction inhibitors, for example (13.001) fludioxonil, (13.002) iprodione, (13.003) procymidone, (13.004) proquinazid, (13.005) quinoxyfen, (13.006) vinclozolin.

[0187] 14) Compounds capable of acting as uncouplers, for example (14.001) fluazinam and (14.002) meptyldinocap.

[0188] 15) Other fungicides selected from: (15.001) abscisic acid, (15.002) benthiazole, (15.003) bethoxazin, (15.004) capsimycin, (15.005) carvone, (15.006) chinomethionat, (15.007) cufraneb, (15.008) cyflufenamid, (15.009) cymoxanil, (15.010) cyprosulfamide, (15.011) flutianil, (15.012) fosetyl-aluminium, (15.013) fosetyl-calcium, (15.014) fosetyl-sodium, (15.015) methyl isothiocyanate isothiocyanate), (15.016) metrafenone, (15.017) mildiomycin, (15.018) natamycin, (15.019) nickeldimethyldithiocarbamate, (15.020) nitrothal-isopropyl, (15.021) oxamocarb, (15.022) oxathiapiprolin, (15.023) oxyfenthiin, (15.024) pentachlorophenol and its salts, (15.025) phosphorous acid and its salts itssalts), (15.026) propamocarb-fosetylate, (15.027) pyriofenone (chlazafenone), (15.028) tebufloquin, (15.029) tecloftalam, (15.030) tolnifanide, (15.031) 1-(4-{4-[(5R)-5-(2,6-difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, (15.032) 1-(4-{4-[(5S)-5-(2,6-difluoromethyl)-4,5-dihydro-1,2-oxazol-3-yl]-1,3-thiazol-2-yl}piperidin-1-yl)-2-[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanone, (15.033) 2-(6-benzylpyridin-2-yl)quinazoline, (15.034) dipymetitrone, (15.035) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1 -yl]ethanone, (15.036) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-chloro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.037) 2-[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]-1-[4-(4-{5-[2-fluoro-6-(prop-2-yn-1-yloxy)phenyl]-4,5-dihydro-1,2-oxazol-3-yl}-1,3-thiazol-2-yl)piperidin-1-yl]ethanone, (15.038) 2-[6-(3-fluoro-4-methoxy 2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate, (15.040) 2-{(5S)-3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}-3-chlorophenyl methanesulfonate, (15.041) ipflufenoquinoline, (1 5.042) 2-{2-fluoro-6-[(8-fluoro-2-methylquinolin-3-yl)oxy]phenyl}propan-2-ol, (15.043) fluoxapiprolin, (15.044) 2-{3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-4,5-dihydro-1,2-oxazol-5-yl}phenyl methanesulfonate, (15.045) 2-phenylphenol and its salts, (15.046) 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinoline, (15.047) quinofumelin, (15.048)048) 4-amino-5-fluoropyrimidin-2-ol (tautomer: 4-amino-5-fluoropyrimidin-2(1H)-one), (15.049) 4-oxo-4-[(2-phenylethyl)amino]butyric acid, (15.050) 5-amino-1,3,4-thiadiazole-2-thiol, (15.051) 5-chloro-N'-phenyl-N'-(prop-2-yn-1-yl)thiophene-2-sulfonylhydrazide, (15.052) 5-fluoro-2-[(4-fluorobenzyl)oxy]pyrimidin-4-amine, (15.053) 5-fluoro-2-[(4-methylbenzyl)oxy]pyrimidin-4-amine, (15.054) 9-fluoro-2,2-dimethyl-5-(quinolin-3-yl)-2,3-dihydro-1, 4-Benzoxazepine, (15.055) but-3-yn-1-yl {6-[({[(Z)-(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate, (15.056) (2Z)-3-amino-2-cyano-3-phenylacrylate ethyl ester, (15.057) phenazine-1-carboxylic acid, (15.058) 3,4,5-trihydroxybenzoic acid propyl ester, (15.059) quinolin-8-ol, (15.060) quinolin-8-ol sulfate (2:1), (15.061) {6-[({[(1-methyl-1H-tetrazol-5-yl)(phenyl)methylene]amino}oxy)methyl]pyridin-2-yl}carbamate} tert-butyl carbamate, (15.062) 5-fluoro-4-imino-3-methyl-1-[(4-methylphenyl)sulfonyl]-3,4-dihydropyrimidin-2(1H)-one, (15.063) aminopyrifen, (15.064) (N'-[2-chloro-4-(2-fluorophenoxy)-5-methylphenyl]-N-ethyl-N-methyliminocarboxamide), (15.065) (N'-(2-chloro-5-methyl-4-phenoxyphenyl)-N-ethyl-N-methyliminocarboxamide), (15.066) (2-{2-[(7,8-difluoro-2-methylquinolin-3-yl)oxy]-6-fluorophenyl}propan-2-ol), (15.067) (5-bromo -1-(5,6-dimethylpyridin-3-yl)-3,3-dimethyl-3,4-dihydroisoquinoline), (15.068) (3-(4,4-difluoro-5,5-dimethyl-4,5-dihydrothieno[2,3-c]pyridin-7-yl)quinoline), (15.069) (1-(4,5-dimethyl-1H-benzoimidazol-1-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline), (15.070) 8-fluoro-3-(5-fluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)quinolone, (15.071) 8-fluoro-3-(5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl)quinolone, (15.072) 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl)-8-fluoroquinoline, (15.073) (N-methyl-N-phenyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide), (15.074) methyl {4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}carbamate, (15.075) (N-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzyl}cyclopropanecarboxamide), (15.076) N-methyl-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.077) N-[(E)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.078) N-[(Z)-methoxyiminomethyl]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.079) N-[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]cyclopropanecarboxamide, (15.080) N-(2-fluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.081) 2,2-difluoro-N-methyl-2-[4-[5-(trifluoromethyl)-1,2,4- oxadiazol-3-yl]phenyl]acetamide, (15.082) N-propenyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl]methyl]acetamide, (15.083) N-[(E)-N-methoxy-C-methyl-carbonimido]-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.084) N-[(Z)-N-methoxy-C-methyl-carbonimido]-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.085) N-propenyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]acetamide phenyl]methyl]propanamide, (15.086) 4,4-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one, (15.087) N-methyl-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]thiobenzamide, (15.088) 5-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]pyrrolidin-2-one, (15.089) N-((2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]-3,3,3-trifluoropropanamide, (15.090) 1-methoxy-1-methyl-3-[[4-[5-(trifluoromethyl}-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.091) 1,1-diethyl-3-[[4-[5-(trifluoromethyl}-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.092) N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, (15.093) N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, (15.094) 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl] urea, (15.095) N-methoxy-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]cyclopropanecarboxamide, (15.096) N,2-dimethoxy-N-[[4-[5-(trifluoromethyl}-1,2,4-oxadiazol-3-yl]phenyl]methyl]propanamide, (15.097) N-ethyl-2-methyl-N-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl)phenyl]methyl]propanamide, (15.098) 1-methoxy-3-methyl-1-[[4-[5-(trifluoromethyl)-1,2,4- 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.099) 1,3-dimethoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.100) 3-ethyl-1-methoxy-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]urea, (15.101) 1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one, (15.102) 4,4-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, (15.103) 15.103) 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, (15.104) 3,3-dimethyl-1-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]piperidin-2-one, (15.105) 1-[[3-fluoro-4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]azepan-2-one, (15.106) 4,4-dimethyl-2-[[4-(5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, (15.107)107) 5,5-dimethyl-2-[[4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl]methyl]isoxazolidin-3-one, (15.108) 1-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzyl}-1H-pyrazole-4-carboxylic acid ethyl ester, (15.109) N,N-dimethyl-1-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzyl}-1H-1,2,4-triazol-3-amine, (15.110) N-{2,3-difluoro-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzyl}butanamide, (15.111) 111) N-(1-methylcyclopropyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.112) N-(2,4-difluorophenyl)-4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzamide, (15.113) 1-(5,6-dimethylpyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.114) 1-(6-(difluoromethyl)-5-methyl-pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.115) 1-(5-(fluoromethyl)-6-methyl- pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.116) 1-(6-(difluoromethyl)-5-methoxy-pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.117) 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl dimethylcarbamate, (15.118) N-{4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]phenyl}propionamide, (15.119) 3-[2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4 -yl)-1,3-thiazol-4-yl]-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate, (15.120) 9-fluoro-3-[2-(1-{[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate, (15.121) 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate, (15.122) 3-[2-(1-{[3,5-bis(difluoromethyl)-1H-pyrazol-1-yl]acetyl}piperidin-4-yl)-1,3-thiazol-4-yl]-9-fluoro-1,5-dihydro-2,4-benzodioxepin-6-yl methanesulfonate, (15.123) 1-(6,7-dimethylpyrazolo[1,5-a]pyridin-3-yl)-4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinoline, (15.124) 8-fluoro-N-(4,4,4 -trifluoro-2-methyl-1-phenylbutan-2-yl)quinoline-3-carboxamide, (15.125) 8-fluoro-N-[(2S)-4,4,4-trifluoro-2-methyl-1-phenylbutan-2-yl]quinoline-3-carboxamide, (15.126) N-(2,4-dimethyl-1-phenylpentan-2-yl)-8-fluoroquinoline-3-carboxamide and (15.127) N-[(2S)-2,4-dimethyl-1-phenylpentan-2-yl)-8-fluoroquinoline-3-carboxamide. If the functional groups of all named mixed compatibilizers of classes (1) to (15) are capable of forming salts with suitable bases or acids, they may optionally form salts with suitable bases or acids.

[0189] Another aspect of the present invention relates to one or more of the following combinations of compounds:

[0190] (I.001)+(1.001)、(I.001)+(1.002)、(I.001)+(1.003)、(I.001)+(1.004)、(I.001)+(1.005)、(I.001)+(1.006)、(I.001)+(1.007)、(I.001)+(1.008)、(I.001)+(1.009)、(I.001)+(1.010)、(I.001)+(1.011)、(I.001)+(1.012)、(I.001)+(1.013)、(I.001)+(1.014)、(I.001)+(1.015)、(I.001)+(1.016)、(I.001)+(1.017)、(I.001)+(1.018)、(I.001)+(1.019)、(I.001)+(1.020)、(I.001)+(1.021)、(I.001)+(1.022)、(I.001)+(1.023)、(I.001)+(1.024)、(I.001)+(1.025)、(I.001)+(1.026)、(I.001)+(1.027)、(I.001)+(1.028)、(I.001)+(1.029)、(I.001)+(1.030)、(I.001)+(1.031)、(I.001)+(1.032)、(I.001)+(1.033)、(I.001)+(1.034)、(I.001)+(1.035)、(I.001)+(1.036)、(I.001)+(1.037)、(I.001)+(1.038)、(I.001)+(1.039)、(I.001)+(1.040)、(I.001)+(1.041)、(I.001)+(1.042)、(I.001)+(1.043)、(I.001)+(1.044)、(I.001)+(1.045)、(I.001)+(1.046)、(I.001)+(1.047)、(I.001)+(1.048)、(I.001)+(1.049)、(I.001)+(1.050)、(I.001)+(1.051)、(I.001)+(1.052)、(I.001)+(1.053)、(I.001)+(1.054)、(I.001)+(1.055)、(I.001)+(1.056)、(I.001)+(1.057)、(I.001)+(1.058)、(I.001)+(1.059)、(I.001)+(1.060)、(I.001)+(1.061)、(I.001)+(1.062)、(I.001)+(1.063)、(I.001)+(1.064)、(I.001)+(1.065)、(I.001)+(1.066)、(I.001)+(1.067)、(I.001)+(1.068)、(I.001)+(1.069)、(I.001)+(1.070)、(I.001)+(1.071)、(I.001)+(1.072)、(I.001)+(1.073)、(I.001)+(1.074)、(I.001)+(1.075)、(I.001)+(1.076)、(I.001)+(1.077)、(I.001)+(1.078)、(I.001)+(1.079)、(I.001)+(1.080)、(I.001)+(1.081)、(I.001)+(1.082)、(I.001)+(1.083)、(I.001)+(1.084)、(I.001)+(1.085)、(I.001)+(1.086)、(I.001)+(1.087)、(I.001)+(1.088)、(I.001)+(1.089)、(I.001)+(2.001)、(I.001)+(2.002)、(I.001)+(2.003)、(I.001)+(2.004)、(I.001)+(2.005)、(I.001)+(2.006)、(I.001)+(2.007)、(I.001)+(2.008)、(I.001)+(2.009)、(I.001)+(2.010)、(I.001)+(2.011)、(I.001)+(2.012)、(I.001)+(2.013)、(I.001)+(2.014)、(I.001)+(2.015)、(I.001)+(2.016)、(I.001)+(2.017)、(I.001)+(2.018)、(I.001)+(2.019)、(I.001)+(2.020)、(I.001)+(2.021)、(I.001)+(2.022)、(I.001)+(2.023)、(I.001)+(2.024)、(I.001)+(2.025)、(I.001)+(2.026)、(I.001)+(2.027)、(I.001)+(2.028)、(I.001)+(2.029)、(I.001)+(2.030)、(I.001)+(2.031)、(I.001)+(2.032)、(I.001)+(2.033)、(I.001)+(2.034)、(I.001)+(2.035)、(I.001)+(2.036)、(I.001)+(2.037)、(I.001)+(2.038)、(I.001)+(2.039)、(I.001)+(2.040)、(I.001)+(2.041)、(I.001)+(2.042)、(I.001)+(2.043)、(I.001)+(2.044)、(I.001)+(2.045)、(I.001)+(2.046)、(I.001)+(2.047)、(I.001)+(2.048)、(I.001)+(2.049)、(I.001)+(2.050)、(I.001)+(2.051)、(I.001)+(2.052)、(I.001)+(2.053)、(I.001)+(2.054)、(I.001)+(2.055)、(I.001)+(2.056)、(I.001)+(2.057)、(I.001)+(2.058)、(I.001)+(2.059)、(I.001)+(2.060)、(I.001)+(3.001)、(I.001)+(3.002)、(I.001)+(3.003)、(I.001)+(3.004)、(I.001)+(3.005)、(I.001)+(3.006)、(I.001)+(3.007)、(I.001)+(3.008)、(I.001)+(3.009)、(I.001)+(3.010)、(I.001)+(3.011)、(I.001)+(3.012)、(I.001)+(3.013)、(I.001)+(3.014)、(I.001)+(3.015)、(I.001)+(3.016)、(I.001)+(3.017)、(I.001)+(3.018)、(I.001)+(3.019)、(I.001)+(3.020)、(I.001)+(3.021)、(I.001)+(3.022)、(I.001)+(3.023)、(I.001)+(3.024)、(I.001)+(3.025)、(I.001)+(3.026)、(I.001)+(3.027)、(I.001)+(3.028)、(I.001)+(3.029)、(I.001)+(3.030)、(I.001)+(3.031)、(I.001)+(4.001)、(I.001)+(4.002)、(I.001)+(4.003)、(I.001)+(4.004)、(I.001)+(4.005)、(I.001)+(4.006)、(I.001)+(4.007)、(I.001)+(4.008)、(I.001)+(4.009)、(I.001)+(4.010)、(I.001)+(4.011)、(I.001)+(4.012)、(I.001)+(4.013)、(I.001)+(4.014)、(I.001)+(4.015)、(I.001)+(4.016)、(I.001)+(4.017)、(I.001)+(4.018)、(I.001)+(4.019)、(I.001)+(4.020)、(I.001)+(4.021)、(I.001)+(4.022)、(I.001)+(4.023)、(I.001)+(4.024)、(I.001)+(4.025)、(I.001)+(4.026)、(I.001)+(5.001)、(I.001)+(5.002)、(I.001)+(5.003)、(I.001)+(5.004)、(I.001)+(5.005)、(I.001)+(5.006)、(I.001)+(5.007)、(I.001)+(5.008)、(I.001)+(5.009)、(I.001)+(5.010)、(I.001)+(5.011)、(I.001)+(5.012)、(I.001)+(5.013)、(I.001)+(5.014)、(I.001)+(5.015)、(I.001)+(5.016)、(I.001)+(5.017)、(I.001)+(5.018)、(I.001)+(5.019)、(I.001)+(5.020)、(I.001)+(5.021)、(I.001)+(5.022)、(I.001)+(5.023)、(I.001)+(6.001)、(I.001)+(6.002)、(I.001)+(6.003)、(I.001)+(6.004)、(I.001)+(7.001)、(I.001)+(7.002)、(I.001)+(7.003)、(I.001)+(7.004)、(I.001)+(7.005)、(I.001)+(7.006)、(I.001)+(8.001)、(I.001)+(9.001)、(I.001)+(9.002)、(I.001)+(9.003)、(I.001)+(9.004)、(I.001)+(9.005)、(I.001)+(9.006)、(I.001)+(9.007)、(I.001)+(9.008)、(I.001)+(9.009)、(I.001)+(10.001)、(I.001)+(10.002)、(I.001)+(10.003)、(I.001)+(11.001)、(I.001)+(11.002)、(I.001)+(12.001)、(I.001)+(12.002)、(I.001)+(12.003)、(I.001)+(12.004)、(I.001)+(13.001)、(I.001)+(13.002)、(I.001)+(13.003)、(I.001)+(13.004)、(I.001)+(13.005)、(I.001)+(13.006)、(I.001)+(14.001)、(I.001)+(14.002)、(I.001)+(15.001)、(I.001)+(15.002)、(I.001)+(15.003)、(I.001)+(15.004)、(I.001)+(15.005)、(I.001)+(15.006)、(I.001)+(15.007)、(I.001)+(15.008)、(I.001)+(15.009)、(I.001)+(15.010)、(I.001)+(15.011)、(I.001)+(15.012)、(I.001)+(15.013)、(I.001)+(15.014)、(I.001)+(15.015)、(I.001)+(15.016)、(I.001)+(15.017)、(I.001)+(15.018)、(I.001)+(15.019)、(I.001)+(15.020)、(I.001)+(15.021)、(I.001)+(15.022)、(I.001)+(15.023)、(I.001)+(15.024)、(I.001)+(15.025)、(I.001)+(15.026)、(I.001)+(15.027)、(I.001)+(15.028)、(I.001)+(15.029)、(I.001)+(15.030)、(I.001)+(15.031)、(I.001)+(15.032)、(I.001)+(15.033)、(I.001)+(15.034)、(I.001)+(15.035)、(I.001)+(15.036)、(I.001)+(15.037)、(I.001)+(15.038)、(I.001)+(15.039)、(I.001)+(15.040)、(I.001)+(15.041)、(I.001)+(15.042)、(I.001)+(15.043)、(I.001)+(15.044)、(I.001)+(15.045)、(I.001)+(15.046)、(I.001)+(15.047)、(I.001)+(15.048)、(I.001)+(15.049)、(I.001)+(15.050)、(I.001)+(15.051)、(I.001)+(15.052)、(I.001)+(15.053)、(I.001)+(15.054)、(I.001)+(15.055)、(I.001)+(15.056)、(I.001)+(15.057)、(I.001)+(15.058)、(I.001)+(15.059)、(I.001)+(15.060)、(I.001)+(15.061)、(I.001)+(15.062).(I.001)+(15.063).(I.001)+(15.064).(I.001)+(15.065)、(I.001)+15.066)、(I.001)+(15.067)、(I.001)+(15.068)、(I.001)+(15.069)、(I.001)+(15.070)、(I.001)+(15.071)、(I.001)+(15.072)、(I.001)+(15.073)、(I.001)+(15.074)、(I.001)+(15.075)、(I.001)+(15.076)、(I.001)+(15.077)、(I.001)+(15.078)、(I.001)+(15.079)、(I.001)+(15.080)、(I.001)+(15.081)、(I.001)+(15.082)、(I.001)+(15.083)、(I.001)+(15.084)、(I.001)+(15.085)、(I.001)+(15.086)、(I.001)+(15.087)、(I.001)+(15.088)、(I.001)+(15.089)、(I.001)+(15.090)、(I.001)+(15.091)、(I.001)+(15.092)、(I.001)+(15.093)、(I.001)+(15.094)、(I.001)+(15.095)、(I.001)+(15.096)、(I.001)+(15.097)、(I.001)+(15.098)、(I.001)+(15.099)、(I.001)+(15.100)、(I.001)+(15.101), (I.001)+(15.102), (I.001)+(15.103), (I.001)+(15.104), (I.001)+(15.105), (I.001)+(15.106), (I.001)+(15.107), (I.0 01)+(15.108), (I.001)+(15.109), (I.001)+(15.110), (I.001)+(15.111), (I.001)+(15.112), (I.001)+(15.113), (I.001)+(15.11 4), (I.001)+(15.115), (I.001)+(15.116), (I.001)+(15.117), (I.001)+(15.118), (I.001)+(15.119), (I.001)+(15.120), (I.001) +(15.121), (I.001)+(15.122), (I.001)+(15.123), (I.001)+(15.124), (I.001)+(15.125), (I.001)+(15.126), (I.001)+(15.127). .

[0191] In these combinations, the first component is a compound of formula (I) as defined in Tables 1a and 1b (e.g. I.001) and the second component is a fungicide from Groups 1 to 15 as defined herein. For example, the combination (I.001) + (1.001) corresponds to a combination comprising compound I.001 in Tables 1a and 1b and cyproconazole (1.001).

[0192] In some other embodiments, the compound combinations correspond to the above combinations, wherein compound (I.001) is replaced by any one of the compounds listed in Tables Ia and Ib.

[0193] The compound of formula (I) and the fungicide selected from groups (1) to (15) may be present in a weight ratio of 100:1 to 1:100 (compound of formula (I) : fungicide selected from groups (1) to (15)), or in the range of 50:1 to 1:50, or in the range of 20:1 to 1:20. Other examples of weight ratio ranges include 95: 1 to 1:95, 90: 1 to 1:90, 85: 1 to 1:85, 80: 1 to 1:80, 75: 1 to 1:75, 70: 1 to 1:70, 65: 1 to 1:65, 60: 1 to 1:60, 55: 1 to 1:55, 45: 1 to 1:45, 40: 1 to 1:40, 35: 1 to 1:35, 30: 1 to 1:30, 25: 1 to 1:25, 15: 1 to 1:15, 10: 1 to 1:10, 5: 1 to 1:5, 4: 1 to 1:4, 3: 1 to 1:3, and 2: 1 to 1:2.

[0194] Another fungicide selected from Groups 1 to 15 as defined herein may be added to the combination of compounds.

[0195] The compounds of formula (I) and compositions comprising the same may be combined with one or more biological control agents.

[0196] Examples of biological control agents that can be combined with the compounds of formula (I) and compositions comprising the same are:

[0197] (A) an antibacterial agent selected from the group consisting of:

[0198] (A1) bacteria, for example (A1.1) Bacillus subtilis, in particular strain QST713 / AQ713 (SERENADE OPTI or SERENADE ASO available from Bayer CropScience LP, US, with NRRL accession number B21661, described in US Pat. No. 6,060,051); (A1.2) Bacillus amyloliquefaciens, in particular strain D747 (Double Nickel available from Certis, US TM , with accession number FERM BP-8234, disclosed in U.S. Pat. No. 7,094,592); (A1.3) Bacillus pumilus, in particular strain BU F-33 (with NRRL accession number 50185); (A1.4) Bacillus subtilis var. amyloliquefaciens strain FZB24 (available from Novozymes, US (A1.5) Paenibacillus sp. strain, having accession number NRRL B-50972 or accession number NRRL B-67129, described in International Patent Publication No. WO 2016 / 154297; and

[0199] (A2) fungi, for example (A2.1) budding spores of Aureobasidium pullulans, in particular the blastospores of strain DSM 14940; (A2.2) blastospores of Aureobasidium pullulans strain DSM 14941; (A2.3) blastospores of Aureobasidium pullulans, in particular a mixture of blastospores of strains DSM 14940 and DSM 14941;

[0200] (B) a fungicide selected from the group consisting of:

[0201] (B1) bacteria, for example (B1.1) Bacillus subtilis, in particular strain QST713 / AQ713 (SERENADE OPTI or SERENADE ASO available from Bayer CropScience LP, US, having NRRL accession number B21661, described in US Pat. No. 6,060,051); (B1.2) Bacillus pumilus, in particular strain QST2808 (available from Bayer CropScience LP, US Accession No. NRRL B-30087, described in U.S. Pat. No. 6,245,551); (B1.3) Bacillus pumilus, in particular strain GB34 (available from Bayer AG, DE as YIELD ); (B1.4) Bacillus pumilus, in particular strain BU F-33 (having NRRL accession number 50185); (B1.5) Bacillus amyloliquefaciens, in particular strain D747 (available from Double Nickel, Certis, US TM , with accession number FERM BP-8234, disclosed in U.S. Pat. No. 7,094,592); (B1.6) Bacillus subtilis Y1336 (available from Bion-Tech, Taiwan, China WP, registered as a biofungicide in Taiwan, China with registration numbers 4764, 5454, 5096 and 5277); (B1.7) Bacillus amyloliquefaciens strain MBI 600 (available from SUBTILEX of BASF SE); (B1.8) Bacillus subtilis strain GB03 (available from Bayer AG, DE ); (B1.9) Bacillus subtilis var. amyloliquefaciens strain FZB24 (fungicide available from Novozymes Biologicals Inc., Salem, Virginia or Syngenta Crop Protection, LLC, Greensboro, North Carolina or ECO (EPA registration number 70127-5); (B1.10) Bacillus mycoides, isolate J (available from BMJ TGAI or WG from Certis USA); (B1.11) Bacillus licheniformis, in particular strain SB3086 (available from EcoGuard from Novozymes); TM Biofungicide and GreenReleaf); (B1.12) Paenibacillus sp. strain, having accession number NRRL B-50972 or accession number NRRL B-67129, described in International Patent Publication No. WO 2016 / 154297;

[0202] In some embodiments, the biological control agent is a Bacillus subtilis or Bacillus amyloliquefaciens strain that produces a fengycin or plipastatin type compound, an iturin type compound, and / or a surfactin type compound. For background, see the following review article: Ongena, M., et al., "Bacillus Lipopeptides: Versatile Weapons for Plant Disease Biocontrol," Trends in Microbiology, Vol 16, No. 3, March 2008, pp. 115-125. Bacillus strains capable of producing lipopeptides include Bacillus subtilis QST713 (available as SERENADE OPTI or SERENADE ASO from Bayer CropScience LP, US, having NRRL accession number B-21661, described in US Pat. No. 6,060,051), Bacillus amyloliquefaciens strain D747 (available as Double Nickel from Certis, US, TM , with accession number FERM BP-8234, disclosed in U.S. Pat. No. 7,094,592), Bacillus subtilis MBI600 (available from Becker Underwood, U.S. EPA Reg. No. 71840-8); Bacillus subtilis Y1336 (available from Bion-Tech, Taiwan, China WP, registered as a biofungicide in Taiwan under the registration numbers 4764, 5454, 5096 and 5277; Bacillus amyloliquefaciens, in particular strain FZB42 (available from ABiTEP, DE ); and Bacillus subtilis var. amyloliquefaciens strain FZB24 (fungicides available from Novozymes Biologicals Inc., Salem, Virginia or Syngenta Crop Protection, LLC, Greensboro, North Carolina or ECO (EPA Registration No. 70127-5); and

[0203] (B2) Fungi, for example: (B2.1) Coniothyrium minitans, in particular strain CON / M / 91-8 (accession number DSM-9660; e.g., Bayer ); (B2.2) Metschnikowia fructicola, in particular strain NRRL Y-30752 (e.g. ); (B2.3) Microsphaeropsis ochracea (e.g. Prophyta ); (B2.5) Trichoderma sp. including Trichoderma atroviride strain SC1, described in International Application No. PCT / IT2008 / 000196); (B2.6) Trichoderma harzianum rifai strain KRL-AG2 (also known as strain T-22, / ATCC 208479, such as PlantShield T-22G from BioWorks, US, and TurfShield); (B2.14) Gliocladium roseum strain 321U from WF Stoneman Company LLC; (B2.35) Talaromyces flavus strain V117b; (B2.36) Trichoderma asperellum strain ICC 012 from Isagro; (B2.37) Trichoderma asperellum strain SKT-1 (e.g., Kumiai Chemical Industry ); (B2.38) Trichoderma atroviride, strain CNCM I-1237 (e.g. Agrauxine, FR ); (B2.39) dark green Trichoderma strain number V08 / 002387; (B2.40) dark green Trichoderma, strain NMI number V08 / 002388; (B2.41) dark green Trichoderma, strain NMI number V08 / 002389; (B2.42) dark green Trichoderma, strain NMI number V08 / 002390; (B2.43) dark green Trichoderma, strain LC52 (e.g. Tenet from Agrimm Technologies Limited); (B2.44) dark green Trichoderma, strain ATCC 20476 (IMI206040); (B2.45) dark green Trichoderma, strain T11 (IMI352941 / CECT20498); (B2.46) hooked Trichoderma (Trichoderma harmatum); (B2.47) Trichoderma harzianum; (B2.48) Trichoderma harzianum T39 (e.g. Makhteshim, US ); (B2.49) Trichoderma harzianum, in particular strain KD (e.g. Trichoplus from Biological Control Products, SA (available from Becker Underwood)); (B2.50) Trichoderma harzianum, strain ITEM 908 (e.g. Trianum-P from Koppert); (B2.51) Trichoderma harzianum, strain TH35 (e.g. Root-Pro from Mycontrol); (B2.52) Trichoderma virens (also known as Gliocladium virens), in particular strain GL-21 (e.g. SoilGard 12G from Certis, US); (B2.53) Trichoderma viride, strain TV1 (e.g. Trianum-P from Koppert); (B2.54) Ampelomyces quisqualis, in particular strain AQ10 (e.g. AQ from IntrachemBio Italia); (B2.56) budding spores of Aureobasidium, in particular strain DSM 14940; (B2.57) budding spores of Aureobasidium, in particular strain DSM 14941; (B2.58) budding spores of Aureobasidium, in particular strains DSM 14940 and DSM 14941 (e.g. bio-ferm, CH ); (B2.64) Cladosporium cladosporioides, strain H39 (from Stichting Dienst Landbouwkundig Onderzoek); (B2.69) Gliocladium catenulatum Synonyms: Clonostachys rosea f.catenulate strain J1446 (e.g. from AgBio Inc. and for example Kemira Agro Oy ); (B2.70) conidia of Lecanicillium lecanii (formerly Verticillium lecanii) strain KV01 (e.g. Koppert / Arysta ); (B2.71) Penicillium vermiculatum; (B2.72) Pichia anomala, strain WRL-076 (NRRL Y-30842); (B2.75) Trichoderma aureum, strain SKT-1 (FERM P-16510); (B2.76) Trichoderma aureum, strain SKT-2 (FERM P-16511); (B2.77) Trichoderma aureum, strain SKT-3 (FERMP-17021); (B2.78) Trichoderma gamsii (formerly known as T. viride), strain ICC080 (IMICC 392151CABI, such as AGROBIOSOL DE MEXICO, SADE CV's BioDerma); (B2.79) Trichoderma harzianum, strain DB 103 (such as Dagutat (B2.80) Trichoderma polysporum, strain IMI 206039 (e.g. Binab TF WP from BINAB Bio-Innovation AB, Sweden); (B2.81) Trichoderma stromaticum (e.g. Tricovab from Ceplac, Brazil); (B2.83) Ulocladium oudemansii, in particular strain HRU3 (e.g. Botry-Zen Ltd, NZ ); (B2.84) Verticillium albo-atrum (formerly known as V. dahlia), strain WCS850 (CBS276.92; for example, Dutch Trig from Tree Care Innovations); (B2.86) Verticillium chlamydosporium; (B2.87) a mixture of Trichoderma spinulosa strain ICC 012 and Trichoderma gemsii strain ICC 080 (products such as BO-TAM from Bayer CropScience LP, US TM ).

[0204] Other examples of biological control agents that can be combined with the compounds of formula (I) and compositions comprising the same are:

[0205] Bacteria selected from the group consisting of Bacillus cereus, in particular Bacillus licheniformis strain CNCM I-1562 and Bacillus firmus strain I-1582 (accession number CNCM I-1582), Bacillus subtilis strain OST 30002 (accession number NRRL B-50421), Bacillus thuringiensis, in particular Bacillus thuringiensis subspecies israelensis (serotype H-14) strain AM65-52 (accession number ATCC 1276), Bacillus thuringiensis subsp. aizawai, in particular strain ABTS-1857 (SD-1372), Bacillus thuringiensis subsp. kustak strain (B. thuringiensis subsp. kurstaki) HD-1, Bacillus thuringiensis subsp. tenebrionis strain NB 176 (SD-5428), Pasteuria spp. (Rotylenchulus reniformisnematode)-PR3 (Accession No. ATCC SD-5834), Streptomyces microflavus strain AQ6121 (=QRD 31.013, NRRL B-50550), and Streptomyces galbus strain AQ6047 (Accession No. NRRL 30232);

[0206] Fungi and yeasts selected from Beauveria bassiana, in particular strain ATCC 74040, Lecanicillium spp., in particular strain HRO LEC 12, Metarhizium anisopliae, in particular strain F52 (DSM 3884 or ATCC 90448), Paecilomyces fumosoroseus (now: Isaria fumosorosea), in particular strain IFPC 200613, or strain Apopka 97 (accession number ATCC 20874), and Paecilomyces lilacinus, in particular Paecilomyces lilacinus strain 251 (AGAL 89 / 030550);

[0207] The virus is selected from the group consisting of Adoxophyes orana granulovirus (GV), Cydiapomonella granulovirus (GV), Helicoverpa armigera nuclear polyhedrosis virus (NPV), Spodoptera exigua mNPV, Spodoptera frugiperda mNPV, and Spodoptera littoralis NPV.

[0208] Bacteria and fungi that can be added to plants or plant parts or plant organs as "inoculants" can, due to their special properties, promote plant growth and plant health. Examples are: Agrobacterium spp., Azorhizobium caulinodans, Azospirillum spp., Azotobacter spp., Bradyrhizobium spp., Burkholderia spp., in particular Burkholderia cepacia (formerly Pseudomonas cepacia), Gigaspora spp., or Gigaspora monosporum, Glomus spp., Laccaria spp., Lactobacillus buchneri, Paraglomus spp.), Pisolithus tinctorus, Pseudomonas spp., Rhizobium spp., particularly Rhizobium trifolii, Rhizopogon spp., Scleroderma spp., Suillus spp., and Streptomyces spp.

[0209] Plant extracts and products formed by microorganisms that can be used as biological control agents, including proteins and secondary metabolites, such as Allium sativum, Artemisia absinthium, azadirachtin, Biokeeper WP, Cassia nigricans, Celastrusangulatus, Chenopodium anthelminticum, chitin, Armour-Zen, Dryopteris filix-mas, Equisetum arvense, Fortune Aza, Fungastop, Heads Up (Chenopodium quinoa saponin extract), Pyrethrum / Pyrethrins, Quassia amara, Quercus, Quillaja, Regalia, " insecticides", rotenone, ryania / ryanodine, Symphytum officinale, Tanacetum vulgare, thymol, Triact 70, TriCon, Tropaeulum majus, Urtica dioica, Veratrin, Viscum album, extracts from the Brassicaceae family, especially canola or mustard powder.

[0210] Examples of insecticides, acaricides and nematicides, respectively, which can be mixed with the compounds of formula (I) and compositions comprising them are:

[0211] (1) Acetylcholinesterase (AChE) inhibitors, such as carbamates selected from the group consisting of alanycarb, aldicarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofuran, carbosulfan, ethiofencarb, fenbuta ... obucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, triazamate, trimethacarb, XMC, and xylylcarb;or organophosphates, such as acephate, azamethiphos, azinphos-ethyl, azinphos-methyl, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos-methyl, cyanophos, demeton-S-methyl, diazinon, dichlorvos (DDVP), dicrotophos, dimethoate, dimethylvinphos, disulphoton, EPN, ethion, ethoprophos, famphur, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl O-(methoxyaminothiophosphoryl) salicylate O-(methoxyaminothiophosphoryl)salicylate), isoxathion, malathion, mecarbam, methidathion, mevinphos, naled, omethoate, oxydemeton-methyl, phenthoate, phorate, phosalone, phosmet, phoxim, pyrimidinphos irimiphos-methyl), profenofos, propetamphos, prothiofos, pyraclofos, pyridaphenthion, quinalphos, tebupirimfos, temephos, tetrachlorvinphos, thiometon, triazophos, triclorfon and vamidothion.

[0212] (2) GABA-gated chloride channel blockers, such as cyclopentadiene-organochlorines selected from chlordane; or phenylpyrazoles (fiproles) selected from ethiprole and fipronil.

[0213] (3) Sodium channel modulators, such as pyrethroids, for example, acrinathrin, allethrin, d-cis-trans allethrin, d-transallethrin, bifenthrin, bioallethrin, bioallethrin s-cyclopentenyl isomer, isomer), bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cypermethrin [(1R)-trans isomer] cyphenothrin [(1R)-trans-isomers]), deltamethrin, empenthrin [(EZ)-(1R)-isomers], esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, imiprothrin, kadethrin, momfluorothrin,permethrin, phenothrin [(1R)-trans-isomer], prallethrin, pyrethrins (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tralomethrin, and transfluthrin, or methoxychlor.

[0214] (4) Competitive modulators of the nicotinic acetylcholine receptor (nAChR), for example neonicotinoids, for example acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam or nicotine or sulfoxaflor or flupyradifurone.

[0215] (5) Nicotinic acetylcholine receptor (nAChR) allosteric modulators, such as spinosyns, for example spinetoram and spinosad.

[0216] (6) Glutamate-gated chloride channel (GluCl) allosteric modulators, such as avermectins / milbemycins, such as abamectin, emamectin benzoate, lepimectin and milbemycin.

[0217] (7) Juvenile hormone analogs, for example juvenile hormone analogs, such as hydroprene, kinoprene and methoprene or fenoxycarb or pyriproxifen.

[0218] (8) Various nonspecific (multi-site) inhibitors, for example halogenated hydrocarbons, such as methyl bromide and other halogenated hydrocarbons, or sulphuryl fluoride or borax or tartar emetic or methyl isocyanate generators, such as diazomet and metam.

[0219] (9) String modifiers, such as pymetrozine and flonicamid.

[0220] (10) Mite growth inhibitors, for example clofentezine, hexythiazox and diflovidazin or etoxazole.

[0221] (11) Microbial disruptors of insect gut membranes, such as Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies tenebrionis, and Bacillus thuringiensis subspecies: Cry1Ab, Cry1Ac, Cry1Fa, Cry1A.105, Cry2Ab, Vip3A, mCry3A, Cry3Ab, Cry3Bb, Cry34Ab1 / 35Ab1.

[0222] (12) Mitochondrial ATP synthase inhibitors, for example ATP disruptors, for example diafenthiuron or organotin compounds, for example azocyclotin, cyhexatin and fenbutatinoxide or propargite or tetradifon.

[0223] (13) Oxidative phosphorylation uncouplers that act by disrupting the proton gradient, such as chlorfenapyr and dinitrocresol (DNOC).

[0224] (14) Nicotinic acetylcholine receptor channel blockers, for example, bensultap, cartap hydrochloride, thiocylam and thiosultap-sodium.

[0225] (15) Type O chitin biosynthesis inhibitors, for example bistrifluron, chlofluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron.

[0226] (16) Type 1 chitin biosynthesis inhibitors, such as buprofezin.

[0227] (17) Molting disruptors (especially Diptera, i.e. insects of the order Diptera), for example cyromazine.

[0228] (18) Ecdysone receptor agonists, such as chromafenozide, halofenozide, methoxyfenozide and tebufenozide.

[0229] (19) Octopamine receptor agonists, such as amitraz.

[0230] (20) Mitochondrial complex III electron transfer inhibitors, such as hydramethylnone, acequinocyl or fluacrypyrim.

[0231] (21) Mitochondrial complex I electron transfer inhibitors, for example METI acaricides, for example fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad, tolfenpyrad and rotenone (Derris).

[0232] (22) Voltage-dependent sodium channel blockers, such as indoxacarb or metaflumizone.

[0233] (23) Acetyl-CoA carboxylase inhibitors, for example tetronic acid and tetramicacid derivatives, for example spirodiclofen, spiromesifen and spirotetramate.

[0234] (24) Mitochondrial complex IV electron transfer inhibitors, for example phosphine compounds, such as aluminum phosphide, and phosphine or cyanides, such as calcium cyanide, potassium cyanide and sodium cyanide.

[0235] (25) Mitochondrial complex II electron transfer inhibitors, for example, beta-ketonitrile derivatives, such as cyenopyrafen and cyflumetofen, and carboxanilides, such as pyflubumide.

[0236] (28) Ryanodine receptor modulators, for example diamides, such as chlorantraniliprole, cyantraniliprole and flubendiamide.

[0237] Other active compounds, such as Afidopyropen, Afoxolaner, Azadirachtin, Benclothiaz, Benzoximate, Bifenazate, Broflanilide, Bromopropylate, Chinomethionat, Chloroprallethrin, Cryolite, Cyclaniliprole, Cyclomethanil Cycloxaprid, Cyhalodiamide, Dicloromezotiaz, Epsilon-Metofluthrin, Epsilon-Momfluthrin, Flometoquin, Fluazaindolizine, Fluensulfone, Flufenerim, Flufenoxystrobin, Flufiprole, Fluhexafon, Fluopyram opyram), Fluralaner, Fluxametamide, Fufenozide, Guadipyr, Heptafluthrin, Imidaclothiz, Iprodione, kappa-Bifenthrin, kappa-Tefluthrin, Lotilaner, Meperfluthrin, Paichongding, Triflumethrin Pyridalyl, Pyrifluquinazon, Pyriminostrobin, Spirobudiclofen, Tetramethylfluthrin, Tetraniliprole, Tetrachlorantraniliprole, Tigolaner, Tioxazafen, Thiofluoximate, Triflumezopyrim, and Iodomethane,Other Bacillus firmus preparations (I-1582, BioNeem, Votivo), and the following compounds: 1-{2-fluoro-4-methyl-5-[(2,2,2-trifluoroethane)sulfinyl]phenyl}-3-(trifluoromethyl)-1H-1,2,4-triazol-5-amine (known from WO 2006 / 043635) (CAS 885026-50-6), {1'-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]-5-fluorospiro[indole-3,4'-piperidinyl]-1(2H)-yl}(2-chloropyridin-4-yl)methanone (known from WO 2003 / 106457) (CAS 637360-23-7), 2-chloro-N-[2-{1-[(2E)-3-(4-chlorophenyl)prop-2-en-1-yl]piperidin-4-yl}-4-(trifluoromethyl)phenyl]isonicotinamide (known from WO 2006 / 003494) (CAS 872999-66-1), 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8-methoxy-1,8-diazaspiro[4.5]dec-3-en-2-one (known from WO 2010 / 052161) (CAS 1225292-17-0), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-yl ethyl carbonate (known from EP 2647626) (CAS 1440516-42-6), 4-(but-2-yn-1-oxy)-6-(3,5-dimethylpiperidin-1-yl)-5-fluoropyrimidine (known from WO 2004 / 099160) (CAS 792914-58-0), PF1364 (known from JP 2010 / 018586) (CAS 1204776-60-2), N-[(2E)-1-[(6-chloropyridin-3-yl)methyl]pyridin-2(1H)-ylidene]-2,2,2-trifluoroacetamide (known from WO 2012 / 029672) (CAS 1363400-41-2), (3E)-3-[1-[(6-chloro-3-pyridinyl)methyl]-2-pyridylidene]-1,1,1-trifluoro-propan-2-one (known from WO 2013 / 144213) (CAS 1461743-15-6), N-[3-(benzyloxycarbamoyl)-4-chlorophenyl]-1-methyl-3-(pentafluoroethyl)-4-(trifluoromethyl)-1H-pyrazole-5-carboxamide (known from WO 2010 / 051926) (CAS 1226889-14-0), 5-bromo-4-chloro-N-[4-chloro-2-methyl-6-(methylcarbamoyl)phenyl]-2-(3-chloro-2-pyridyl)pyrazole-3-carboxamide (known from CN 103232431) (CAS 1449220-44-3),4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-epoxy(oxido)-3-thietanyl)-benzamide, 4-[5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(trans-1-epoxy-3-thietanyl)-benzamide and 4-[(5S)-5-(3,5-dichlorophenyl)-4,5-dihydro-5-(trifluoromethyl)-3-isoxazolyl]-2-methyl-N-(cis-1-epoxy-3-thietanyl)-benzamide (by WO 2013 / 050317 A1) (CAS 1332628-83-7), N-[3-chloro-1-(3-pyridyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]-propionamide, (+)-N-[3-chloro-1-(3-pyridyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]-propionamide and (-)-N-[3-chloro-1-(3-pyridyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)sulfinyl]-propionamide (known from WO 2013 / 162715 A2, WO 2013 / 162716 A2, US 2014 / 0213448A1 known) (CAS1477923-37-7), 5-[[(2E)-3-chloro-2-propen-1-yl]amino]-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile (known from CN 101337937 A) (CAS1105672-77-2), 3-bromo-N-[4-chloro-2-methyl-6-[(methylamino)thiomethyl]phenyl]-1-(3-chloro-2-pyridyl)-1H-pyrazole-5-carboxamide, (Liudaibenjiaxuanan, known from CN 103109816 A known) (CAS 1232543-85-9); N-[4-chloro-2-[[(1,1-dimethylethyl)amino]carbonyl]-6-methylphenyl]-1-(3-chloro-2-pyridyl)-3-(fluoromethoxy)-1H-pyrazole-5-carboxamide (known from WO 2012 / 034403 A1) (CAS 1268277-22-0), N-[2-(5-amino-1,3,4-thiadiazol-2-yl)-4-chloro-6-methylphenyl]-3-bromo-1-(3-chloro-2-pyridyl)-1H-pyrazole-5-carboxamide (known from WO 2011 / 085575 A1) (CAS 1233882-22-8),4-[3-[2,6-dichloro-4-[(3,3-dichloro-2-propen-1-yl)oxy]phenoxy]propoxy]-2-methoxy-6-(trifluoromethyl)-pyrimidine (known from CN 101337940 A) (CAS 1108184-52-6); (2E)- and 2(Z)-2-[2-(4-cyanophenyl)-1-[3-(trifluoromethyl)phenyl]ethylidene]-N-[4-(difluoromethoxy)phenyl]-hydrazinecarboxamide (known from CN 101715774 A) (CAS 1232543-85-9); 3-(2,2-dichlorovinyl)-2,2-dimethyl-4-(1H-benzimidazol-2-yl)phenyl-cyclopropanecarboxylate (known from CN 103524422 A known from (CAS 1542271-46-4); (4aS)-7-chloro-2,5-dihydro-2-[[(methoxycarbonyl)[4-[(trifluoromethyl)thio]phenyl]amino]carbonyl]-indeno[1,2-e][1,3,4]oxadiazine-4a(3H)-carboxylic acid methyl ester (known from CN 102391261 A) (CAS 1370358-69-2); 6-deoxy-3-O-ethyl-2,4-di-O-methyl-, 1-[N-[4-[1-[4-(1,1,2,2,2-pentafluoroethoxy)phenyl]-1H-1,2,4-triazol-3-yl]phenyl]carbamate]-α-L-pyranose (known from US2014 / 0275503 A1 known) (CAS 1181213-14-8); 8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-azabicyclo[3.2.1]octane (CAS 1253850-56-4), (8-trans)-8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-azabicyclo[3.2.1]octane (CAS 933798-27-7), (8-cis)-8-(2-cyclopropylmethoxy-4-trifluoromethyl-phenoxy)-3-(6-trifluoromethyl-pyridazin-3-yl)-3-azabicyclo[3.2.1]octane (WO 2007 / 040280 A1, WO 2007 / 040282 A1 known) (CAS 934001-66-8),N-[3-chloro-1-(3-pyridyl)-1H-pyrazol-4-yl]-N-ethyl-3-[(3,3,3-trifluoropropyl)thio]-propionamide (known from WO 2015 / 058021 A1, WO 2015 / 058028 A1) (CAS 1477919-27-9) and N-[4-(aminothiomethyl)-2-methyl-6-[(methylamino)carbonyl]phenyl]-3-bromo-1-(3-chloro-2-pyridyl)-1H-pyrazole-5-carboxamide (known from CN 103265527 A) (CAS 1452877-50-7), 5-(1,3-dioxan-2-yl)-4-[[4-(trifluoromethyl)phenyl]methoxy]-pyrimidine (known from WO 2013 / 115391 A1) (CAS 1449021-97-9), 3-(4-chloro-2,6-dimethylphenyl)-4-hydroxy-8-methoxy-1-methyl-1,8-diazaspiro[4.5]dec-3-en-2-one (known from WO 2010 / 066780 A1, WO 2011 / 151146 A1) (CAS 1229023-34-0), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-1,8-diazaspiro[4.5]decane-2,4-dione (known from WO 2014 / 187846 A1 known) (CAS 1638765-58-8), 3-(4-chloro-2,6-dimethylphenyl)-8-methoxy-1-methyl-2-oxo-1,8-diazaspiro[4.5]dec-3-en-4-yl-carbonic acid ethyl ester (known from WO 2010 / 066780A1, WO2011151146 A1) (CAS 1229023-00-0), N-[1-[(6-chloro-3-pyridyl)methyl]-2(1H)-pyridylidene]-2,2,2-trifluoro-acetamide (known from DE 3639877 A1, WO 2012029672 A1) (CAS 1363400-41-2), [N(E)]-N-[1-[(6-chloro-3-pyridyl)methyl]-2(1H)-pyridylidene]-2,2,2-trifluoro-acetamide (known from WO 2016005276 A1) (CAS 1689566-03-7), [N(Z)]-N-[1-[(6-chloro-3-pyridyl)methyl]-2(1H)-pyridylidene]-2,2,2-trifluoro-acetamide (CAS 1702305-40-5), 3-endo-3-[2-propoxy-4-(trifluoromethyl)phenoxy]-9-[[5-(trifluoromethyl)-2-pyridyl]oxy]-9-azabicyclo[3.3.1]nonane (known from WO 2011 / 105506 A1, WO 2016 / 133011 A1 known)(CAS1332838-17-1).

[0238] Examples of safeners that can be mixed with the compounds of formula (I) and compositions comprising them are, for example, benoxacor, cloquintocet (-mexyl), cyometrinil, cyprosulfamide, dichlormid, fenchlorazole (-ethyl), fenclorim, flurazole, fluxofenim, furilazole , isoxadifen(-ethyl), mefenpyr(-diethyl), naphthalic anhydride, oxabetrinil, 2-methoxy-N-({4-[(methylcarbamoyl)amino]phenyl}sulfonyl)benzamide (CAS129531-12-0), 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (CAS71526-07-3), 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine (CAS 52836-31-4).

[0239] Examples of herbicides that can be mixed with the compounds of formula (I) and compositions comprising the same are:

[0240] Acetochlor, acifluorfen, acifluorfen-sodium, aclonifen, alachlor, allidochlor, alloxydim, alloxydim-sodium, ametryn, amicarbazone, amidochlor, amidosulfuron, 4-amino-3-chloro-6-(4-chloro-2-fluoro-3-methylphenyl)-5-fluoropyridine-2-carboxylic acid, aminocyclopyrachlor, aminocyclopyrachlor-potassium, aminocyclopyrachlor-methyl, aminopyralid, amitrole, ammonium sulfamate sulfamate), anilofos, asulam, atrazine, azafenidin, azimsulfuron, beflubutamid, benazolin, benazolin-ethyl, benfluralin, benfuresate, bensulfuron, bensulfuron-methyl, bensulfuron-methyl, bensulide, bentazone, benzobicyclon, benzofenap, bicyclopyron, bifenox, bilanafos, bilanafos-sodium, bispyribac, bispyribac-sodium, bromacil, bromobutide, bromofenoxim, bromoxynil, bromoxynil-butyrate, bromoxynil-potassium, bromoxynil-heptanoate and bromoxynil-octanoate,busoxinone, butachlor, butafenacil, butamifos, butenachlor, butralin, butroxydim, butylate, cafenstrole, carbetamide, carfentrazone, carfentrazone-ethyl, chloramben, chlorbromuron, chloramben orfenac), chlorfenac-sodium, chlorfenprop, chlorflurenol, chlorflurenol-methyl, chloridazon, chlorimuron, chlorimuron-ethyl, chlorophthalim, chlorotoluron, chlorthal-dimethyl, chlorsulfuron, indolone cinidon, cinidon-ethyl, cinmethylin, cinosulfuron, clacyfos, clethodim, clodinafop, clodinafop-propargyl, clomazone, clomeprop, clopyralid, cloransulam, cloransulam-methyl, cumyluron ron), cyanamide, cyanazine, cycloate, cyclopyrimorate, cyclosulfamuron, cycloxydim, cyhalofop, cyhalofop-butyl, cyprazine, 2,4-D, 2,4-D-butotyl, 2,4-D-butyl, 2,4-D-dimethylammonium salt, 2,4-D-diolamine, 2,4-D-ethyl ester,2,4-D-2-ethylhexyl ester, 2,4-D-isobutyl ester, 2,4-D-isooctyl ester, 2,4-D-isopropylammonium salt, 2,4-D-potassium salt, 2,4-D-triisopropanol ammonium salt and 2,4-D-triethanolamine (2,4-D-trolamine), 2,4-DB, 2,4-DB-butyl ester, 2,4-DB-dimethylammonium salt, 2,4-DB-isooctyl ester, 2,4-DB-potassium salt and 2,4-DB-sodium salt, daimuron (dymron), dalapon, dazomet, n-decanol, desmedipham, DTP (detosyl-p yrazolate (DTP), dicamba, dichlobenil, 2-(2,4-dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one), 2-(2,5-dichlorobenzyl)-4,4-dimethyl-1,2-oxazolidin-3-one, dichlorprop, dichlorprop-P, diclofop, diclofop-methyl, diclofop-P-methyl, diclosulam, difenzoquat, pyridinium chloride diflufenican, diflufenzopyr, diflufenzopyr-sodium, dimefuron, dimepiperate, dimethachlor, dimethametryn, dimethenamid, dimethenamid-P, dimetrasulfuron, diinitramine, dinoterb, diphenamid 、diquat、diquat-dibromid、dithiopyr、diuron、DNOC、endothal、EPTC、esprocarb、ethalfluralin、ethametsulfuron、ethametsulfuron-methyl、ethiozin、ethofumesate、ethoxyfen、ethoxyfen-ethyl、Ethoxysulfuron, etobenzanid, F-9600, F-5231 (N-{2-chloro-4-fluoro-5-[4-(3-fluoropropyl)-5-oxo-4,5-dihydro-1H-tetrazol-1-yl]phenyl}ethanesulfonamide, F-7967 (3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)pyrimidine-2,4(1H,3H)-dione, fenoxaprop, fenoxaprop-P, fenoxaprop-ethyl, fenoxaprop fenoxaprop-P-ethyl, fenoxasulfone, fenquinotrione, fentrazamide, flamprop, flamprop-M-isopropyl, flamprop-M-methyl, flazasulfuron, florasulam, fluazifop, fluazifop-P, fluazifop-butyl, fluazifop-P-butyl, flucarbazone, flucarbazone-sodium, flucetosulfuron, fluchloralin, flufenacet, flufenpyr, flufenpyr-ethyl, flumetsulam, flumiclorac, flumiclorac-pentyl, flumi oxazin), fluometuron, flurenol, flurenol-butyl, flurenol-dimethylammonium and flurenol-methyl, fluoroglycofen, fluoroglycofen-ethyl, flupropanate, flupyrsulfuron, flupyrsulfuron-methyl-sodium,Fluridone, flurochloridone, fluroxypyr, fluroxypyr-meptyl, flurtamone, fluthiacet, fluthiacet-methyl, fomesafen, fomesafen-sodium, foramsulfuron, fosamine, glufosinate, glufosinate-ammonium, glufosinate-P-sodium, glufosinate-P-ammoni um), glufosinate-P-sodium, glyphosate, glyphosate-ammonium, glyphosate-isopropylammonium, glyphosate-diammonium, glyphosate-dimethylammonium, glyphosate-potassium, glyphosate-sodium and glyphosate-trimesium, H-9201, O-(2,4-dimethyl-6-nitrophenyl) O-ethyl isopropylthiophosphoramidate isopropylphosphoramidothioate), halauxifen, halauxifen-methyl, halosafen, halosulfuron, halosulfuron-methyl, haloxyfop, haloxyfop-P, haloxyfop-ethoxyethyl, haloxyfop-P-ethoxyethyl, haloxyfop-methyl, haloxyfop-P-methyl, hexazinone, HW-02, 1-(dimethoxyphosphoryl)ethyl-(2,4-dichlorophenoxy)acetate, imazamethabenz,imazamethabenz-methyl, imazamox, imazamox-ammonium, imazapic, imazapic-ammonium, imazapyr, imazapyr-isopropylammonium, imazaquin, imazaquin-ammonium, imazethapyr, imazethapyr-i mmonium, imazosulfuron, indanofan, indaziflam, iodosulfuron, iodosulfuron-methyl-sodium, ioxynil, ioxynil-octanoate, ioxynil-potassium and ioxynil-sodium, ipfencarbazone, isoproturon, isour on), isoxaben, isoxaflutole, karbutilate, KUH-043 (3-({[5-(difluoromethyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]methyl}sulfonyl)-5,5-dimethyl-4,5-dihydro-1,2-oxazole), ketospiradox, lactofen, lenacil, linuron, MCPA, MCPA-butoxyethyl ester, MCPA-dimethylammonium salt, MCPA-2-ethylhexyl ester, MCPA-isopropylammonium salt, MCP A-potassium salt and MCPA-sodium salt, MCPB, MCPB-methyl ester, MCPB-ethyl ester and MCPB-sodium salt, 2-methyl-4-chloropropionic acid (mecoprop), 2-methyl-4-chloropropionic acid sodium and 2-methyl-4-chloropropionic acid butoxyethyl ester (mecoprop-butotyl), 2-methyl-4-chloropropionic acid (mecoprop-P), 2-methyl-4-chloropropionic acid butoxyethyl ester (mecoprop-P-butotyl), 2-methyl-4-chloropropionic acid-dimethylammonium salt, 2-methyl-4-chloropropionic acid-2-ethylhexyl ester and 2-methyl-4-chloropropionic acid-potassium salt, mefenacet, mefluidide,mesosulfuron, mesosulfuron-methyl, mesotrione, methabenzthiazuron, metam, metamifop, metamitron, metazachlor, metazosulfuron, methabenzthiazuron, methiopyrsulfuron, metiozolin, methylisothiocyanate, metobromuron, metolachlor, S-m etolachlor), metosulam, metoxuron, metribuzin, metsulfuron, metsulfuron-methyl, molinat, monolinuron, monosulfuron, monosulfuron-ester, MT-5950 (N-(3-chloro-4-isopropylphenyl)-2-methylpentanamide), NGGC-011, napropamide, NC-310 ([5-(benzyloxy)-1-methyl-1H-pyrazol-4-yl](2,4-dichlorophenyl)methanone), neburon, nicosulfuron, nonanoic acid acid, pelargonic acid), norflurazon, oleic acid (fatty acid), orbencarb, orthosulfamuron, oryzalin, oxadiargyl, oxadiazon, oxasulfuron, oxaziclomefon, oxyfluorfen, paraquat dichloride, pebulate, pendimethalin, penoxsulam, pentachlorphenol, pentoxazone, pethoxamid, petroleum oils,Phenmedipham, picloram, picolinafen, pinoxaden, piperophos, pretilachlor, primisulfuron, primisulfuron-methyl, prodiamine, profoxydim, prometon, prometryn, propachlor, propanil, oxadiazine propaquizafop, propazine, propham, propisochlor, propoxycarbazone, propoxycarbazone-sodium, propyrisulfuron, propyzamide, prosulfocarb, prosulfuron, pyraclonil, pyraflufen, pyraflufen-ethyl thyl), pyrasulfotole, pyrazolynate (pyrazolate), pyrazosulfuron, pyrazosulfuron-ethyl, pyrazoxyfen, pyribambenz, pyribambenz-isopropyl, pyribambenz-propyl, pyribenzoxim, pyributicarb, pyridafo l), pyridate, pyriftalid, pyriminobac, pyriminobac-methyl, pyrimisulfan, pyrithiobac, pyrithiobac-sodium, pyroxasulfone, pyroxsulam, quinclorac, quinmerac, quinoclamine, quizalofop,Quizalofop-ethyl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, rimsulfuron, saflufenacil, sethoxydim, siduron, simazine, simetryn, SL-261, sulcotrion, sulfentrazone, sulfome turon), sulfometuron-methyl, sulfosulfuron, SYN-523, SYP-249 (1-ethoxy-3-methyl-1-oxobut-3-en-2-yl 5-[2-chloro-4-(trifluoromethyl)phenoxy]-2-nitrobenzoate), SYP-300 (1-[7-fluoro-3-oxo-4-(prop-2-yn-1-yl)-3,4-dihydro-2H-1,4-benzoxazin-6-yl]-3-propyl-2-thioimidazolidine-4,5-dione), 2,3,6-TBA, trichloroacetic acid (TCA), TCA sodium salt, Tebuthiuron, tefuryltrione, tembotrione, tepraloxydim, terbacil, terbucarb, terbumeton, terbuthylazin, terbutryn, thenylchlor, thiazopyr, thiencarbazone, thiencarbazone-methyl, thifensulfuron sulfuron), thifensulfuron-methyl, thiobencarb, tiafenacil, tolpyralate, topramezone, tralkoxydim, triafamone, tri-allate, triasulfuron, triaziflam, tribenuron, tribenuron-methyl, triclopyr,trietazine, trifloxysulfuron, trifloxysulfuron-sodium, trifludimoxazin, trifluralin, triflusulfuron, triflusulfuron-methyl, tritosulfuron, urea sulfate, vernolate, XDE-848, ZJ-0862, for example, 3,4-dichloro-N-{2-[(4,6-dimethoxypyrimidin-2-yl)oxy]benzyl}aniline, and the following compounds:

[0241]

[0242] Examples of plant growth regulators are:

[0243] Acibenzolar, acibenzolar-S-methyl, 5-aminolevulinic acid, ancymidol, 6-benzylaminopurine, brassinolid, catechine, chlormequat chloride, cloprop, cyclanilide, 3-(cycloprop-1-enyl)propionic acid, daminozide, dazomet, n-decanol, dikegulac, dikegulac-sodium, endothal, endothal-dipotassium, endothal-disodium and endothal-mono (N,N-dimethylalkylammonium), ethephon, flumetralin, flurenol, butyl fluorenol, flurprimidol, forchlorfenuron, gibberellic acid, inabenfide, indol-3-acetic acid (IAA), 4-indol-3-ylbutyric acid, isoprothiolane, probenazole, jasmonic acid, maleic hydrazide, mepiquat chloride), 1-methyl-cyclopropene, methyl jasmonate, 2-(1-naphthyl)acetamide, 1-naphthylacetic acid, 2-naphthyloxyacetic acid, nitrophenolate-mixture, paclobutrazol, N-(2-phenylethyl)-β-alanine, N-phenylphthalamic acid, prohexadione, prohexadione-calcium, prohydrojasmone, salicylic acid, strigolactone, tecnazene, thidiazuron, triacontanol, trinexapac, trinexapac-ethyl, tsitodef, uniconazole, uniconazole-P. ,

[0244] Methods and uses

[0245] Formula (I) compound and the composition comprising it have potent microbicidal activity. They can be used to control unwanted microorganisms, such as unwanted fungi and bacteria. They can be particularly used for crop protection (they control the microorganisms that cause plant diseases) or for protecting materials (such as industrial materials, timber, stored goods), as described in detail below. More specifically, formula (I) compound and the composition comprising it can be used to protect the soil in which seeds, germinated seeds, sprouted seedlings, plants, plant parts, fruits, harvests and / or plants are grown from unwanted microorganisms.

[0246] As used herein, control includes protective, curative and eradicative treatment of unwanted microorganisms. The unwanted microorganisms can be pathogenic bacteria, pathogenic viruses, pathogenic oomycetes or pathogenic fungi, more specifically, plant pathogenic bacteria, plant pathogenic viruses, plant pathogenic oomycetes or plant pathogenic fungi. As described in detail below, these plant pathogenic microorganisms are the causative agents of a broad spectrum of plant diseases.

[0247] More specifically, the compounds of formula (I) and compositions comprising the same can be used as fungicides. For the purposes of this specification, the term "fungicide" refers to compounds or compositions that can be used in crop protection to control unwanted fungi (e.g. Plasmodiophoromycetes, Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes) and / or for controlling oomycetes, more preferably compounds or compositions for controlling Basidiomycetes (causing rust).

[0248] The present invention also relates to a method for controlling unwanted microorganisms, such as phytopathogenic fungi, oomycetes and bacteria, comprising the step of applying at least one compound of formula (I) or at least one composition comprising the same to the microorganisms and / or their habitat (plants, plant parts, seeds, fruits or soil in which the plants grow).

[0249] Typically, when the compounds and compositions of the invention are used in a method of treatment or protection against plant pathogenic fungi and / or plant pathogenic oomycetes, an effective and plant-compatible amount is applied to the plant, plant parts, fruit, seed or soil or substrate in which the plant grows. Suitable substrates that can be used to cultivate plants include inorganic substrates, such as mineral wool, in particular asbestos, perlite, sand or gravel; organic substrates, such as peat, pine bark or sawdust; and petroleum-based substrates, such as polymer foams or plastic beads. An effective and plant-compatible amount is an amount that is sufficient to control or destroy fungi present or likely to appear on farmland and does not produce any obvious phytotoxic symptoms to the crop. Such an amount may vary over a wide range, depending on the fungi to be controlled, the crop type, the crop growth stage, the climatic conditions and the corresponding compound or composition of the invention used. This amount can be determined by systematic field trials within the capabilities of a person skilled in the art.

[0250] Plants and plant parts

[0251] The compounds of formula (I) and compositions comprising the same can be applied to any plant or plant part.

[0252] Plants are understood to mean all plants and plant populations, such as desired and undesired wild plants or crop plants (including naturally occurring crop plants). Crop plants may be plants which can be obtained by conventional breeding and optimization methods or by biotechnology and genetic engineering methods or a combination of these methods, including transgenic plants (GMO or transgenic plants) and plant varieties which are or are not protected by plant variety property rights.

[0253] Plant parts are understood to mean all above-ground and underground parts and organs of plants, such as buds, leaves, flowers and roots, for example including leaves, needles, stalks, stems, flowers, fruiting bodies, fruits and seeds, also including roots, tubers and rhizomes. Plant parts also include harvested material and asexual and sexual propagation material, such as cuttings, tubers, rhizomes, young branches and seeds.

[0254] Plants that can be treated according to the method of the present invention include: cotton, flax, grapevines, fruits, vegetables, such as Rosaceae sp. (e.g., pome fruits, such as apples and pears, and stone fruits, such as apricots, cherries, almonds and peaches, and small fruit, such as strawberries), Ribesioidae sp., Juglandaceae sp., Betulaceae sp., Anacardiaceae sp., Fagaceae sp., Moraceae sp., Oleaceae sp., Actinidaceae sp., Lauraceae sp., Musaceae sp. (e.g., banana trees and plantations), Rubiaceae sp. (e.g., coffee), Theaceae sp., Sterculiceae sp., Rutaceae sp. sp.) (e.g. lemon, orange and grapefruit), Solanaceae sp.) (e.g. tomato), Liliaceae sp., Asteraceae sp.) (e.g. lettuce), Umbelliferae sp., Cruciferae sp., Chenopodiaceae sp., Cucurbitaceae sp. (e.g. cucumber), Allium sp. (e.g. leek, onion), Papilionaceae sp. (e.g. pea); major crop plants, such as Gramineae sp. (e.g. corn, turf, cereals such as wheat, rye, rice, barley, oats, millet and triticale), Asteraceae sp. (e.g. sunflower), Brassicaceae sp. sp.) (e.g. white cabbage, red cabbage, broccoli, cauliflower, Brussels sprouts, pakchoi, kohlrabi, radish and rapeseed, mustard, horseradish and watercress), Fabacae sp. (e.g. beans, peanuts), Papilionaceae sp. (e.g. soybeans), Solanaceae sp. (e.g. potatoes), Chenopodiaceae sp. (e.g. beets, fodder beets, Swiss chard, beetroot), useful plants for gardens and woodlands and ornamental plants; and genetically modified varieties of each of these plants.

[0255] In some preferred embodiments, wild plant species and plant cultivars or those obtained by conventional biological breeding methods such as hybridization or protoplast fusion, and parts thereof are treated according to the methods of the invention.

[0256] In some other preferred embodiments, transgenic plants and plant cultivars (genetically modified organisms) obtained by genetic engineering methods, if appropriate in combination with conventional methods, and parts thereof are treated according to the method of the invention. More preferably, plants of commercially available or in use plant cultivars are treated according to the invention. Plant cultivars are understood to mean plants having new properties ("traits") and obtained by conventional breeding, mutagenesis or recombinant DNA techniques. They can be cultivars, variants, biotypes or genotypes.

[0257] The method according to the present invention can be used to process genetically modified organisms (GMOs), such as plants or seeds.Genetically modified plants (or transgenic plants) are plants in which heterologous genes have been stably integrated into the genome.The term "heterologous gene" refers essentially to a gene provided or assembled outside a plant, which, when introduced into a nuclear, chloroplast or mitochondrial genome, imparts new or improved agronomic characteristics or other characteristics to a transformed plant by expressing a target protein or polypeptide or by lowering or silencing other genes present in the plant (such as using antisense technology, co-suppression technology, RNA interference-RNAi-technology or microRNA-miRNA-technology).The heterologous gene located in the genome is also referred to as transgenic.The transgenic defined by its specific position in the plant genome is referred to as transformation or transgenic strain (transgenic event).

[0258] Plants and plant cultivars which can be treated by the methods disclosed above include all plants which have genetic material which impart particularly advantageous, useful traits to these plants (whether obtained by breeding and / or biotechnological means).

[0259] Plants and plant cultivars which can be treated by the methods disclosed above include plants and plant cultivars which are resistant to one or more biotic stresses, i.e. the plants exhibit improved resistance to animal and microbial pests, for example to nematodes, insects, mites, phytopathogenic fungi, bacteria, viruses and / or viroids.

[0260] Plants and plant cultivars that can be treated by the above disclosed methods include those plants that are resistant to one or more abiotic stresses. Abiotic stress conditions can include, for example, drought, low temperature exposure, heat exposure, osmotic stress, flooding, increased soil salinity, increased mineral exposure, ozone exposure, high light exposure, limited availability of nitrogen nutrients, limited availability of phosphorus nutrients, and shade avoidance.

[0261] Plants and plant cultivars that can be processed by the above-mentioned disclosed method include those plants characterized by the yield characteristics of improvement. The output of the plant increase can come from, for example, improving plant physiology, growth and development, such as water use efficiency, water retention efficiency, improving nitrogen utilization, strengthening carbon assimilation, improving photosynthesis, improving germination efficiency and accelerating maturity. Output can also be subject to the impact of improved plant structure (under stress and non-stress conditions), including but not limited to early flowering, flowering control, seedling vigor, plant size, internode number and distance, root growth, seed size, fruit size, pod size, pod or ear number, the number of seeds of each pod or ear, seed quality, the seed filling degree of improvement, reducing seed scattering, reducing pod cracking and lodging. Other yield traits include seed composition, such as carbohydrate content and composition, such as cotton or starch, protein content, oil content and composition, nutritional value, reducing anti-nutritional compounds, improving processability and better storage stability.

[0262] Plants and plant cultivars that can be treated by the above disclosed methods include plants and plant cultivars that are hybrid plants that have shown characteristics of heterosis or hybrid vigor, which generally results in higher yields, vigor, health, and resistance to biotic and abiotic stresses. Plants and plant cultivars that can be treated by the above disclosed methods (obtained by plant biotechnology methods such as genetic engineering) include plants and plant cultivars that are herbicide-tolerant plants, i.e., plants that tolerate one or more given herbicides. Such plants can be obtained by genetic transformation or by selecting plants that contain mutations that confer such herbicide tolerance.

[0263] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that may be treated by the methods disclosed above include plants and plant cultivars that are insect-resistant transgenic plants, i.e. plants made resistant to attack by certain target insects. Such plants can be obtained by genetic transformation or by selection of plants containing mutations that impart such insect resistance.

[0264] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that may be treated by the methods disclosed above include plants and plant cultivars that are tolerant to abiotic stresses. Such plants can be obtained by genetic transformation or by selecting plants containing mutations that confer such stress resistance.

[0265] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which may be treated by the methods disclosed above include plants and plant cultivars which display altered quantity, quality and / or storage stability of the harvested products and / or altered properties of specific components of the harvested products.

[0266] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that can be treated by the above disclosed methods include plants and plant cultivars with changed fiber characteristics, such as cotton plants. Such plants can be obtained by genetic transformation or by selecting plants containing mutations that confer such fiber characteristics changes.

[0267] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that may be treated by the above disclosed methods include plants and plant cultivars with altered oil profile characteristics, such as rapeseed or related Brassica species. Such plants can be obtained by genetic transformation or by selecting plants containing mutations that confer such altered oil profile characteristics.

[0268] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) that may be treated by the methods disclosed above include plants and plant cultivars with altered seed shattering characteristics, for example rapeseed or related Brassica species. Such plants can be obtained by genetic transformation or by selection of plants containing a mutation imparting such altered seed shattering characteristics, including, for example, rapeseed plants with delayed or reduced seed shattering.

[0269] Plants and plant cultivars (obtained by plant biotechnology methods such as genetic engineering) which may be treated by the methods disclosed above include plants and plant cultivars, such as tobacco plants, with altered patterns of post-translational protein modifications.

[0270] Pathogens and Diseases

[0271] The methods disclosed above can be used to control disease-causing microorganisms, in particular phytopathogenic microorganisms such as phytopathogenic fungi, for example:

[0272] Diseases caused by powdery mildew pathogens, such as Blumeria species (e.g. Blumeria graminis), Podosphaera species (e.g. Podosphaera leucotricha), Sphaerotheca species (e.g. Sphaerotheca fuliginea), Uncinula species (e.g. Uncinula necator);

[0273] Diseases caused by rust pathogens, for example Gymnosporangium species (e.g. Gymnosporangium sabinae), Hemileia species (e.g. Hemileia vastatrix), Phakopsora species (e.g. Phakopsora pachyrhizi or Phakopsora meibomiae), Puccinia species (e.g. Puccinia recondite, Puccinia graminis or Puccinia striiformis), Uromyces species (e.g. Uromyces appendiculatus);

[0274] Diseases caused by oomycete pathogens, for example Albugo species (e.g. Albugocandida), Bremia species (e.g. Bremia lactucae), Peronospora species (e.g. Peronospora pisi or P. brassicae), Phytophthora species (e.g. Phytophthora infestans), Plasmopara species (e.g. Plasmopara viticola), Pseudoperonospora species (e.g. Pseudoperonospora humuli or Pseudoperonospora cubensis), Pythium species (e.g. Pythium ultimum);

[0275] Leaf blotch disease and leaf wilt disease caused by pathogens such as Alternaria species (e.g. Alternaria solani), Cercospora species (e.g. Cercospora beticola), Cladiosporium species (e.g. Cladiosporium cucumerinum), Cochliobolus species (e.g. Cochliobolus sativus (conidial form: Drechslera, synonym: Helminthosporium) or Cochliobolus miyabeanus), Colletotrichum species (e.g. Colletotrichum lindemuthanium), Cycloconium species (e.g. ), Cycloconium species (e.g., Cycloconium oleaginum), Diaporthe species (e.g., Diaporthe citri), Elsino species (e.g., Elsinoe fawcettii), Gloeosporium species (e.g., Gloeosporium laeticolor), Glomerella species (e.g., Glomerella cingulate), Guignardia species (e.g., Guignardia bidwelli), Leptosphaeria species (e.g., Leptosphaeria maculans), Magnaporthe species (e.g., Magnaporthe grisea), Microdochium species (e.g., Microdochium snow mold Microdochium nivale), Mycosphaerella species (e.g., Mycosphaerella graminicola, Mycosphaerellaarachidicola or Mycosphaerellafijiensis), Phaeosphaeria species (e.g., Phaeosphaerianodorum), Pyrenophora species (e.g., Pyrenophora teres or Pyrenophora tritici repentis), Ramularia species (e.g., Ramularia collo-cygni or Ramularia areola), Rhynchosporium species (e.g., Rhynchosporium secalis), Septoria species (e.g., Septoria apii or Septorialycopersici), Stagonospora species) (e.g. Stagonosporanodorum), Typhula species (e.g. Typhula incarnate), Venturia species (e.g. Venturia inaequalis),

[0276] Root and stem diseases caused by pathogens such as Corticium species (e.g. Corticium graminearum), Fusarium species (e.g. Fusarium oxysporum), Gaeumannomyces species (e.g. Gaeumannomyces graminis), Plasmodiophora species (e.g. Plasmodiophora brassicae), Rhizoctonia species (e.g. Rhizoctonia solani), Sarocladium species (e.g. Sarocladium oryzae), Sclerotium species (e.g. Sclerotium oryzae), Tapesia species (e.g. Tapesia acuformis), Thielaviopsis species (e.g. species) (e.g., Thielaviopsis basicola);

[0277] Ear and panicle diseases (including corn cobs) caused by pathogens such as Alternaria (e.g., Alternaria species), Aspergillus species (e.g., Aspergillus flavus), Cladosporium species (e.g., Cladosporium budding), Claviceps species (e.g., Claviceps purpurea), Fusarium (e.g., Fusarium culmorum), Gibberella species (e.g., Gibberella zeae), Monographella species (e.g., Monographella nivalis), Stagnospora species (e.g., Stagnospora nodorum);

[0278] Diseases caused by smut fungi, such as Sphacelotheca species (e.g. Sphacelotheca reiliana), Tilletia species (e.g. Tilletia caries or Tilletia controversa), Urocystis species (e.g. Urocystis occulta), Ustilago species (e.g. Ustilago nuda);

[0279] Fruit rot caused by pathogens such as Aspergillus species (e.g. Aspergillus flavus), Botrytis species (e.g. Botrytis cinerea), Penicillium species (e.g. Penicillium expansum or Penicillium purpurogenum), Rhizopus species (e.g. Rhizopus stolonifer), Sclerotinia species (e.g. Sclerotiniasclerotiorum), Verticilium species (e.g. Verticilium alboatrum);

[0280] Seed-borne and soil-borne rot and wilt diseases, and seedling diseases caused by pathogens such as Alternaria (e.g. Alternaria brassicicola), Aphanomyces species (e.g. Aphanomyces euteiches), Ascochyta species (e.g. Ascochyta lentis), Aspergillus (e.g. Aspergillus flavus), Cladosporium species (e.g. Cladosporium herbarum), Coccidiales (e.g. Coccidiales graminis (conidial forms: Endotrichum, Bipolaris, synonym: Helminthosporium)), Anthracnose (e.g. Colletotrichum coccodes), Fusarium (e.g. Fusarium luteum), Gibberellum (e.g. Gibberellum zeae), Macrophomina ), Phoma species (e.g., Phomalingam), Phomopsis species (e.g., Phomopsis sojae), Phytophthora species (e.g., Phytophthora cactorum), Pyrenophora species (e.g., Pyrenophora graminea), Pyricularia species (e.g., Pyricularia oryzae), Pythium species (e.g., Pythium ultimum), Rhizoctonia species (e.g., Rhizopus solani), Rhizopus species (e.g., Rhizopus oryzae), Sclerotium species (e.g., Sclerotium rolfsii), Septoria species (e.g. Septorianodorum), Psoralea species (e.g. Psoralea spp.), Verticillium species (e.g. Verticillium dahlia);

[0281] Cancers, crown galls and witches' broom caused by pathogens such as Nectria species (e.g. Nectria galligena);

[0282] blight caused by pathogens such as Monilinia species (e.g. Monilinia laxa);

[0283] Leaf, flower and fruit deformations caused by pathogens such as Exobasidium species (e.g. Exobasidium vexans), Taphrina species (e.g. Taphrina deformans);

[0284] Degenerative diseases of woody plants caused by pathogens such as Esca species (e.g. Phaeomoniella chlamydospora, Phaeoacremoniumaleophilum or Fomitiporia mediterranea), Ganoderma species (e.g. Ganoderma boninense);

[0285] Flower and seed diseases caused by pathogens such as Botrytis species (e.g. Botrytis cinerea); tuber diseases caused by pathogens such as Rhizoctonia species (e.g. Rhizoctonia solani), Helminthosporium species (e.g. Helminthosporium solani);

[0286] Diseases caused by bacterial pathogens, such as Xanthomonas species (e.g. Xanthomonas campestris pv. Oryzae), Pseudomonas species (e.g. Pseudomonas syringae pv. Lachrymans), Erwinia species (e.g. Erwinia amylovora).

[0287] Seed treatment

[0288] The method for controlling undesirable microorganisms can be used to protect seeds from attack by phytopathogenic microorganisms such as fungi.

[0289] As used herein, the term "seed" includes dormant seeds, primed seeds, pre-germinated seeds, and seeds with sprouted roots and leaves.

[0290] Therefore, the present invention also relates to a method for protecting seeds and / or crops from harmful microorganisms such as bacteria or fungi, which comprises the step of treating seeds with one or more compounds of formula (I) or compositions comprising the same. Treating seeds with compounds of formula (I) or compositions comprising the same not only protects seeds from plant pathogenic microorganisms, but also protects germinating plants, germinating seedlings and plants after germination.

[0291] Seed treatment can be carried out before sowing, at sowing or shortly after sowing. When seed treatment is carried out before sowing (e.g., so-called application on seeds), the following seed treatment can be carried out: the seeds can be placed in a mixer with the required amount of the compound of formula (I) or a composition comprising it (either by itself or after dilution), and the seeds and the compound of formula (I) or a composition comprising it are mixed until a uniform distribution on the seeds is achieved. If suitable, the seeds can then be dried.

[0292] The present invention also relates to seeds treated with one or more compounds of formula (I) or compositions comprising the same. As previously mentioned, the use of treated seeds can not only protect the seeds from unwanted microorganisms such as phytopathogenic fungi before and after sowing, but also protect the germinating plants and the seedlings grown from the treated seeds. Most of the damage caused by harmful organisms to crops is caused by infection of the seeds before sowing or after plant germination. This stage is particularly critical because the roots and shoots of growing plants are particularly sensitive and even small damage may lead to plant death.

[0293] Therefore, the present invention also relates to a method for protecting seeds, germinating plants and germinating seedlings, more generally to a method for protecting crops from phytopathogenic microorganisms, which comprises the step of using seeds treated with one or more compounds of formula (I) or a composition comprising the same.

[0294] Preferably, the seed is treated in a state where it is sufficiently stable to not be damaged during the treatment process. In general, the seed can be treated at any time between harvesting and shortly after sowing. Seeds separated from the plant and having cobs, shells, stems, skins, hairs or pulp removed are usually used. For example, seeds that have been harvested, cleaned and dried to a moisture content of less than 15% by weight can be used. Alternatively, dried seeds can also be used, for example, seeds that have been treated with water and then dried again, or seeds just after germination, or seeds stored under germination conditions or pre-germinated seeds, or seeds sown on seedling trays, bands or paper.

[0295] The amount of the compound of formula (I) or the composition comprising it applied to the seed is generally such that the germination of the seed is not affected or the resulting plant is not damaged. This must be ensured in particular in the case where the active ingredient exhibits phytotoxic effects at certain application rates. When determining the amount of the compound of formula (I) or the composition comprising it applied to the seed, the inherent phenotype of the transgenic plant should also be taken into account so that the compound of formula (I) or the composition comprising it is used in the minimum amount to achieve optimal seed and germinating plant protection.

[0296] As described above, the compound of formula (I) can be applied directly to the seed, i.e. without any other components and without dilution, or a composition comprising the compound of formula (I) can be applied. Preferably, the composition is applied to the seed in any suitable form. Examples of suitable formulations include solutions, emulsions, suspensions, powders, foams, slurries or in combination with other coating compositions of the seed, such as film-forming materials, granulating materials, fine iron or other metal powders, granules, coating materials for inactivating seeds, and ULV formulations. The formulation can be a ready-to-use formulation or can be a concentrate that needs to be diluted before use.

[0297] These formulations are prepared in a known manner, for example by mixing the active ingredients or mixtures thereof with customary additives, such as customary extenders and solvents or diluents, dyes, wetting agents, dispersants, emulsifiers, defoamers, preservatives, secondary thickeners, binders, gibberellins, and also water.

[0298] These formulations are prepared in a known manner by mixing the active ingredients or active ingredient combinations with customary additives, such as customary extenders and solvents or diluents, dyes, wetting agents, dispersants, emulsifiers, defoamers, preservatives, secondary thickeners, binders, gibberellins, and also water.

[0299] Useful dyes that may be present in the seed dressing formulations are all dyes that are commonly used for such purposes. Pigments that are slightly soluble in water or dyes that are soluble in water can be used. Examples include dyes named Rhodamine B, CI Pigment Red 112 and CI Solvent Red 1. Useful wetting agents that may be present in the seed dressing formulations are all substances that promote wetting that are commonly used to formulate agrochemical active ingredients. Alkylnaphthalene sulfonates, such as diisopropylnaphthalene sulfonate or diisobutylnaphthalene sulfonate, are preferably used. Useful dispersants and / or emulsifiers that may be present in the seed dressing formulations are all nonionic, anionic and cationic dispersants that are conventionally used for active agricultural chemical ingredient formulations. Nonionic or anionic dispersants or mixtures of nonionic or anionic dispersants are preferably used. Useful nonionic dispersants particularly include ethylene oxide / propylene oxide block polymers, alkylphenol polyglycol ethers and tristyrylphenol polyglycol ethers, as well as phosphated or sulfated derivatives thereof. Suitable anionic dispersants are particularly lignin sulfonates, polyacrylates and aryl sulfonate / formaldehyde condensates. Defoamers that may be present in the seed dressing formulation are all antifoaming substances that are commonly used to formulate agrochemical active ingredients. Silicone defoamers and magnesium stearate can be preferably used. Preservatives that may be present in the seed dressing formulation are all substances that can be used in agrochemical compositions for such purposes. Examples include dichlorobenzene and benzyl alcohol hemiformal. Secondary thickeners that may be present in the seed dressing formulation are all substances that can be used in agrochemical compositions for such purposes. Preferred examples include cellulose derivatives, acrylic acid derivatives, xanthan gum, modified clays and finely divided silica. Adhesives that may be present in the seed dressing formulation are all commonly used adhesives that can be used for seed dressing products. Preferred examples include polyvinyl pyrrolidone, polyvinyl acetate, polyvinyl alcohol and methylcellulose (tylose).

[0300] Formula (I) compound and the composition comprising it are applicable to the seed of any plant variety for protecting agriculture, greenhouse, forest or gardening. More specifically, it is the seed of cereal (such as wheat, barley, rye, millet, triticale and oat), rape, corn, cotton, soybean, rice, potato, sunflower, kidney bean, coffee, pea, beet (such as sugar beet and fodder beet), peanut, vegetables (such as tomato, cucumber, onion and lettuce), lawn and ornamental plants. Particularly important is the processing of wheat, soybean, rape, corn and rice seeds.

[0301] The compounds of formula (I) or compositions comprising them can be used to treat transgenic seeds, in particular plant seeds that are able to express proteins against pests, herbicide damage or abiotic stress, thereby improving protection. Synergistic effects may also occur in the interaction with substances formed by expression.

[0302] Nematodes

[0303] In the present context, the term "nematodes" encompasses all species of the phylum Nematoda, and in particular species here which parasitize plants or fungi (e.g. species of the orders Aphelenchida, Meloidogyne, Tylenchida, etc.) or humans and animals (e.g. species of the orders Trichinellida, Tylenchida, Rhabditina and Spirurida) and cause damage in or on these living organisms, as well as other parasitic helminths.

[0304] Nematicides in crop protection as described herein are capable of controlling nematodes.

[0305] The term "controlling nematodes" means killing the nematodes or preventing or retarding their development or their growth or preventing or retarding their penetration into plant tissue or sucking on plant tissue.

[0306] Here, the efficacy of the compound is determined by comparing the mortality, gall formation, cyst formation, nematode density per volume of soil, nematode density per root, number of nematode eggs per soil volume, nematode mobility between plants or plant parts treated with compounds of formula (I) and untreated plants or plant parts or untreated soil (100%). Preferably, the reduction achieved is 25-50%, particularly preferably 51-79%, and very particularly preferably completely killing or completely preventing the development and growth of nematodes with a reduction of 80% to 100% compared to untreated plants, plant parts or untreated soil. Controlling nematodes as described herein also includes controlling the proliferation of nematodes (development of cysts and / or eggs). The compounds of formula (I) can also be used to maintain the health of plants or animals, and they can be used for treatment, prevention or systemic use for controlling nematodes. The person skilled in the art knows methods for determining mortality, gall formation, cyst formation, nematode density per volume of soil, nematode density per root, number of nematode eggs per volume of soil, mobility of nematodes.

[0307] The use of compounds of formula (I) can maintain plant health and also include reducing damage caused by nematodes and increasing harvest yields.

[0308] In the present context, the term "nematodes" refers to plant nematodes, which includes all nematodes that damage plants. Plant nematodes include plant parasitic nematodes and soil-borne nematodes. Plant parasitic nematodes include ectoparasites, such as Xiphinema spp., Longidorus spp., and Trichodorus spp.; hemiparasites, such as Tylenchulus spp.; migratory endoparasites, such as Pratylenchus spp., Radopholus spp., and Scutellonema spp.; non-migratory parasites, such as Heterodera spp., Globodera spp., and Meloidogyne spp.; and stem and leaf endoparasites, such as Ditylenchus spp. spp.), Aphelenchoides spp. and Hirschmaniella spp. Parasitic soil nematodes that particularly damage roots are cyst-forming nematodes such as those of the genera Heterodera or Globodera, and / or root gall nematodes of the genus Meloidogyne. Destructive species of these genera are, for example, Meloidogyne incognita, Heterodera glycines (soybean cyst nematode), Globodera pallida and Globodera rostochiensis (yellow potato cyst nematode), which are effectively controlled by the compounds described herein. However, the use of the compounds described herein is by no means limited to these genera or species, but also extends to other nematodes in the same manner.

[0309] Plant nematodes include, for example, Aglenchus agricola, Anguina tritici, Aphelenchoides arachidis, Aphelenchoides fragaria, and stem and leaf endoparasites Aphelenchoides species, Belonolaimus gracilis, Belonolaimus longicaudatus, Belonolaimus nortoni, Bursaphelenchus cocophilus, Bursaphelenchus eremus, Bursaphelenchus xylophilus, and Bursaphelenchus spp., Cacopaurus pestis, Criconemella curvata, Criconemella onoensis, Criconemella ornata, Criconemella rusium, Criconemella xenoplax (= Mesocriconema xenoplax) and Criconemella spp., Criconemoides ferniae, Criconemoides onoense, Criconemoidesornatum and Criconemoides spp., Ditylenchus destructor, Ditylenchus dipsaci, Ditylenchus myceliophagus and stem and leaf endoparasites Ditylenchus spp., Dolichodorus heterocephalus, Heterodera pallidum (= Heterodera pallida), Globodera rostochiensis (yellow potato cyst nematode), Globodera solanacearum, Globodera tabacum, Globodera virginicavirginia and the non-migratory cyst-forming parasites Coccotylenchus species, Helicotylenchus digonicus, Helicotylenchus dihystera, Helicotylenchus erythrine, Helicotylenchus multicinctus, Helicotylenchus nannus, Helicotylenchus pseudorobustus and Helicotylenchus spp., Hemicriconemoides, Hemicycliophora arenaria, Hemicycliophora nudata, Hemicycliophora parvana, Heterodera avenae, Heterodera cruciferae, Heterodera glycines), Heterodera oryzae, Heterodera schachtii, Heterodera zeae, and non-migratory cyst-forming parasites Heterodera species, Hirschmaniella gracilis, Hirschmaniella oryzae, Hirschmaniella spinicaudata, and stem and leaf endoparasites Hoplolaimus species, Hoplolaimus aegyptii, Hoplolaimus californicus, Hoplolaimus columbus, Hoplolaimus galeatus, Hoplolaimus indicus, Hoplolaimus magnistylus, Hoplolaimus pararobustus), Longidorusafricanus, Longidorus breviannulatus, Longidorus longatus, Longidoruslaevicapitatus, Longidorus vineacola and external parasites Meloidogyne species, sorghum root-knot nematode (Meloidogyne acronea), African root-knot nematode (Meloidogyne africana), peanut root-knot nematode (Meloidogyne arenaria), Thames peanut root-knot nematode (Meloidogyne arenariathamesi), cabbage root-knot nematode (Meloidogyne artiella), Qi root-knot nematode (Meloidogynechitwoodi), coffee root-knot nematode (Meloidogyne coffeicola), Ethiopian root-knot nematode (Meloidogyne ethiopica), short root-knot nematode (Meloidogyne exigua), pseudo root-knot nematode (Meloidogyne fallax), grass root-knot nematode (Meloidogyne graminicola), grass root-knot nematode (Meloidogyne graminis), Meloidogyne hapla, Meloidogyne incognita acrita, Meloidogyne javanica, Meloidogyne kikuyensis, Meloidogyne minor, Meloidogyne naasi, Meloidogyne paranaensis, Meloidogyne thamesi, and non-migratory parasites of the genera Meloinema, Nacobbus aberrans, Neotylenchus vigissi, Paraphelenchus pseudoparietinus, Paratrichodorus allius), Paratrichodorus lobatus, Paratrichodorus minor, Paratrichodorus nanus, Paratrichodorus porosus, Paratrichodorus teres, and Paratrichodorus species.spp.), Paratylenchus shamatus, Paratylenchus minutus, Paratylenchus projectus and Paratylenchus spp., Pratylenchus agilis, Pratylenchus alleni, Pratylenchus andinus, Pratylenchus brachyurus, Pratylenchus cerealis, Pratylenchus coffeae, Pratylenchus crenatus, Pratylenchus delattrei, Pratylenchus giibbicaudatus, Pratylenchus goodeyi, Pratylenchus hamatus), Pratylenchus hexincisus, Pratylenchus loosi, Pratylenchus neglectus, Pratylenchus penetrans, Pratylenchus pratensis, Pratylenchus scribneri, Pratylenchus teres, Pratylenchus thornei, Pratylenchus vulnus, Pratylenchus zeae and migratory endoparasites of the genus Pratylenchus, Pseudohalenchus minutus, Psilenchus magnidens, Psilenchus tumidus, Punctodera chalcoensis), Quinisulciusacutus, Radopholus citrophilus, Radopholussimilis, migratory endoparasites Radopholus species, Rotylenchulus borealis, Rotylenchulus microreniformis,parvus), Rotylenchulus reniformis and Rotylenchulus spp., Rotylenchus laurentinus, Rotylenchus macrodoratus, Rotylenchus robustus, Rotylenchus uniformis and Rotylenchus spp., Scutellonema brachyurum, Scutellonema bradys, Scutellonema malathrica udatum and migratory endoparasites of the genus Rotylenchus, Subanguina radiciola, Tetylenchus nicotianae, Trichodorus cylindricus, Trichodorus microtrichum minor), Trichodorus primitivus, Trichodorus proximus, Trichodorus similis, Trichodorus sparsus and ectoparasites Trichodorus species, Tylenchorhynchus agri, Tylenchorhynchus brassicae, Tylenchorhynchus clarus, Tylenchorhynchus claytoni, Tylenchorhynchus digitatus, Tylenchorhynchus ebriensis, Tylenchorhynchus maximus, Tylenchorhynchus nudus, Tylenchorhynchus vulgaris and Tylenchorhynchus species. spp.), Tylenchulus semipenetrans and semiparasitic Tylenchulus species, Xiphinema americanum, Xiphinema brevicolle, Xiphinemadimorphicaudatum, standard Xiphinema (Xiphinema index), and ectoparasites Xiphinema spp.

[0310] Nematodes that can be controlled using the compounds of formula (I) include nematodes of the genus Meloidogyne, for example the southern root-knot nematode (Meloidogyne incognita), the Java root-knot nematode (Meloidogyne javanica), the northern root-knot nematode (Meloidogyne hapla) and the peanut root-knot nematode (Meloidogyne arenaria); nematodes of the genus Ditylenchus, for example the potato rot nematode (Ditylenchus destructor) and the stem and bulb nematode (Ditylenchus dipsaci); nematodes of the genus Pratylenchus, for example the corn root-damaging nematode (Pratylenchus penetrans), the chrysanthemum root-damaging nematode (Pratylenchus pseudobrachiatus); fallax), coffee root-damaging nematodes (Pratylenchus coffeae), tea root-damaging nematodes (Pratylenchus loosi), and walnut root-damaging nematodes (Pratylenchus vulnus); nematodes of the genus Globodera, such as the yellow potato cyst nematode (Globodera rostochiensis) and the white potato cyst nematode (Globodera pallida); nematodes of the genus Heterodera, such as the soybean cyst nematode (Heterodera glycines) and the sugar beet cyst nematode (Heterodera schachtii); nematodes of the genus Aphelenchoides, for example, the rice stem tip nematode (Aphelenchoides besseyi), the chrysanthemum leaf nematode (Aphelenchoides ritzemabosi) and the strawberry nematode (Aphelenchoides fragariae); nematodes of the genus Aphelenchus, for example, the fungus-feeding nematode (Aphelenchus avenae); nematodes of the genus Radopholus, for example, the burrowing nematode (Radopholus similis); nematodes of the genus Tylenchulus, for example, the citrus root nematode (Tylenchulus semipenetrans);Nematodes of the genus Rotylenchulus, such as the reniform nematode (Rotylenchulus reniformis); nematodes present in trees, such as the pine wood nematode (Bursaphelenchus xylophilus) and the red ringnematode (Bursaphelenchus cocophilus), etc.;

[0311] Plants that can be protected using the compounds of formula (I) include the following: for example, cereals (e.g., rice, barley, wheat, rye, oats, corn, etc.), legumes (soybeans, red beans, kidney beans, broad beans, peas, peanuts, etc.), fruit trees / fruits (apples, citrus species, pears, grapes, peaches, Japanese apricots, cherries, walnuts, almonds, bananas, strawberries, etc.), vegetable species (cabbage, tomatoes, spinach, broccoli, lettuce, onions, green onions, peppers, etc.), root crops (carrots, potatoes, sweet potatoes, radishes, etc.), , lotus root, turnip, etc.), industrial raw material crops (cotton, hemp, paper mulberry, three-leaf twig, rapeseed, sugar beet, hop, sugar cane, sugar beet, olive, rubber, palm tree, coffee, tobacco, tea, etc.), melons (pumpkin, cucumber, watermelon, melon, etc.), forage plants (duckgrass, sorghum, timothy, alfalfa, purple alfalfa, etc.), lawn grass (zoysia, bentgrass, etc.), spice plants (lavender, rosemary, thyme, parsley, pepper, ginger, etc.), and flowers (chrysanthemum, rose, orchid, etc.).

[0312] The compounds of formula (I) are particularly suitable for controlling nematodes in coffee, especially Brachyura brachyura, Brachyura coffee, short root-knot nematodes, southern root-knot nematodes, coffee root-knot nematodes, spiral nematodes, as well as Parana root-knot nematodes, spiral nematodes, Xiphinema species, dwarf nematodes, and shield nematodes.

[0313] The compounds of formula (I) are particularly suitable for controlling nematodes in potatoes, in particular Pratylenchus brachyura, Pratylenchus prausnitzii, Pratylenchus penetrans, Pratylenchus coffeae, Ditylenchus truncatus, as well as Pratylenchus eigenwiss, Pratylenchus andeanensis, Pratylenchus cerealis, notched short-bodied nematode, six-lobed short-bodied nematode, Luce short-bodied nematode, defeated short-bodied nematode, smooth short-bodied nematode, Sow's short-bodied nematode, disabled short-bodied nematode, long-tailed thorn nematode, barrel burr nematode, original burr nematode, adjacent burr nematode, similar burr nematode, rare burr nematode, microscopic pseudo-burr nematode, onion pseudo-burr nematode, short pseudo-burr nematode, smooth pseudo-burr nematode, peanut root-knot nematode, pseudo-root-knot nematode, northern root-knot nematode, Thames root-knot nematode, southern root-knot nematode, Qi's root-knot nematode, Java root-knot nematode, abnormal pearl nematode, potato golden nematode, potato white nematode, destroy stem nematode, similar piercing nematode, kidney-shaped small spiral nematode, Neotylenchus vigissi, false wall grass heteroslip blade nematode (Paraphelenchus pseudoparietinus), Pseudocercus pseudoparietinus, and Meloinema spp.

[0314] The compounds of formula (I) are particularly suitable for controlling nematodes in tomatoes, in particular peanut root-knot nematodes, northern root-knot nematodes, java root-knot nematodes, southern root-knot nematodes, puncturing Pratylenchus, as well as Brachyura brachyurae, coffee Pratylenchus coffeae, Pratylenchus stejnjeri, Pratylenchus injuris, microtrichopteran nematodes, short root-knot nematodes, abnormal pearl nematodes, Solanum solani, Dolichodorus heterocephalus and reniform spiral nematodes.

[0315] The compounds of formula (I) are particularly suitable for controlling nematodes in cucumber plants, in particular the peanut root-knot nematode, the northern root-knot nematode, the javanic root-knot nematode, the southern root-knot nematode, the reniform spiral nematode, and the sowerby's nematode.

[0316] The compounds of formula (I) are particularly suitable for controlling nematodes in cotton, especially the longicaudal nematode, the southern root-knot nematode, the Columbian nematode, the cap-shaped nematode, and the reniform spiral nematode.

[0317] The compounds of formula (I) are particularly suitable for controlling nematodes in corn, in particular the long-tailed thorn nematode, the microscopic thorn nematode, and the short-tailed thorn nematode, the delat thorn nematode, the six-lobed thorn nematode, the puncturing thorn nematode, the corn thorn nematode, (the fine thorn nematode), the Norton thorn nematode (Belonolaimus nortoni), the short-ringed long needle nematode, the peanut root knot nematode, Meloidogyne arenaria thamesi, the grass root knot nematode, the southern root knot nematode, Meloidogyne incognita acrita, Java root-knot nematode, Nasi root-knot nematode, Avena sativa, Rice Heterodera, Zea mays, Chalco spot-bark nematode, Teasel grass stem nematode, Egyptian tie nematode, Large needle tie nematode, Cap tie nematode, Indian tie nematode, Double-horned spiral nematode, Double-palace spiral nematode, Pseudo-robust spiral nematode, American sword nematode, Dolichodorusheterocephalus, Ornamental small ring nematode, Ouni small ring nematode, Similar piercing nematode, Northern small spiral nematode, Micro kidney-shaped nematode, Farmland dwarf nematode, Clear dwarf nematode, Clayton dwarf nematode, Maximum dwarf nematode, Naked dwarf nematode, Common dwarf nematode, Sharp five-hook nematode, Micro needle nematode, Micro fine sheath nematode, Ju Nong rough-striped membrane pad nematode, Wheat grain gall nematode, Peanut sliding blade nematode, Small tail shield nematode and root gall sub-granule nematode.

[0318] The compounds of formula (I) are particularly suitable for controlling nematodes in soybeans, especially the short-tailed Pratylenchus, the grassland Pratylenchus, the piercing Pratylenchus, the Steinernema Pratylenchus, the long-tailed thorn nematode, the soybean Heterodera, the Columbian nematode, as well as the coffee Pratylenchus, the six-lobed Pratylenchus, the defeated Pratylenchus, the notched Pratylenchus, the Ehrlich Pratylenchus, the agile Pratylenchus, the corn Pratylenchus, the injured Pratylenchus, (the fine thorn nematode), the peanut root-knot nematode, the southern root-knot nematode, the Javan root-knot nematode, the northern root-knot nematode, the Columbian nematode, the cap-shaped nematode and the kidney-shaped spiral nematode.

[0319] The compounds of formula (I) are particularly suitable for controlling nematodes in tobacco, especially the southern root-knot nematode, the Java root-knot nematode, and the short-tailed Braybody nematode, the grassland Braybody nematode, the six-lobed Braybody nematode, the piercing Braybody nematode, the defeated Braybody nematode, the notched Braybody nematode, the sow's Braybody nematode, the disabled Braybody nematode, the corn Braybody nematode, the escaped long needle nematode, Paratrichodorus lobatus, the burr nematode, the peanut root-knot nematode, the northern root-knot nematode, the tobacco ball Heterodera, the soya ball Heterodera, the virginia ball Heterodera, the teasel grass stem nematode, the spiral nematode, the spiral nematode, the American sword nematode, the small ring nematode, the kidney-shaped small spiral nematode, the Clayton dwarf nematode, the needle nematode and the tobacco head pad nematode.

[0320] The compounds of formula (I) are particularly suitable for controlling nematodes in citrus, in particular Braytria coffeae, as well as Braytria brachyurae, Braytria incisi, Braytria longicauda, ​​Paratrichum callosum, Trichodina spp., Meloidogyne incognita acrita, Meloidogyne incognita acrita, Meloidogyne javanica, Macrocystis spp., Xiphinema americana, Xiphinema short-necked, Xiphinema standard, Microcirculina species, Hemicycline spp., Similar and citrus puncture nematodes, Fleas sheath nematodes, Hemicycliophora nudata and Semipuncture nematodes.

[0321] The compounds of formula (I) are particularly suitable for controlling nematodes in bananas, in particular Pratylenchus coffeeii, similar nematodes, and Pratylenchus giibbicaudatus, Pratylenchus lousei, Meloidogyne species, Helicoverpa multitapes, Helicoverpa divaricata and Helicoverpa microstomata species.

[0322] The compounds of formula (I) are particularly suitable for controlling nematodes in pineapples, in particular Pratylenchus zeae, Pratylenchus prausnitzii, Brachyura caudalis, Brachyrenchyma goosensis, root-knot nematodes, reniform spiral nematodes, as well as Longidorus laevicapitatus, Original burr nematodes, Small burr nematodes, Heterodera species, Ditylenchus mycorrhizus, California tie nematodes, Weak tie nematodes, Indian tie nematodes, Double-housed spiral nematodes, Short spiral nematodes, Multi-banded spiral nematodes, Erythrina spiral nematodes, Xiphinema dimorphicaudatum, Similar piercing nematodes, Digital dwarf nematodes, Tylenchorhynchus ebriensis, Micronematodes, Shield nematodes, Slow shield nematodes, Caudal naked lancet nematodes, Psilenchus magnidens, Pseudohalenchus minutus, Vernia small ring nematodes, Ouni small ring nematodes and Ornamental small ring nematodes.

[0323] The compounds of formula (I) are particularly suitable for controlling nematodes in grapevines, in particular Pratylenchus injuris, peanut root-knot nematodes, southern root-knot nematodes, javanic root-knot nematodes, American sword nematodes, standard sword nematodes, as well as Pratylenchus frugiperda, Pratylenchus stejnensis, Pratylenchus suspensorianus, Pratylenchus brachyura, Pratylenchus sommersii and Pratylenchus semipenetratingensis.

[0324] The compounds of formula (I) are particularly suitable for controlling nematodes in tree crops - pome fruits, in particular Pratylenchus penetrans, as well as Pratylenchus injuris, Pratylenchus escapingus, Meloidogyne incognita and Meloidogyne northernis.

[0325] The compounds of formula (I) are particularly suitable for controlling nematodes in tree crops - stone fruits, in particular the puncturing nematode, the wounding nematode, the peanut root-knot nematode, the northern root-knot nematode, the Java root-knot nematode, the southern root-knot nematode, the thin-leaved small ring nematode, as well as the short-tailed nematode, the coffee nematode, the Steinernema, the corn nematode, the long-tailed thorn nematode, the double-house spiral nematode, the American sword nematode, the curved small ring nematode, the Clayton dwarf nematode, the curved hook nematode, the protruding needle nematode, the small-tailed shield nematode and the cap-shaped tie nematode.

[0326] The compounds of formula (I) are particularly suitable for controlling nematodes in tree crops, sugar cane and rice, in particular Trichodina species, Microcircle nematode species, as well as Pratylenchus species, Pseudocranulus species, Root-knot nematode species, Heliconematode species, Dwarf nematode species, Pseudocranulus species, Heterodera species, Xiphinema species and Cacopauruspestis.

[0327] application

[0328] The compounds of formula (I) can be applied as such or, for example, as ready-to-use solutions, emulsions, water-based or oil-based suspensions, dusts, wettable powders, pastes, soluble powders, powders, soluble granules, granules for broadcasting, suspoemulsion concentrates, natural products impregnated with the compounds of formula (I), synthetic substances impregnated with the compounds of formula (I), fertilizers or microcapsules in polymers.

[0329] Application is accomplished in a conventional manner, for example by watering, spraying, atomizing, broadcasting, dusting, foaming, smearing, etc. It can also be applied by ultra-low volume methods, by drip irrigation systems or perfusion, by furrowing the compound of formula (I) or by injecting it into the soil stem or trunk. It can also be applied by wound sealing, paint or other wound dressings.

[0330] The effective and phytocompatible amount of a compound of formula (I) applied to plants, plant parts, fruits, seeds or soil will depend on various factors, such as the compound / composition used, the object of treatment (plant, plant part, fruit, seed or soil), the type of treatment (dusting, spraying, seed dressing), the purpose of the treatment (curative and protective), the type of microorganism, the development stage of the microorganism, the sensitivity of the microorganism, the crop growth stage and the environmental conditions.

[0331] When formula (I) compound is used as fungicide, the rate of application can change in a relatively wide range according to the type used. For the processing of plant parts such as leaves, the rate of application can be 0.1 to 10000g / ha, preferably 10 to 1000g / ha, more preferably in the range of 50 to 300g / ha (when applied by watering or drip irrigation, the rate of application can even be reduced, particularly when using inert substrates such as rock wool or perlite). For the processing of seeds, the rate of application can be 0.1 to 200g per 100kg seeds, preferably 1 to 150g per 100kg seeds, more preferably 2.5 to 25g per 100kg seeds, even more preferably 2.5 to 12.5g per 100kg seeds. For the processing of soil, the scope of the rate of application can be 0.1 to 10000g / ha, preferably 1 to 5000g / ha.

[0332] These application rates are merely examples and are not intended to limit the scope of the invention.

[0333] Material protection

[0334] The compounds and compositions of the invention can also be used for protecting materials, especially industrial materials, from attack and destruction by harmful microorganisms.

[0335] Furthermore, the compounds and compositions of the present invention can be used as antifouling compositions alone or in combination with other active ingredients.

[0336] In this article, industrial materials are understood to refer to inanimate materials that are ready for use in industry. For example, industrial materials that are prevented from being changed or destroyed by microorganisms can be adhesives, glues, paper, wallpaper and board / cardboard, textiles, carpets, leather, wood, fibers and fabrics, paints and plastic products, cooling lubricants and other materials that can be infected or destroyed by microorganisms. The parts of production equipment and buildings, such as cooling water circuits, cooling and heating systems and ventilation and air-conditioning devices, may be damaged due to the breeding of microorganisms, which can also be mentioned in the material range to be protected. Industrial materials within the scope of the present invention preferably include adhesives, sizing materials, paper and card, leather, wood, paints, cooling lubricants and heat transfer fluids, more preferably wood.

[0337] The compounds and compositions of the present invention can prevent adverse effects such as rotting, decay, discoloration, fading or mold formation.

[0338] In the case of the treatment of wood, the compounds and compositions according to the invention may also be used to combat fungal diseases liable to grow on or in wood.

[0339] Wood refers to all types of wood, as well as all types of wood workpieces to be used in construction, such as solid wood, high-density wood, laminated wood and plywood. In addition, the compounds and compositions according to the invention can be used for protecting objects which come into contact with salt or brackish water, in particular hulls, screens, nets, buildings, moorings and signalling systems, from contamination.

[0340] The compounds and compositions of the present invention can also be used to protect stored goods. Stored goods are understood to refer to natural substances of plant or animal origin or processed products of their natural origin, and require long-term protection. Stored goods of plant origin, such as plants or plant parts, such as stems, leaves, tubers, seeds, fruits, grains, can be protected by (pre) drying, moistening, crushing, grinding, pressing or baking just after harvesting or processing. Stored goods also include unprocessed wood, such as building wood, poles and barriers, or wood in finished form, such as furniture. Stored goods of animal origin are, for example, skins, leather, furs and hair. The compounds and compositions of the present invention can prevent adverse effects, such as rotting, decaying, discoloration, fading or mold formation.

[0341] Microorganisms capable of degrading or modifying industrial materials include, for example, bacteria, fungi, yeasts, algae and slime organisms. The compounds and compositions of the invention are preferably active against fungi, especially molds, wood-discoloring and wood-destroying fungi (ascomycetes, basidiomycetes, deuteromycetes and zygomycetes), as well as against slime organisms and algae.Examples include microorganisms of the genera Alternaria, such as Alternaria spp.; Aspergillus, such as Aspergillus niger; Chaetomium, such as Chaetomium globosum; Coniophora, such as Coniophora puetana; Lentinus, such as Lentinus tigrinus; Penicillium, such as Penicillium glaucum; Polyporus, such as Polyporus versicolor; Aureobasidium, such as Aureobasidium pullulans; Sclerophoma, such as Sclerophoma pityophila; Trichoderma, such as Trichoderma viride; Ophiostoma spp.), Ceratocystis spp., Humicola spp., Petriella spp., Trichurus spp., Coriolus spp., Gloeophyllum spp., Pleurotus spp., Poria spp., Serpula spp., and Tyromyces spp., Cladosporium spp., Paecilomyces spp., Mucor spp., Escherichia spp., for example Escherichia coli. coli); Pseudomonas species, such as Pseudomonas aeruginosa; Staphylococcus species, such as Staphylococcus aureus, Candida spp., and Saccharomyces spp., such as Saccharomyces cerevisae.

[0342] Aspects of the present specification can be further understood based on the following examples, which should not be construed as limiting the scope of the present specification in any way.

[0343] Example

[0344] Synthesis of compounds of formula (I)

[0345] Preparation Example 1 : Preparation of S-ethyl 1-{[(4,5-dichloro-3-methyl-2-thienyl)carbonyl]amino}cyclopropanethiocarboxylate (Compound I.049)

[0346] Step 1 :Preparation of 1-{[(4,5-dichloro-3-methyl-2-thienyl)carbonyl]amino}cyclopropanecarboxylic acid methyl ester

[0347] To a solution of 2.08 g (12.3 mmol) of 2-chloro-1,3-dimethylimidazolidinium chloride dissolved in 12.3 mL of dichloromethane was added a solution of 2.00 g (9.47 mmol) of 4,5-dichloro-3-methylthiophene-2-carboxylic acid and 7.10 mL (40.7 mmol) of N,N-diisopropylethylamine dissolved in 75 mL of dichloromethane. After stirring for 15 min, 333 mg (2.37 mmol) of 1-aminocyclopropanecarboxylic acid methyl ester hydrochloride (1:1) was added, and the reaction mixture was stirred at room temperature for 72 hours. Water was added, and the reaction mixture was extracted twice with dichloromethane. The combined organic layers were dried over anhydrous sodium sulfate, filtered and concentrated under reduced pressure. The residue was purified by a first silica gel column chromatography (gradient n-heptane / ethyl acetate) and then by a second silica gel column chromatography (gradient dichloromethane / ethyl acetate) to give 2.12 g (98% purity, 71% yield) of the title compound as a white solid. LogP = 2.75. (M+H) = 308.

[0348] step 2: Preparation of 1-{[(4,5-dichloro-3-methyl-2-thienyl)carbonyl]amino}cyclopropanecarboxylic acid

[0349] To a solution of 600 mg (1.94 mmol) of methyl 1-{[(4,5-dichloro-3-methyl-2-thienyl)carbonyl]amino}cyclopropanecarboxylate dissolved in 16 mL of tetrahydrofuran was added dropwise 4.3 mL of 1 M aqueous potassium hydroxide solution (4.3 mmol). The reaction mixture was stirred at room temperature for 18 hours. The resulting reaction mixture was then carefully acidified to pH 1 with 1.0 M aqueous hydrochloric acid at 0°C and extracted three times with ethyl acetate. The combined organic layers were purified by Chem Elut TM Cartridge filtration and concentration under reduced pressure afforded 557 mg (100% purity, 97% yield) of the title compound as a white solid. LogP = 2.17. (M+H) = 294.

[0350] step3: Preparation of S-ethyl 1-{[(4,5-dichloro-3-methyl-2-thienyl)carbonyl]amino}cyclopropanethiocarboxylate (Compound I.049)

[0351] Under an inert atmosphere, to a solution of 100 mg (0.34 mmol) of 1-{[(4,5-dichloro-3-methyl-2-thienyl)carbonyl]amino}cyclopropanecarboxylic acid dissolved in 3.2 mL of anhydrous dichloromethane at room temperature, 178 μL (1.02 mmol) of N,N-diisopropylethylamine was added, followed by 194 mg (0.51 mmol) of 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate. After stirring at room temperature for 15 min, 32 mg (0.51 mmol) of ethanethiol was added and the reaction mixture was stirred at room temperature for 18 hours. Saturated aqueous sodium bicarbonate solution was added, and the resulting reaction mixture was extracted twice with dichloromethane. The combined organic layers were filtered through a silica gel cartridge and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (gradient n-heptane / ethyl acetate) to give 56 mg (100% purity, 49% yield) of the title compound as a white solid. LogP=3.67. (M+H)=388.

[0352] Preparation Example 2 : Preparation of ethyl 1-({N-[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]glycyl}amino)cyclopropanecarboxylate (Compound I.024)

[0353] Step 1 :Preparation of N-[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]glycine

[0354] In a first round-bottom flask, to a solution of 300 mg (1.0 mmol) of 4,5-dibromo-3-methylthiophene-2-carboxylic acid dissolved in 8 mL of anhydrous dichloromethane at room temperature was added 96 μL (1.1 mmol) of oxalyl chloride and one drop of N,N-dimethylformamide. After stirring at room temperature for 1 hour, the reaction mixture was concentrated under reduced pressure and dissolved in 6 mL of anhydrous 1,4-dioxane to give an acid chloride solution. In a second round-bottom flask, to a solution of 150 mg (2.0 mmol) of glycine dissolved in 0.9 mL of water was added 1 mL of 2M aqueous sodium hydroxide solution (2.0 mmol). The reaction mixture was stirred at room temperature and then slowly added to the previously prepared acid chloride solution at 0°C. An additional 0.5 mL of 2M aqueous sodium hydroxide solution (1.0 mmol) was added to the reaction mixture. The resulting reaction mixture was stirred at room temperature for 18 hours, diluted with water and carefully acidified to pH 1 with 37% (w / w) aqueous hydrochloric acid at 0°C. The resulting precipitate was filtered off, washed with water and dissolved in ethyl acetate. The resulting organic layer was dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to give 233 mg (100% purity, 65% yield) of the title compound as a white solid. LogP = 2.05. (M+H) = 356.

[0355] Step 2 : Preparation of ethyl 1-({N-[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]glycyl}amino)cyclopropanecarboxylate (Compound I.024)

[0356] In a 50 mL round-bottom flask under an inert atmosphere, 144 mg (0.87 mmol) of 1-aminocyclopropanecarboxylic acid ethyl ester hydrochloride (1:1) was added to a solution of 208 mg (0.58 mmol) of N-[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]glycine and 304 μL (1.74 mmol) of N,N-diisopropylethylamine in 5 mL of anhydrous dichloromethane at room temperature, followed by 332 mg (0.87 mmol) of 1-[bis(dimethylamino)methylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxide hexafluorophosphate. The reaction mixture was stirred at room temperature for 18 hours. Saturated aqueous sodium bicarbonate solution was added, and the resulting reaction mixture was extracted twice with dichloromethane. The combined organic layer was dried over anhydrous magnesium sulfate, filtered, and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (gradient n-heptane / ethyl acetate) to give 225 mg (100% purity, 82% yield) of the title compound as a white solid. LogP=2.55. (M+H)=467.

[0357] Preparation Example 3 :Preparation of N-[(4,5-dibromo-3-methyl-2-thienyl)thiocarbonyl]valine ethyl ester (Compound I.023)

[0358] Step 1 :Preparation of N-[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]valine ethyl ester

[0359] To a solution of 154 mg (0.50 mmol) of 4,5-dibromo-3-methylthiophene-2-carboxylic acid and 183 mg (1.00 mmol) of DL-valine ethyl ester hydrochloride dissolved in 3 mL of tetrahydrofuran was added 0.21 mL (1.51 mmol) of triethylamine, followed by 0.45 mL (0.75 mmol) of a 50% (w / w) solution of propanephosphonic anhydride dissolved in ethyl acetate. The reaction mixture was stirred at room temperature for 2 hours. The reaction mixture was terminated with saturated aqueous sodium bicarbonate solution and extracted with ethyl acetate. The combined organic layers were dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (gradient n-heptane / ethyl acetate) to give 103 mg (95% purity, 45% yield) of the title compound as a white solid. LogP = 4.32. (M+H) = 426.

[0360] Step 2 :Preparation of N-[(4,5-dibromo-3-methyl-2-thienyl)thiocarbonyl]valine ethyl ester (Compound I.023)

[0361] To a solution of 150 mg (0.35 mmol) of N-[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]valine ethyl ester dissolved in 1.5 mL of dichloromethane was added 71 mg (0.17 mmol) of Lawesson's reagent. The reaction mixture was stirred at 50°C for 20 hours. The resulting reaction mixture was diluted with dichloromethane and reacted with an alkaline Filter through an alumina cartridge and concentrate under reduced pressure. The residue was purified by preparative high performance liquid chromatography (gradient acetonitrile / aqueous formic acid solution (1%)) to give 106 mg (100% purity, 68% yield) of the title compound as a yellow solid. LogP = 5.22. (M+H) = 442.

[0362] Preparation Example 4 : Preparation of N-[(4,5-dibromo-3-methyl-2-thienyl)thiocarbonyl]valine (Compound I.031)

[0363] To a solution of 203 mg (0.47 mmol) of N-[(4,5-dibromo-3-methyl-2-thienyl)thiocarbonyl] valine ethyl ester (Compound I.023) dissolved in 8 mL of tetrahydrofuran was added dropwise 2.56 mL of 1 M aqueous potassium hydroxide solution (2.56 mmol). The reaction mixture was stirred at room temperature for 18 hours. A solution of 33 mg (1.39 mmol) of lithium hydroxide dissolved in 2 mL of water was added and the resulting reaction mixture was stirred at room temperature for 6 hours. An additional 28 mg (1.15 mmol) of lithium hydroxide was added and the resulting reaction mixture was further stirred at room temperature for 48 hours. The resulting reaction mixture was then carefully acidified to pH 1 with 1.0 M aqueous hydrochloric acid solution at 0°C and extracted 3 times with ethyl acetate. The combined organic layers were purified by Chem Elut TM Cartridge filtration and concentration under reduced pressure afforded 479 mg (98% purity, 97% yield) of the title compound as a yellow solid. LogP = 3.72. (M+H) = 412.

[0364] Preparation Example 5 : Preparation of cyclopropyl{[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]amino}acetic acid (Compound 1.080)

[0365] In the first round-bottom flask, 38 μL (0.44 mmol) of oxalyl chloride and one drop of N,N-dimethylformamide were added to a solution of 120 mg (0.4 mmol) of 4,5-dibromo-3-methylthiophene-2-carboxylic acid dissolved in 3 mL of anhydrous dichloromethane at room temperature. After stirring at room temperature for 45 min, the reaction mixture was concentrated under reduced pressure and dissolved in 2 mL of anhydrous 1,4-dioxane to obtain an acid chloride solution. In the second round-bottom flask, 1.6 mL of 1 M aqueous sodium hydroxide solution (1.6 mmol) was added to a solution of 121 mg (0.8 mmol) of amino(cyclopropyl)acetic acid hydrochloride (1:1) dissolved in 0.6 mL of water. The reaction mixture was stirred at room temperature for 30 min and then slowly added to the previously prepared acid chloride solution at 0°C. The resulting reaction mixture was stirred at room temperature for 24 h, diluted with water and carefully acidified to pH 1 with 1.0 M aqueous hydrochloric acid at 0°C and extracted with ethyl acetate. The combined organic layers were purified by Chem Elut TM The residue was purified by preparative HPLC to give 60 mg (100% purity, 38% yield) of the title compound as a white solid. LogP = 2.67. (M+H) = 396.

[0366] Preparation Example 6 : Preparation of cyclopropyl{[(4,5-dichloro-3-methyl-2-thienyl)carbonyl]amino}acetic acid methyl ester (Compound I.081)

[0367] To a solution of 180 mg (1.06 mmol) of 2-chloro-1,3-dimethylimidazolidinium chloride dissolved in 3 mL of dichloromethane was added a solution of 150 mg (0.71 mmol) of 4,5-dichloro-3-methylthiophene-2-carboxylic acid, 532 μL (3.05 mmol) of N,N-diisopropylethylamine and 176 mg (1.06 mmol) of amino(cyclopropyl)acetic acid methyl ester hydrochloride (1:1) dissolved in 3 mL of dichloromethane. The reaction mixture was stirred at room temperature for 18 hours. Water was added and the resulting reaction mixture was extracted twice with dichloromethane. The combined organic layers were dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue was dissolved in dichloromethane, filtered through a silica gel cartridge and concentrated under reduced pressure. The residue was purified by preparative high performance liquid chromatography to give 145 mg (100% purity, 64% yield) of the title compound as a white solid. LogP = 3.31. (M+H)=322.

[0368] Preparation Example 7 :N 2 Preparation of -[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]-N-methoxyvalinamide (Compound I.074)

[0369] Step 1 :Preparation of N-[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]valine ethyl ester

[0370] To a solution of 154 mg (0.50 mmol) of 4,5-dibromo-3-methylthiophene-2-carboxylic acid and 183 mg (1.00 mmol) of DL-valine ethyl ester hydrochloride dissolved in 3 mL of tetrahydrofuran was added 0.21 mL (1.51 mmol) of triethylamine, followed by 0.45 mL (0.75 mmol) of a 50% (w / w) solution of propanephosphonic anhydride dissolved in ethyl acetate. The reaction mixture was stirred at room temperature for 2 hours. The reaction mixture was terminated with saturated aqueous sodium bicarbonate solution and extracted with ethyl acetate. The combined organic layers were dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (gradient n-heptane / ethyl acetate) to give 103 mg (95% purity, 45% yield) of the title compound as a white solid. LogP = 4.32. (M+H) = 426.

[0371] Step 2 :Preparation of N-[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]valine

[0372] To a solution of 164 mg (0.38 mmol) of N-[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]valine ethyl ester dissolved in 3 mL of tetrahydrofuran was added dropwise 0.81 mL of 1 M lithium hydroxide solution (0.81 mmol). The reaction mixture was stirred at room temperature for 18 hours. The reaction mixture was diluted with ethyl acetate and saturated aqueous sodium bicarbonate solution. The organic layer was washed twice with saturated aqueous sodium bicarbonate solution. The combined aqueous layers were carefully acidified with 37% (w / w) aqueous hydrochloric acid solution at 0°C and extracted with ethyl acetate. The combined organic layers were dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure to give 151 mg (98% purity, 96% yield) of the title compound as a white solid. LogP = 2.92. (M+H) = 398.

[0373] Step 3 :N 2 Preparation of -[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]-N-methoxyvalinamide (Compound I.074)

[0374] To a solution of 200 mg (0.50 mmol) of N-[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]valine, 52 mg (0.60 mmol) of o-methylhydroxylamine hydrochloride (1:1) and 300 mg (1.00 mmol) of 3-(diethoxyphosphoryloxy)-1,2,3-benzotriazine-4(3H)-one dissolved in 3 mL of anhydrous tetrahydrofuran, 140 μL (1.00 mmol) of triethylamine was added. The reaction mixture was stirred at room temperature for 17 hours. The resulting reaction mixture was concentrated under reduced pressure, diluted with water and extracted twice with dichloromethane. The combined organic layers were dried over anhydrous magnesium sulfate, filtered and concentrated under reduced pressure. The residue was dissolved in dichloromethane, filtered through a silica gel cartridge and concentrated under reduced pressure. The residue was purified by preparative high performance liquid chromatography to give 35 mg (100% purity, 16% yield) of the title compound as a white solid. LogP = 2.77. (MH)=425.

[0375]

[0376]

[0377]

[0378]

[0379]

[0380]

[0381]

[0382]

[0383]

[0384]

[0385] NMR peak list

[0386] Table A provides NMR data for some of the compounds disclosed in the above table ( 1 H).

[0387] Selected Embodiments 1 H-NMR data 1 H-NMR peaks are listed in the form of a table. Each signal peak is listed with the δ value in ppm and the signal intensity in parentheses. The δ value-signal intensity pairs are separated by semicolons.

[0388] The peak list for the example thus has the following form:

[0389] δ 1 (strength 1 );δ 2 (strength 2 );……δ i (strength i );……δ n (strength n )

[0390] In the example of a printed NMR spectrum in centimeters, the intensity of a sharp signal is related to the height of the signal and shows the true relationship of the signal strength. From a broad signal, several peaks or intermediate signals of the signal can be shown and their relative intensities compared to the strongest signal in the spectrum.

[0391] For calibration 1 For the chemical shifts of H spectra, we use the chemical shift of tetramethylsilane and / or the solvent used, particularly in cases where the spectra were measured in DMSO. Therefore, in the NMR peak list, tetramethylsilane peaks may, but do not necessarily, appear.

[0392] 1 The H-NMR peak list is similar to the classical 1 H-NMR printed diagrams therefore usually contain all peaks which are listed in a classical NMR description.

[0393] In addition, they can be like classic 1 The H-NMR print also shows signals of solvent, stereoisomers of the target compound (also the target of the present invention) and / or impurity peaks.

[0394] To display the signal of compounds in the delta range of solvent and / or water, the common peak of solvent, such as DMSO-D 6 The DMSO peak and water peak in the 1 In the H-NMR peak list, the peaks generally have high intensities on average.

[0395] The average intensity of the stereoisomer peaks and / or impurity peaks of the target compound is usually lower than that of the target compound peak (eg, purity > 90%).

[0396] Such stereoisomers and / or impurities may be typical for a particular preparation process. Therefore, their peaks help to identify the reproducibility of our preparation process through "by-product fingerprints".

[0397] Experts who calculate the peaks of the target compounds using known methods (MestreC, ACD simulation, and empirically evaluated expectation values) can optionally use additional intensity filters to separate the peaks of the target compounds as needed. This separation is similar to the classical 1 Relevant peak detection in H-NMR interpretation.

[0398] You can find further details on NMR data description and peak lists in the publication "Citation of NMR Peaklist Data within Patent Applications" in Research Disclosure Database Number 564025.

[0399] Table A : NMR peak list

[0400]

[0401]

[0402]

[0403]

[0404]

[0405]

[0406]

[0407]

[0408]

[0409]

[0410]

[0411]

[0412]

[0413]

[0414] Biological data

[0415] Example A described below shows the activity of the compound of formula (I) in Arabidopsis thaliana. (Arabidopsis thaliana) These compounds induce host defenses and thus protect plants from a wide range of pathogens, including bacteria and fungi.

[0416] Examples B, C, D, E and F described below demonstrate the in vivo activity of compounds of formula (I) in plants by stimulating the plant's defense against a variety of pathogens, including bacteria and fungi, that infect the plant.

[0417] Examples G, H, I and J described below show in vitro cell assays for the direct inactivation of compounds of formula (I) against various pathogens including bacteria and fungi, thereby illustrating the mode of action of compounds of formula (I) as plant host defense inducers.

[0418] Examples K, L, M, N and O described below show the in planta activity of comparative compounds CMP1, CMP2, CMP3, CMP4, CMP5, CMP6 and CMP7 prepared according to the teaching of WO2004 / 024692 and compounds according to the invention.

[0419] Comparison of the activities of CMP1, CMP2, CMP3, CMP4, CMP5, CMP6 and CMP7 with the compounds of the present invention shows that the activities of these prior art compounds are significantly lower and therefore cannot provide the beneficial technical effects of the compounds of the present invention.

[0420] Examples P, Q, R, S and T described below show the in planta activity of comparative compounds CMP8, CMP9, CMP10, CMP11, CMP12, CMP13, CMP14, CMP15 and CMP16 prepared according to the teaching of EP0450355 and compounds according to the invention.

[0421] Comparison of the activities of CMP8, CMP9, CMP10, CMP11, CMP12, CMP13, CMP14, CMP15 and CMP16 with the compounds of the present invention shows that the activities of these prior art compounds are significantly lower and therefore cannot provide the beneficial technical effects of the compounds of the present invention.

[0422] Example A: Inducing defense gene expression in Arabidopsis thaliana

[0423] Arabidopsis reporter plants containing a green fluorescent protein (GFP) coding sequence linked to the salicylic acid-responsive promoter sequence of the PR1 (pathogenesis-related protein 1) gene (AT2G14610) were grown for 5 days and then sprayed with the compound. On the 3rd day after spraying, plant fluorescence was assessed using a MacroFluo instrument from Leica Microsystems (Wetzlar, Germany). Fluorescence was quantified using Meta-Morph microscope automation and image analysis software (Molecular Devices, Sunnyvale, Calif., United States).

[0424] The background fluorescence of mock-treated leaves was set to 1.00. The relative fluorescence value obtained for salicylic acid treatment (300 ppm) was 2.70, demonstrating the effectiveness of the test system.

[0425] During the examination, the level of the compound in the lower row of the base book was 300ppm, and the time was as low as 2. 01;I.002;I.004;I.006;I.007;I.008;I.009;I.010;I.012 ;I.013;I.014;I.015;I.016;I.018;I.019;I.021;I.022;I.023;I.025;I.026;I.031;I.032;I.033;I.034;I.035;I.0 36;I.037;I.038;I.039;I.040;I.041;I.042;I.043;I.044;I.045;I.047;I.048;I.049;I.050;I.052;I.053;I.054; I.055; I.060; I.061; I.062; I.066; I.067; I.068; I.069; I.070; I.071; I.072; I.073; I.074; I.076; I.077; I.078; I.07 9; I.080; I.081; I.083; I.084; I.085; I.087; I.088; I.089; I.090; I.091; I.092; I.094; I.095; I.099; .102;I.103;I.104;I.105;I.108;I.110;I.113;I.114;I.115;I.116;I.117;I.118;I.119;I.120;I.121;I.122;I.123 ;I.124;I.125;I.126;I.127;I.128;I.129;I.131;I.132;I.133;I.134;I.135;I.136;I.137;I.149;I.150;I.154;I. 155; I.157; I.158; I.159; I.161; I.162; I.164; I.165; I.167; I.168; I.169; I.171; I.172; I.173; I.174; I.175; I.176.

[0426] In this test, the following compounds according to the invention showed a relative fluorescence value of at least higher than 2 at a compound concentration of 75 ppm: I.002; 024;I.025;I.026;I.031;I.032;I.039;I.040;I.044;I.049;I.050;I .053; I.055; I.060; I.067; I.068; I.071; I.072; I.077; I.080; I.081; I .089; I.091; I.094; I.095; I.100; I.102; I.104; I.105; I.108; I.110; I.113;I.115;I.118;I.119;I.122;I.123;I.124;I.125;I.127;I.128; I.129; I.131; I.132; I.133; I.134; I.136; I.137; I.150; I.154; I.155; I.157; I.158; I.161; I.164; I.171; I.172; I.173; I.174; I.175; I.176.

[0427] Salicylate is the primary defense hormone against plant pathogens. All of the above compounds stimulate the salicylate pathway and thus protect plants from a wide range of pathogens.

[0428] Example B: In vivo prevention of Colletotrichum lindemuthianum (Bean Anthracnose) test

[0429] By acetone / dimethyl sulfoxide / The active ingredients to be tested were prepared by homogenizing a mixture of 1% ethanol and then diluting with water to obtain the desired concentration of active material.

[0430] Young bean plants were treated by spraying with the active ingredient prepared as described above. Control plants were treated with acetone / DMSO / of aqueous solution treatment.

[0431] After 72 hours, the plants were infected by spraying the leaves with an aqueous suspension of Colletotrichum spores. The infected bean plants were incubated at 20°C and 100% relative humidity for 24 hours and then at 20°C and 90% relative humidity for 5 days.

[0432] The test is evaluated 6 days after inoculation. 0% indicates an efficacy which corresponds to the control plants, while an efficacy of 100% means that no disease is observed.

[0433] In this test, the following compounds of the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 500 ppm: 1.006; 1.021; 1.032; 1.038; 1.072; 1.078; 1.080; 1.127; 1.132.

[0434] In this test, the following compounds of the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 500 ppm: 1.003; 1.045; 1.071; 1.081; 1.122; 1.131; 1.136.

[0435] In this test, the following compounds of the present invention showed an efficacy of 90% to 100% at an active ingredient concentration of 500 ppm: I.013; I.014; I.023; I.031; I.033; I.039; I.040; I.041; I.042; I.043; I.044; I.047; I.077; I.083; I.099; I.101; I.108; I.137; I.173.

[0436] In this test, the following compounds of the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 31 ppm: 1.014.

[0437] In this test, the following compounds of the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 31 ppm: 1.042; 1.044; 1.077; 1.099; 1.165.

[0438] In this test, the following compounds of the invention showed an efficacy of 90% to 100% at an active ingredient concentration of 31 ppm: 1.023; 1.041; 1.043; 1.047.

[0439] In this test, the following compounds according to the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 125 ppm: 1.021; 1.095; 1.115; 1.122; 1.175.

[0440] In this test, the following compounds of the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 125 ppm: 1.013; 1.014; 1.033; 1.042; 1.060; 1.077; 1.099; 1.108; 1.165; 1.167; 1.172.

[0441] In this test, the following compounds of the invention showed an efficacy of 90% to 100% at an active ingredient concentration of 125 ppm: 1.023; 1.040; 1.041; 1.043; 1.044; 1.047.

[0442] Example C: In vivo prevention test of Peronospora parasitica (Crucifer downy mildew)

[0443] By acetone / dimethyl sulfoxide / The active ingredients to be tested were prepared by homogenizing a mixture of 1% ethanol and then diluting with water to obtain the desired concentration of active material.

[0444] Cabbage seedlings were treated by spraying with the active ingredient prepared as described above. Control plants were treated with acetone / DMSO / of aqueous solution treatment.

[0445] After 72 hours, the plants were infected by spraying the leaves with an aqueous suspension of spores of Peronospora parasitica. The infected cabbage plants were incubated at 20°C and 100% relative humidity for 5 days.

[0446] The test is evaluated 5 days after inoculation. 0% indicates an efficacy which corresponds to the control plants, while an efficacy of 100% means that no disease is observed.

[0447] In this test, the following compounds according to the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 500 ppm: 1.059; 1.098.

[0448] In this test, the following compounds according to the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 500 ppm: 1.022; 1.033; 1.035; 1.134.

[0449] In this test, the following compounds of the invention showed 90% to 100% efficacy at an active ingredient concentration of 500 ppm: I.003; I.006; I.007; I.008; I.014; I.015; I.016; I.021; I.023; I.031; I.032; I.039; I.040; I.041; I.042; I.043; I.044; I.045; I.047; I.048 9; I.056; I.057; I.058; I.060; I.070; I.071; I.072; I.076; I.077; I.078; I.079; I.080; I.081; I. 083; I.095; I.099; I.101; I.108; I.122; I.127; I.128; I.131; I.132; I.133; I.136; I.137; I.173.

[0450] In this test, the following compounds of the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 31 ppm: 1.008; 1.021; 1.038; 1.070; 1.071; 1.108; 1.133; 1.137; 1.173; 1.176.

[0451] In this test, the following compounds of the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 31 ppm: 1.001; 1.002; 1.006; 1.023; 1.032; 1.077; 1.078; 1.079; 1.081; 1.095; 1.101; 1.131; 1.132; 1.136.

[0452] In this test, the following compounds of the present invention showed an efficacy of 90% to 100% at an active ingredient concentration of 31 ppm: 1.014; 1.015; 1.016; 1.039; 1.042; 1.043; 1.044; 1.045; 1.047; 1.049; 1.060; 1.083; 1.099; 1.122; 1.162; 1.164; 1.165; 1.167; 1.171; 1.172; 1.175.

[0453] In this test, the following compounds of the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 125 ppm: 1.022; 1.033; 1.035; 1.108; 1.110; 1.163.

[0454] In this test, the following compounds of the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 125 ppm: 1.003; 1.056; 1.071; 1.072; 1.101; 1.132.

[0455] In this test, the following compounds of the invention showed 90% to 100% efficacy at an active ingredient concentration of 125 ppm: I.006; I.008; I.014; I.015; I.016; I.021; I.023; I.031; I.032; I.039; I.041; I.042; I.043; I.044; I.045; I.047; I.049; I.060; I.070; I.071 6;I.077;I.078;I.079;I.080;I.081;I.083;I.095;I.098;I.099;I.115;I.122;I.127;I.128;I. 131; I.133; I.136; I.137; I.162; I.164; I.165; I.167; I.171; I.172; I.173; I.174; I.175; I.176.

[0456] Example D: Xanthomonas campestris pv. In vivo prevention test of Pv. campestris (cabbage black rot)

[0457] By acetone / dimethyl sulfoxide / The active ingredients to be tested were prepared by homogenizing a mixture of 1% ethanol and then diluting with water to obtain the desired concentration of active material.

[0458] Cabbage seedlings were treated by spraying with the active ingredient prepared as described above. Control plants were treated with acetone / DMSO / of aqueous solution treatment.

[0459] After 72 hours, the plants were infected by spraying the leaves with an aqueous bacterial suspension of Xanthomonas campestris pv. brassicae. The infected cabbage plants were incubated at 27°C and 95% relative humidity for 8 or 10 days.

[0460] The tests are evaluated 8 or 10 days after inoculation. 0% indicates an efficacy which corresponds to the control plants, while an efficacy of 100% means that no disease is observed.

[0461] In this test, the following compounds of the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 500 ppm: 1.023.

[0462] In this test, the following compounds of the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 500 ppm: 1.006; 1.034; 1.049; 1.060; 1.127.

[0463] In this test, the following compounds of the invention showed an efficacy of 90% to 100% at an active ingredient concentration of 500 ppm: 1.032; 1.080; 1.095; 1.097; 1.122; 1.137.

[0464] In this test, the following compounds of the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 31 ppm: 1.033; 1.039; 1.044; 1.070; 1.076; 1.078; 1.079; 1.080; 1.095; 1.167; 1.175.

[0465] In this test, the following compounds of the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 31 ppm: 1.049; 1.077; 1.081; 1.127; 1.164; 1.172.

[0466] In this test, the following compounds according to the invention showed an efficacy of 90% to 100% at an active ingredient concentration of 31 ppm: 1.032; 1.122.

[0467] In this test, the following compounds of the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 125 ppm: 1.033; 1.039; 1.060; 1.071; 1.171; 1.174.

[0468] In this test, the following compounds of the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 125 ppm: 1.009; 1.023; 1.035; 1.042; 1.044; 1.047; 1.070; 1.077; 1.080; 1.173; 1.175.

[0469] In this test, the following compounds of the invention showed an efficacy of 90% to 100% at an active ingredient concentration of 125 ppm: 1.032; 1.081; 1.095; 1.122; 1.127; 1.137.

[0470] Example E: In vivo prevention test of Uromvces appendiculatus (bean rust)

[0471] By acetone / dimethyl sulfoxide / The active ingredients to be tested were prepared by homogenizing a mixture of 1% ethanol and then diluting with water to obtain the desired concentration of active material.

[0472] Young bean plants were treated by spraying with the active ingredient prepared as described above. Control plants were treated with acetone / DMSO / of aqueous solution treatment.

[0473] After 72 hours, the plants were infected by spraying the leaves with an aqueous suspension of U. punctatus spores. The infected bean plants were incubated at 20°C and 100% relative humidity for 24 hours and then at 20°C and 70-80% relative humidity for 9 days.

[0474] The test is evaluated 10 days after inoculation. 0% indicates an efficacy which corresponds to the control plants, while an efficacy of 100% means that no disease is observed.

[0475] In this test, the following compounds of the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 500 ppm: 1.010; 1.013; 1.022; 1.031; 1.038.

[0476] In this test, the following compounds of the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 500 ppm: 1.007; 1.016; 1.021; 1.035; 1.039; 1.049; 1.078; 1.079.

[0477] In this test, the following compounds of the invention showed 90% to 100% efficacy at an active ingredient concentration of 500 ppm: I.003; I.005; I.006; I.008; I.009; I.014; I.015; I.032; I.033; I.034; I.042; I.043; I.044; I.045; I.047; I.060; I.061; I.062; I.063; I.064; I.065; I.066; I.067; I.068; I.070; I.071; I.072; I.073; I.074; I.075; I.076; I.077; I.078; I.079; I.080; I.081; I.08 .070; I.071; I.072; I.076; I.077; I.080; I.081; I.083; I.095; I.097; I.099; I.101; I.108; I.122; I.127; I.128; I.131; I.132; I.133; I.134; I.136; I.137; I.168; I.173.

[0478] In this test, the following compounds according to the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 31 ppm: 1.013; 1.049; 1.077.

[0479] In this test, the following compounds of the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 31 ppm: 1.009; 1.042; 1.047; 1.095; 1.171.

[0480] In this test, the following compounds of the present invention showed an efficacy of 90% to 100% at an active ingredient concentration of 31 ppm: 1.006; 1.014; 1.015; 1.016; 1.032; 1.044; 1.060; 1.083; 1.132; 1.133; 1.136; 1.163; 1.164; 1.165; 1.167; 1.174; 1.176.

[0481] In this test, the following compounds according to the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 125 ppm: I.175.

[0482] In this test, the following compounds of the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 125 ppm: 1.006; 1.009; 1.013; 1.035; 1.043; 1.076; 1.173.

[0483] In this test, the following compounds of the invention showed an efficacy of 90% to 100% at an active ingredient concentration of 125 ppm: I.003; 3;I.095;I.099;I.108;I.110;I.115;I.127;I.131;I.132;I.133;I.136 ;I.137;I.162;I.163;I.164;I.165;I.167;I.171;I.172;I.174;I.176.

[0484] Example F: Pseudomonas syringae pv. Tomato (Tomato In vivo prevention test of bacterial plaque

[0485] By acetone / dimethyl sulfoxide / The active ingredients to be tested were prepared by homogenizing a mixture of 1% ethanol and then diluting with water to obtain the desired concentration of active material.

[0486] Tomato seedlings were treated by spraying with the active ingredient prepared as described above. Control plants were treated only with acetone / DMSO / of aqueous solution treatment.

[0487] After 72 hours, the plants were infected by spraying the leaves with an aqueous bacterial suspension of Pseudomonas syringae pv. tomato. The infected tomato plants were incubated for 4 days in a saturated atmosphere of 22°C day / 20°C night-70% HR, and then for 1 or 2 days at 22°C day / 20°C night and 70-80% relative humidity.

[0488] The tests are evaluated 5 or 6 days after inoculation. 0% indicates an efficacy which corresponds to the control plants, while an efficacy of 100% means that no disease is observed.

[0489] In this test, the following compounds of the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 500 ppm: 1.032; 1.042; 1.059; 1.060; 1.079; 1.080; 1.101; 1.108; 1.127; 1.128; 1.137.

[0490] In this test, the following compounds of the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 500 ppm: 1.058; 1.077; 1.078; 1.095; 1.122.

[0491] In this test, the following compounds according to the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 31 ppm: 1.047; 1.099; 1.122.

[0492] In this test, the following compounds of the invention showed an efficacy of 70% to 79% at an active ingredient concentration of 125 ppm: 1.042; 1.081; 1.083; 1.095; 1.176.

[0493] In this test, the following compounds according to the invention showed an efficacy of 80% to 89% at an active ingredient concentration of 125 ppm: 1.099; 1.115; 1.122; 1.165; 1.167.

[0494] In this test, the following compounds according to the invention showed an efficacy of 90% to 100% at an active ingredient concentration of 125 ppm: 1.010; 1.047; 1.172.

[0495] Example G: Alternaria alternata in vitro cell assay

[0496] Solvent: DMSO

[0497] Medium: 14.6 g anhydrous D-glucose (VWR), 7.1 g mycopeptone (Oxoid), 1.4 g granulated yeast extract (Merck), QSP 1 liter

[0498] Inoculum: Spore suspension

[0499] The fungicides were dissolved in DMSO and this solution was used to prepare the desired concentration range. The final concentration of DMSO used in the assay was ≤ 1%.

[0500] A spore suspension of Alternaria alternifolia was prepared and diluted to the desired spore density.

[0501] The long-term ability of the fungus to suppress the growth of the fungus in liquid culture. As demand increases, compounds are added to the cultivation base containing the ingredients. After 5 days of culture, the toxicity of the compound fungi and the amount of light exposure over the life of the bacteria was determined. By increasing the absorbance in the pores of the fungi containing the fungi, the absorbance in the pores of the pores of the fungi not containing the fungi is determined to ensure long-term suppression of fungal growth.

[0502] During the trial, in this book, the active ingredient concentration of the lower class compound is 5ppm, and the direct activity (effectiveness is low or equal to 30%): I. 001;I.002;I.003;I.004;I.005;I.006;I.007;I.008;I.009; I.010; I.012; I.013; I.014; I.015; I.016; I.017; I.018; I.019; I.020; I.021; I.022; I.023; I.024; I.025; I.026; I.027; I.0 28;I.029;I.030;I.031;I.032;I.033;I.034;I.035;I.037;I.038;I.039;I.041;I.042;I.043;I.044;I.045;I.047;I.048 ;I.049;I.051;I.052;I.053;I.054;I.055;I.056;I.057;I.058;I.059;I.060;I.061;I.062;I.063;I.064;I.065;I.066;I. 067;I.068;I.069;I.070;I.071;I.072;I.073;I.074;I.075;I.076;I.077;I.078;I.079;I.080;I.081;I.082;I.083;I.08 4; I.085; I.086; I.087; I.088; I.089; I.090; I.091; I.092; I.093; I.094; I.095; I.097; I.098; I.101; .105;I.106;I.107;I.108;I.109;I.110;I.113;I.114;I.115;I.116;I.117;I.118;I.119;I.120;I.121;I.122;I.123;I.1 I.125; I.126; I.136; I.139; I.149; I.150; I.152; I.162; I.163; I.164; I.165; I.166; I.167; I.171; I.174; I.175; I.176.

[0503] In this test, the following compounds of the present invention did not show direct activity (efficacy less than or equal to 30%) at an active ingredient concentration of 20 ppm: I.002; I.003; I.004; I.005; I.006; I.007; I.008; I.009; I.010; I.012; I.014; I.016; I.017; I.018; I.019; I.020; I.022; I.023; I.024; I.025; I.027; I.029; I.030; I.031; I.032; I.033; I.034; I.038; I.039; I.041; I.042; I.043; I.045; I.047; I.048; I.051; I.052; I.053; I.054; I.055; I.056; I.057; I.058; I.059; I.060; I.061; I.062; I.063; I.064; I.065; I.066; I.067; I.068; I.069; I.070; I.071; I.072; I.074; I.075; I.076; I.077; I.078; I.080; I.081; I.082; I.083; I.084; I.085; I.086; I.087; I.089; I.091; I.092; I.093; I.094; I.095; I.098; I.102; I.103; I.104; I.105; I.106; I.107; I.108; I.110; I.114; I.115; I.118; I.119; I.120; I.122; I.123; I.124; I.125; I.136; I.139; I.152; I.162; I.164; I.165; I.167; I.171; I.174; I.175; I.176.

[0504] Example H: In vitro cell assay with Colletotrichum lindemuthianum

[0505] Solvent: DMSO

[0506] Culture medium: 14.6 g of anhydrous D-glucose (VWR), 7.1 g of fungal peptone (Oxoid),

[0507] 1.4 g of particulate yeast extract (Merck), QSP 1 liter

[0508] Inoculum: Spore suspension

[0509] The fungicide was dissolved in DMSO, and this solution was used to prepare the required concentration range. The final concentration of DMSO used in the test was ≤1%.

[0510] A spore suspension of Colletotrichum apiospermi was prepared and diluted to the desired spore density.

[0511] The ability of fungicides to inhibit spore germination and mycelial growth was evaluated in a liquid culture test. The desired concentration of the compound was added to the medium containing the spores. After 6 days of incubation, the fungal toxicity of the compound was determined by spectroscopic measurement of mycelial growth. Inhibition of fungal growth was determined by comparing the absorbance values ​​in the wells containing the fungicide with the absorbance values ​​in the control wells without the fungicide.

[0512] During the trial, in this book, the active ingredient concentration of the lower class compound is 5ppm, and the direct activity (effectiveness is low or 30%): I .003;I.004;I.005;I.006;I.007;I.008;I.009;I.012;I.01 3; I.014; I.015; I.016; I.017; I.018; I.019; I.020; I.021; I.022; I.023; I.024; I.025; I.026; I.027; I.029; I.030; I.03 1; I.032; I.033; I.034; I.035; I.036; I.037; I.038; I.039; I.041; I.042; I.043; I.044; I.045; 1; I.052; I.053; I.054; I.055; I.056; I.057; I.058; I.059; I.060; I.061; I.062; I.063; I.064; I.065; ;I.069;I.070;I.071;I.072;I.073;I.074;I.075;I.076;I.077;I.078;I.079;I.080;I.081;I.082;I.083;I.084;I.085 ;I.086;I.087;I.088;I.089;I.090;I.091;I.092;I.093;I.094;I.095;I.097;I.098;I.100;I.101;I.102;I.103;I.104 ;I.105;I.106;I.107;I.109;I.110;I.113;I.114;I.115;I.116;I.117;I.118;I.119;I.120;I.121;I.122;I.123;I.124 I.125; I.126; I.136; I.139; I.149; I.150; I.152; I.162; I.163; I.164; I.165; I.166; I.167; I.171; I.174;

[0513] In this test, the following compounds of the invention showed no direct activity (efficacy less than or equal to 30%) at an active ingredient concentration of 20 ppm: I.004; I.007; I.008; I.009; I.010; I.012; I.014; I.015; I.016; I.018; I.019; I.022; I.023; I.024; I.025; I.027; I.029; I.030; I.031; I.033; I.035; I.039; I.045; I.051; I.052; I.053; I.054; I.055; I. 058; I.059; I.060; I.061; I.062; I.063; I.064; I.065; I.066; I.067; I.068; I.069; I.07 0;I.071;I.072;I.073;I.074;I.075;I.076;I.077;I.078;I.079;I.080;I.081;I.082; I.084; I.085; I.087; I.088; I.090; I.091; I.092; I.093; I.094; I.095; I.097; I.098; I. 101;I.102;I.103;I.104;I.105;I.107;I.109;I.110;I.115;I.117;I.118;I.119;I.12 0;I.122;I.123;I.124;I.125;I.126;I.136;I.139;I.162;I.163;I.164;I.174;I.175.

[0514] Example I: Xanthomonas campestris pv. pv.Campestris) in vitro cell test

[0515] Solvent: DMSO

[0516] Culture medium: LB broth (Luria Broth Miller) Sigma

[0517] Inoculum: Bacterial suspension

[0518] Compounds were dissolved in DMSO and this solution was used to prepare the desired concentration range. The final concentration of DMSO used in the assay was ≤ 1%.

[0519] Inoculum was prepared from a bacterial preculture grown in liquid medium and diluted to the desired optical density (OD).

[0520] The ability of compounds to inhibit bacterial growth was evaluated in a liquid culture assay. The desired concentration of the compound was added to a culture medium containing a bacterial suspension. After 24 hours of incubation, the efficacy of the compound was determined by spectroscopic measurement of bacterial growth. Inhibition was determined by comparing the absorbance values ​​in the wells containing the compound with the absorbance values ​​in the control wells without active ingredient.

[0521] During the trial, in this book, the active ingredient concentration of the lower class compounds is 5ppm, and the direct activity (effectiveness is as low as 30%): I.00 1;I.002;I.003;I.004;I.005;I.006;I.007;I.008;I.009;I.01 0; I.012; I.013; I.014; I.015; I.016; I.017; I.018; I.019; I.020; I.021; I.022; I.023; I.024; I.025; I.026; I.027; 9; I.030; I.031; I.032; I.033; I.034; I.035; I.036; I.037; I.038; I.039; I.040; I.041; I.042; I.043; 8; I.049; I.050; I.051; I.052; I.053; I.054; I.055; I.056; I.057; I.058; I.059; I.060; I.061; I.062; I.067; I.068; I.069; I.070; I.071; I.072; I.073; I.074; I.075; I.076; I.077; I.078; I.079; I.080; I.081; I.082; I.083; I.085; I.086; I.087; I.088; I.089; I.090; I.091; I.092; I.093; I.094; I.095; I.097; I.098; I.099; I.100; I.101; I.102; ;I.104;I.105;I.106;I.107;I.108;I.109;I.110;I.113;I.114;I.115;I.116;I.117;I.118;I.119;I.120;I.121;I.122;I.123 I.124; I.125; I.126; I.136; I.139; I.149; I.150; I.152; I.162; I.163; I.164; I.165;

[0522] During the test, the active ingredients in the lower class compounds in this book have a concentration of 20ppm and show direct activity (effectiveness is low or 30%): I. 001;I.002;I.003;I.004;I.005;I.006;I.007;I.008;I.009;I .010;I.012;I.014;I.015;I.016;I.017;I.018;I.019;I.020;I.021;I.022;I.023;I.024;I.025;I.026;I.027;I.028;I.029 ;I.030;I.031;I.033;I.034;I.035;I.036;I.037;I.038;I.039;I.040;I.041;I.042;I.043;I.044;I.045;I.047;I.048;I.0 49;I.050;I.051;I.052;I.053;I.054;I.055;I.056;I.057;I.058;I.059;I.060;I.061;I.062;I.063;I.064;I.065;I.066;I .067;I.068;I.069;I.070;I.071;I.072;I.073;I.074;I.075;I.076;I.077;I.078;I.079;I.080;I.081;I.082;I.083;I.084 ;I.085;I.086;I.087;I.088;I.089;I.090;I.091;I.092;I.093;I.094;I.095;I.097;I.098;I.100;I.101;I.102;I.103;I.1 04;I.105;I.106;I.107;I.108;I.109;I.110;I.113;I.114;I.115;I.116;I.117;I.118;I.119;I.120;I.121;I.122;I.123;I .124; I.125; I.126; I.136; I.139; I.149; I.150; I.152; I.162; I.163; I.164; I.165; Example J: Pseudomonas syrinuae pv. tomato pv.tomato) in vitro cell test

[0523] Melting agent: DMSO

[0524] Culture base: LB meat soup base (Luria Broth Miller) Sigma

[0525] Inoculum: Bacterial suspension

[0526] Compounds were dissolved in DMSO and this solution was used to prepare the desired concentration range. The final concentration of DMSO used in the assay was ≤ 1%.

[0527] Inoculum was prepared from a bacterial preculture grown in liquid medium and diluted to the desired optical density (OD).

[0528] The ability of compounds to inhibit bacterial growth was evaluated in a liquid culture assay. The desired concentration of the compound was added to a culture medium containing a bacterial suspension. After 24 hours of incubation, the efficacy of the compound was determined by spectroscopic measurement of bacterial growth. Inhibition was determined by comparing the absorbance values ​​in the wells containing the compound with the absorbance values ​​in the control wells without active ingredient.

[0529] During the trial, in this book, the active ingredient concentration of the lower class compound is 20ppm, and the direct activity (effectiveness is low or 30%): I.0 01;I.002;I.003;I.004;I.005;I.006;I.007;I.008;I.009;I.0 10;I.012;I.013;I.014;I.015;I.016;I.017;I.018;I.019;I.020;I.021;I.022;I.023;I.024;I.025;I.026;I.027;I.028;I.0 29;I.030;I.031;I.032;I.033;I.034;I.035;I.036;I.037;I.038;I.039;I.040;I.041;I.042;I.043;I.044;I.045;I.047;I.0 48; I.049; I.050; I.051; I.052; I.053; I.054; I.055; I.056; I.057; I.058; I.059; I.060; I.061; I.062; I.063; I.064; I.065; 6; I.067; I.068; I.069; I.070; I.071; I.072; I.073; I.074; I.075; I.076; I.077; I.078; I.079; I.080; 4; I.085; I.086; I.087; I.088; I.089; I.090; I.091; I.092; I.093; I.094; I.095; I.097; I.098; I.099; ;I.104;I.105;I.106;I.107;I.108;I.109;I.110;I.113;I.114;I.115;I.116;I.117;I.118;I.119;I.120;I.121;I.122;I.123 I.124; I.125; I.126; I.136; I.139; I.149; I.150; I.152; I.162; I.163; I.164; I.165;

[0530] Example K: Comparative Example

[0531] present Xanthomonas campestris pv. brassicae (cabbage black rot) During the physical examination, the compounds CMP1, CMP2, CMP3 and CMP4 were tested under homologous conditions as described in Example D.

[0532] Compounds CMP1, CMP2, CMP3 and CMP4 were prepared according to the teaching of WO2004 / 024692.

[0533] The results are shown in the following table.

[0534]

[0535] *Arithmetic mean of 2 tests

[0536] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP1.

[0537]

[0538] When tested at a concentration of 500 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 1. More specifically, at a concentration of 500 ppm, compounds I.080; I.137 showed at least 90% efficacy, while CMP 1 showed no efficacy at the same concentration.

[0539] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 1. More specifically, at a concentration of 31 ppm, compounds I.076; I.080 showed at least 70% efficacy, while CMP 1 showed 10% efficacy at the same concentration.

[0540] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP2.

[0541] When tested at a concentration of 500 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP2. More specifically, at a concentration of 500 ppm, compounds I.006; I.034 showed at least 80% efficacy, while CMP2 showed no efficacy at the same concentration.

[0542] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP2. More specifically, at a concentration of 31 ppm, compound I.077 showed at least 80% efficacy, while CMP2 showed no efficacy at the same concentration.

[0543] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP3.

[0544]

[0545]

[0546] When tested at a concentration of 500ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP3. More specifically, at a concentration of 500ppm, compounds I.060; I.095 showed at least 80% efficacy, while CMP3 showed no efficacy at the same concentration.

[0547] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP3. More specifically, at a concentration of 31 ppm, compounds I.070; I.095; I.175 showed at least 70% efficacy, while CMP3 showed less than 40% efficacy at the same concentration.

[0548] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP4.

[0549]

[0550] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP4. More specifically, at a concentration of 31 ppm, compounds I.078; I.081; I.079; I.122 showed at least 70% efficacy, while CMP4 showed no efficacy at the same concentration.

[0551] Example L: Comparative Example

[0552] exist Pseudomonas syringae pv. tomato (tomato bacterial spot) In an in vivo prevention assay, compounds CMP1 and CMP2 were tested under the same conditions as described in Example F.

[0553] Compounds CMP1 and CMP2 were prepared according to the teaching of WO2004 / 024692.

[0554] The results are shown in the following table.

[0555]

[0556] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP1.

[0557]

[0558] When tested at a concentration of 500 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 1. More specifically, at a concentration of 500 ppm, compounds I.080; I.137 showed at least 70% efficacy, while CMP 1 showed no efficacy at the same concentration.

[0559] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP2.

[0560]

[0561] When tested at a concentration of 500 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP2. More specifically, at a concentration of 500 ppm, compounds I.077; I.128 showed at least 70% efficacy, while CMP2 showed less than 40% efficacy at the same concentration.

[0562] Example M: ​​Comparative Example

[0563] exist Colletotrichum sphaerocephalus (Bean Anthracnose) In the in vivo prevention assay, compounds CMP2, CMP4, CMP5 and CMP6 were tested under the same conditions as described in Example B.

[0564] Compounds CMP2, CMP4, CMP5 and CMP6 were prepared according to the teaching of WO2004 / 024692.

[0565] The results are shown in the following table.

[0566]

[0567]

[0568]

[0569] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP2.

[0570]

[0571] When tested at a concentration of 500 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP2. More specifically, at a concentration of 500 ppm, compounds I.006; I.014; I.077; I.132 showed at least 70% efficacy, while CMP2 showed no efficacy at the same concentration.

[0572] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP2. More specifically, at a concentration of 125 ppm, compounds I.014; I.077 showed at least 80% efficacy, while CMP2 showed no efficacy at the same concentration.

[0573] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP4.

[0574]

[0575] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP4. More specifically, at a concentration of 125 ppm, compounds I.043; I.122; I.165 showed at least 80% efficacy, while CMP4 showed less than 40% efficacy at the same concentration.

[0576] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP4. More specifically, at a concentration of 31 ppm, compounds I.043; I.122; I.165 showed at least 70% efficacy, while CMP4 showed no efficacy at the same concentration.

[0577] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP5.

[0578]

[0579] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP5. More specifically, at a concentration of 125 ppm, compounds I.033; I.108 showed at least 80% efficacy, while CMP5 showed no efficacy at the same concentration.

[0580] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP6.

[0581]

[0582] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP6. More specifically, at a concentration of 31 ppm, compounds I.044; I.047 showed at least 80% efficacy, while CMP6 showed less than 40% efficacy at the same concentration.

[0583] Example N: Comparative Example

[0584] exist Uromvces appendiculatus (bean rust) In an in vivo prevention assay, compounds CMP2, CMP4 and CMP5 were tested under the same conditions as described in Example E.

[0585] Compounds CMP2, CMP4 and CMP5 were prepared according to the teaching of WO2004 / 024692.

[0586] The results are shown in the following table.

[0587]

[0588] *Arithmetic mean of 3 tests

[0589]

[0590] *Arithmetic mean of 2 tests

[0591] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP2.

[0592]

[0593] When tested at a concentration of 500ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP2. More specifically, at a concentration of 500ppm, compounds I.006; I.014; I.016; I.034; I.077; I.128; I.132 showed at least 80% efficacy, while CMP2 showed less than 30% efficacy at the same concentration.

[0594] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP2. More specifically, at a concentration of 31 ppm, compounds I.006; I.014; I.016; I.077; I.132 showed at least 70% efficacy, while CMP2 showed less than 40% efficacy at the same concentration.

[0595] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP5.

[0596]

[0597]

[0598] *Mixture of stereoisomers

[0599] When tested at a concentration of 500ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP5. More specifically, at a concentration of 500ppm, compounds I.003; I.005; I.015; I.032; I.033; I.035; I.101; I.131; I.136 showed at least 80% efficacy, while CMP5 showed less than 20% efficacy at the same concentration.

[0600] When tested at a concentration of 500ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP5. More specifically, at a concentration of 31ppm, compounds I.015; I.032; I.136 showed at least 90% efficacy, while CMP5 showed no efficacy at the same concentration.

[0601] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP4.

[0602]

[0603] When tested at a concentration of 500 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP4. More specifically, at a concentration of 31 ppm, compounds I.165; I.171; I.176 showed at least 80% efficacy, while CMP4 showed less than 40% efficacy at the same concentration.

[0604] Example O: Comparative Example

[0605] exist Parasitic mildew (Crucifer downy mildew) In the in vivo prevention assay, compounds CMP2, CMP3, CMP4, CMP5, CMP6 and CMP7 were tested under the same conditions as described in Example C.

[0606] Compounds CMP2, CMP3, CMP4, CMP5, CMP6 and CMP7 were prepared according to the teaching of WO2004 / 024692.

[0607] The results are shown in the following table.

[0608]

[0609]

[0610] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP3.

[0611]

[0612] When tested at a concentration of 500ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP3. More specifically, at a concentration of 500ppm, compounds I.060; I.070; I.095 showed at least 90% efficacy, while CMP3 showed no efficacy at the same concentration.

[0613] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP3. More specifically, at a concentration of 125 ppm, compounds I.060; I.070; I.095; I.174; I.175 showed at least 90% efficacy, while CMP3 showed no efficacy at the same concentration.

[0614] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP4.

[0615]

[0616] When tested at a concentration of 500 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP4. More specifically, at a concentration of 500 ppm, compounds I.043; I.078; I.079; I.081; I.122 showed at least 90% efficacy, while CMP4 showed no efficacy at the same concentration.

[0617] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP4. More specifically, at a concentration of 125 ppm, compounds I.043; I.078; I.079; I.081; I.122; I.165; I.171; I.176 showed at least 90% efficacy, while CMP4 showed no efficacy at the same concentration.

[0618] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP6.

[0619]

[0620] When tested at a concentration of 500ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP6. More specifically, at a concentration of 500ppm, compounds I.039; I.040; I.044; I.045; I.047; I.049 showed at least 90% efficacy, while CMP6 showed no efficacy at the same concentration.

[0621] When tested at a concentration of 500ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP6. More specifically, at a concentration of 500ppm, compounds I.039; I.040; I.044; I.045; I.047; I.049; I.164 showed at least 90% efficacy, while CMP6 showed no efficacy at the same concentration.

[0622] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP7.

[0623]

[0624] When tested at a concentration of 500 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP7. More specifically, at a concentration of 500 ppm, compounds I.133; I.134 showed at least 80% efficacy, while CMP7 showed no efficacy at the same concentration.

[0625] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP2.

[0626]

[0627] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP2. More specifically, at a concentration of 125 ppm, compounds I.006; I.014; I.016; I.077; I.128; I.132 showed at least 80% efficacy, while CMP2 showed less than 30% efficacy at the same concentration.

[0628] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP5.

[0629]

[0630] *Mixture of stereoisomers

[0631] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP5. More specifically, at a concentration of 125 ppm, compounds I.003; I.015; I.032; I.033; I.035; I.101; I.131; I.136 showed at least 70% efficacy, while CMP5 showed less than 40% efficacy at the same concentration.

[0632] Example P: Comparative Example

[0633] exist Xanthomonas campestris pv. brassicae (cabbage black rot) In the in vivo prevention assay, compounds CMP8, CMP9 and CMP10 were tested under the same conditions as described in Example D.

[0634] Compounds CMP8, CMP9 and CMP10 were prepared according to the teaching of EP0450355.

[0635] The results are shown in the following table.

[0636]

[0637]

[0638] *Arithmetic mean of 2 tests

[0639] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP8.

[0640]

[0641] When tested at a concentration of 500 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP8. More specifically, at a concentration of 500 ppm, compound I.080 showed at least 90% efficacy, while CMP8 showed less than 10% efficacy at the same concentration.

[0642] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP9.

[0643]

[0644] When tested at a concentration of 500 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP9. More specifically, at a concentration of 500 ppm, compound I.095 showed at least 90% efficacy, while CMP9 showed no efficacy at the same concentration.

[0645] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP9. More specifically, at a concentration of 31 ppm, compound I.095 showed at least 70% efficacy, while CMP9 showed less than 20% efficacy at the same concentration.

[0646] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP10.

[0647]

[0648] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 10. More specifically, at a concentration of 31 ppm, compound I.032 showed at least 90% efficacy, while CMP 10 showed less than 30% efficacy at the same concentration.

[0649] Example Q: Comparative Example

[0650] exist Pseudomonas syringae pv. tomato (tomato bacterial spot) In an in vivo prevention assay, compounds CMP9, CMP11 and CMP12 were tested under the same conditions as described in Example F.

[0651] Compounds CMP9, CMP11 and CMP12 were prepared according to the teaching of WO2004 / 024692.

[0652] The results are shown in the following table.

[0653]

[0654] *Arithmetic mean of 2 tests

[0655]

[0656] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP9.

[0657]

[0658] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP9. More specifically, at a concentration of 125 ppm, compound I.095 showed at least 70% efficacy, while CMP10 showed less than 40% efficacy at the same concentration.

[0659] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP11.

[0660]

[0661] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 11. More specifically, at a concentration of 125 ppm, compound I.083 showed at least 70% efficacy, while CMP 11 showed less than 10% efficacy at the same concentration.

[0662] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP12.

[0663]

[0664] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 12. More specifically, at a concentration of 31 ppm, compound I.122 showed at least 70% efficacy, while CMP 12 showed 10% efficacy at the same concentration.

[0665] Example R: Comparative Example

[0666] exist Uromvces appendiculatus (bean rust) In an in vivo prevention assay, compounds CMP9 and CMP10 were tested under the same conditions as described in Example E.

[0667] Compounds CMP9 and CMP10 were prepared according to the teaching of WO2004 / 024692.

[0668] The results are shown in the following table.

[0669]

[0670] *Arithmetic mean of 2 tests

[0671]

[0672] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP9.

[0673]

[0674] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP9. More specifically, at a concentration of 125 ppm, compound I.095 showed at least 90% efficacy, while CMP9 showed less than 40% efficacy at the same concentration.

[0675] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP10.

[0676]

[0677] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 10. More specifically, at a concentration of 31 ppm, compound I.032 showed at least 90% efficacy, while CMP 10 showed no efficacy at the same concentration.

[0678] Example S: Comparative Example

[0679] exist Parasitic mildew (Crucifer downy mildew) In an in vivo prevention assay, compounds CMP10, CMP13, CMP14 and CMP15 were tested under the same conditions as described in Example C.

[0680] Compounds CMP10, CMP13, CMP14 and CMP15 were prepared according to the teaching of WO2004 / 024692.

[0681] The results are shown in the following table.

[0682]

[0683] *Arithmetic mean of 2 tests

[0684]

[0685] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP13.

[0686]

[0687] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 13. More specifically, at a concentration of 125 ppm, compound I.080 showed at least 90% efficacy, while CMP 13 showed no efficacy at the same concentration.

[0688] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP14.

[0689]

[0690] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 14. More specifically, at a concentration of 125 ppm, compound I.032 showed at least 90% efficacy, while CMP 14 showed no efficacy at the same concentration.

[0691] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 14. More specifically, at a concentration of 31 ppm, compound I.032 showed at least 80% efficacy, while CMP 14 showed no efficacy at the same concentration.

[0692] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP15.

[0693]

[0694] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 15. More specifically, at a concentration of 125 ppm, compound I.056 showed at least 80% efficacy, while CMP 15 showed less than 30% efficacy at the same concentration.

[0695] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP10.

[0696]

[0697] When tested at a concentration of 31 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 10. More specifically, at a concentration of 31 ppm, compound I.032 showed at least 80% efficacy, while CMP 10 showed less than 30% efficacy at the same concentration.

[0698] Example T: Comparative Example

[0699] exist Colletotrichum sphaerocephalus (Bean Anthracnose) In an in vivo prevention assay, compounds CMP9, CMP12 and CMP16 were tested under the same conditions as described in Example B.

[0700] Compounds CMP9, CMP12 and CMP16 were prepared according to the teaching of WO2004 / 024692.

[0701] The results are shown in the following table.

[0702]

[0703]

[0704] *Arithmetic mean of 2 tests

[0705] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP16.

[0706]

[0707] When tested at a concentration of 500 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 16. More specifically, at a concentration of 500 ppm, compound I.136 showed at least 80% efficacy, while CMP 15 showed less than 40% efficacy at the same concentration.

[0708] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP9.

[0709]

[0710] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP9. More specifically, at a concentration of 125 ppm, compound I.095 showed at least 70% efficacy, while CMP9 showed 30% efficacy at the same concentration.

[0711] The compounds of formula (I) of the present invention in the following table show better efficacy than the structurally related compound CMP12.

[0712]

[0713] When tested at a concentration of 125 ppm, the compounds of formula (I) of the present invention showed better efficacy than the structurally related compound CMP 12. More specifically, at a concentration of 125 ppm, compound I.122 showed at least 70% efficacy, while CMP 12 showed less than 20% efficacy at the same concentration.

Claims

1. Compound of formula (I): in R 1 and R 2 the same, and either chlorine or bromine; R 3 It is methyl; R 4 and R 5 independently selected from hydrogen, cyano, C1-C6-alkyl, C1-C6-hydroxyalkyl, C1-C6-alkoxy, C1-C6-haloalkyl, C3-C6-carbocycle, -C(=O)-OH, -C(=O)-O-C1-C6-alkyl, phenyl, -C1-C6-alkyl-C3-C6-carbocycle, -C1-C6-alkyl-SC(=O)-C1-C6-alkyl, -C1-C6- -C1-C6-alkyl-C(=O)-NH2, -C1-C6-alkyl-C(=O)-OH, -C1-C6-alkyl-C(=O)-O-C1-C6-alkyl, -C1-C6-alkyl-NH-C(=NH)-NH2, -C1-C6-alkyl-SC(=O)-NH(C1-C6-alkyl), -C1-C6-alkyl-SC(=S)-NH(C1-C6-alkyl), or R 4 and R 5 Together with the carbon atoms to which they are attached, they form a C3-C6-carbocyclic ring or a 3- to 6-membered heterocyclic ring, wherein the C3-C6-carbocyclic ring and the 3- to 6-membered heterocyclic ring may be replaced by one or more R x Substituent substitution, where R x independently selected from the group consisting of halogen, C2-C8-alkenyl; R 6 and R 7 are independently selected from hydrogen; or R 6 and R 7 Together with the carbon atoms to which they are attached they form a C3-C6-carbocycle; n is 0 or 1; W is oxygen or sulfur; Y is NR 8 , R 8 is hydrogen, C1-C6-alkyl, C1-C6-alkoxy or C3-C6-carbocycle; Z is selected from cyano, -C(=O)-OR a 、-C(=O)-SR a 、-C(=O)-NR b R c , where R a is selected from hydrogen, C1-C6-alkyl, C3-C8-cycloalkyl, benzyl, -C1-C6-alkyl-C3-C8-cycloalkyl, or R a Can be used with R 4 Together with the atoms to which they are attached, they form a 4- to 7-membered heterocyclic ring, R b and R c are independently selected from hydrogen, C1-C6-alkyl, hydroxyl, or R b Can be used with R 4 Together with the atoms to which they are attached, they form a 4- to 7-membered heterocyclic ring; with the proviso that ethyl {[(4,5-dibromo-3-methyl-2-thienyl)carbonyl]amino}(phenyl)acetate and ethyl {[(4,5-dichloro-3-methyl-2-thienyl)carbonyl]amino}(phenyl)acetate were excluded.

2. The compound according to claim 1, wherein R 1 and R 2 is chlorine, R 3 It's methyl.

3. The compound according to claim 1, wherein R 1 and R 2 is bromine, R 3 It's methyl.

4. A compound according to any one of claims 1 to 3, wherein R 4 and R 5 are independently selected from hydrogen, C1-C6-alkyl, C1-C6-hydroxyalkyl, C3-C6-carbocycle, phenyl, -C1-C6-alkyl-C3-C6-carbocycle, C1-C6-alkyl-O-(C=O)-C1-C6-alkyl, -C1-C6-alkyl-C(=O)-OH; or R 4 and R 5 Together with the carbon atoms to which they are attached, they form a C3-C6 carbocyclic ring or a 3- to 6-membered heterocyclic ring, wherein the C3-C6-carbocyclic ring and the 3- to 6-membered heterocyclic ring may be replaced by one or more R x Substituent substitution.

5. The compound according to any one of claims 1 to 3, wherein W is oxygen.

6. A compound according to any one of claims 1 to 3, wherein Y is NR 8 And R 8 It's hydrogen.

7. The compound according to any one of claims 1 to 3, wherein Z is -C(=O)-OR a .

8. A composition comprising at least one compound of formula (I) according to any one of claims 1 to 7 and at least one agriculturally suitable adjuvant.

9. A method for controlling bacteria and / or bacterial diseases in plants, comprising the step of applying at least one compound of formula (I) according to any one of claims 1 to 7 or a composition according to claim 8 to plants, or soil in which plants grow.

10. The method of claim 9, wherein the plant is a plant part.

11. The method of claim 10, wherein the plant part is a seed or a fruit.

12. Use of a compound according to any one of claims 1 to 7 or a composition according to claim 8 for controlling bacterial and / or fungal diseases on plants.

13. The use according to claim 12, wherein the plant is a plant part.

Citation Information

Patent Citations

  • N-benz-3-substituted amino pyrazoles compounds with insecticidal activity

    CN101337937A

  • Nitrogen heterocyclic ring dichlorin allyl ether compounds with insecticidal activity

    CN101337940A

  • Preparation and use of compound having insecticidal activity

    CN101715774A

  • N-substituted dioxazine compound as well as preparation method and application thereof

    CN102391261A

  • Thiobenzamide compounds and application thereof

    CN103109816A